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Abstract 
Melanin synthesis is required for proper development and function of the visual system and for protection 
against ultraviolet radiation. Defects in melanin synthesis result in albinism, which is characterized by 
visual defects and increased skin cancer risk. Melanin is synthesized in pigment cells within specialized 
subcellular organelles called melanosomes. Some forms of albinism result from defects in melanosome 
maturation, but the underlying molecular mechanisms are incompletely understood. Melanosome 
maturation requires the trafficking of melanogenic cargoes to melanosome precursors and an increase in 
melanosome pH, thereby supporting activity of the enzyme tyrosinase to promote melanin synthesis. In 
this work, we investigate melanosome biogenesis and maturation in melanocytes derived from mouse 
models of two forms of albinism, (1) oculocutaneous albinism type 4 (OCA4) due to loss of function of 
SLC45A2, and (2) the Hermansky-Pudlak syndrome mouse model buff that has a missense mutation in 
VPS33A. (1) Here we show that SLC45A2, a putative sugar/proton symporter, localizes to melanosomes 
and increases organellar pH at its sites of localization. Further, we show that SLC45A2 likely functions at 
a later stage of melanosome maturation than the ion channel OCA2, which is also necessary to raise 
melanosomal pH and is defective in another subtype of OCA. Additionally, we show that a common 
SLC45A2-L374F variant associated with lighter pigmentation in humans is degraded more rapidly than the 
dark skin-associated L374 variant, indicating that decreased pigmentation reflects reduced proton export 
from melanosomes. (2) VPS33A, an SM protein that mediates fusion, is required in the endolysosomal 
and autophagosomal pathways, but whether it plays a direct role in melanosomal trafficking is unknown. 
Contrary to a previous report, we show that a VPS33A-D251E mutation in melan-bf cells does not prohibit 
pigmentation; instead, buff melanocytes cells contain enlarged, mature melanosomes despite partial 
mistrafficking of the mature melanosomal marker TYRP1. Replacement of wild-type VPS33A in wild-type 
melanocytes by VPS33A-D251E does not phenocopy buff melanocytes, suggesting that an additional 
mutation may be responsible for our observed buff phenotype. Our analyses of mouse albinism models 
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NOVEL INSIGHTS INTO THE CELLULAR BASIS OF PIGMENTATION USING 
MOUSE MODELS OF ALBINISM 
Linh Le 
Michael S. Marks 
 
Melanin synthesis is required for proper development and function of the visual 
system and for protection against ultraviolet radiation. Defects in melanin synthesis result 
in albinism, which is characterized by visual defects and increased skin cancer risk. 
Melanin is synthesized in pigment cells within specialized subcellular organelles called 
melanosomes. Some forms of albinism result from defects in melanosome maturation, but 
the underlying molecular mechanisms are incompletely understood. Melanosome 
maturation requires the trafficking of melanogenic cargoes to melanosome precursors and 
an increase in melanosome pH, thereby supporting activity of the enzyme tyrosinase to 
promote melanin synthesis. In this work, we investigate melanosome biogenesis and 
maturation in melanocytes derived from mouse models of two forms of albinism, (1) 
oculocutaneous albinism type 4 (OCA4) due to loss of function of SLC45A2, and (2) the 
Hermansky-Pudlak syndrome mouse model buff that has a missense mutation in VPS33A. 
(1) Here we show that SLC45A2, a putative sugar/proton symporter, localizes to 
melanosomes and increases organellar pH at its sites of localization. Further, we show 
that SLC45A2 likely functions at a later stage of melanosome maturation than the ion 
channel OCA2, which is also necessary to raise melanosomal pH and is defective in 
another subtype of OCA.  Additionally, we show that a common SLC45A2-L374F variant 
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associated with lighter pigmentation in humans is degraded more rapidly than the dark 
skin-associated L374 variant, indicating that decreased pigmentation reflects reduced 
proton export from melanosomes. (2) VPS33A, an SM protein that mediates fusion, is 
required in the endolysosomal and autophagosomal pathways, but whether it plays a 
direct role in melanosomal trafficking is unknown. Contrary to a previous report, we show 
that a VPS33A-D251E mutation in melan-bf cells does not prohibit pigmentation; instead, 
buff melanocytes cells contain enlarged, mature melanosomes despite partial 
mistrafficking of the mature melanosomal marker TYRP1. Replacement of wild-type 
VPS33A in wild-type melanocytes by VPS33A-D251E does not phenocopy buff 
melanocytes, suggesting that an additional mutation may be responsible for our observed 
buff phenotype. Our analyses of mouse albinism models have thus yielded significant 








LIST OF FIGURES ....................................................................................................... XII 
LIST OF TABLES ....................................................................................................... XIV 
CHAPTER 1: INTRODUCTION ...................................................................................... 1 
1.1. Specialized cells generate melanin: Epidermal, follicular, and uveal melanocytes 
and pigmented epithelial cells ............................................................................ 1 
1.1.1. Epidermal melanocytes ............................................................................ 2 
1.1.2. Follicular melanocytes.............................................................................. 3 
1.1.3. Uveal melanocytes ................................................................................... 4 
1.1.4. Pigmented epithelial cells ......................................................................... 5 
1.2. Evolution of human pigmentation diversity ......................................................... 7 
1.2.1. UVR effects on metabolism ...................................................................... 7 
1.2.2. Melanin as a defense against UVR .......................................................... 9 
1.3. Melanin synthesis .............................................................................................12 
1.3.1. The TYR family of proteins ......................................................................15 
1.3.2. Melanin subtypes: Eumelanin and pheomelanin .....................................19 
1.3.3. The melanocortin-1 receptor ...................................................................21 
1.4. Melanosomes serve as the site for melanin synthesis and storage ...................24 
1.5. pH regulation of melanosomes .........................................................................29 
ix 
 
1.6. Cargo delivery: Trafficking to and from melanosomes .......................................36 
1.6.1. Function of AP-1 and AP-3 in sorting melanosomal cargo ......................38 
1.6.2. BLOC function in the tubulovesicular pathway ........................................39 
1.6.3. Fusion of transport intermediates with melanosomes ..............................40 
1.6.4. HOPS, VPS33A, and the buff mouse ......................................................42 
1.7. Molecular basis of albinism ...............................................................................45 
1.7.1. Non-syndromic albinism ..........................................................................47 
1.7.2. Syndromic albinism .................................................................................50 
1.8. Dissertation Aims ..............................................................................................54 
CHAPTER 2 ..................................................................................................................57 
2.1. Abstract ............................................................................................................58 
2.2. Introduction .......................................................................................................58 
2.3. Results..............................................................................................................63 
2.3.1. Functionality of HA-SLC45A2. .................................................................63 
2.3.2. HA-SLC45A2 localizes to the limiting membrane of pigmented 
melanosomes and is partially enriched in a membrane subdomain...................65 
2.3.3. SLC45A2 localizes to lysosomes and regulates lysosomal pH when 
ectopically expressed in HeLa cells. .................................................................67 
2.3.4. SLC45A2 and OCA2 function at distinct stages of melanosome 
maturation. ........................................................................................................69 
2.3.5. OCA2 overexpression partially compensates for loss of SLC45A2 
expression. .......................................................................................................74 
2.3.6. The light skin-associated SLC45A2-F374 variant protein is expressed 
at lower levels than the dark skin-associated SLC45A2-L374 variant. ..............76 
2.4. Discussion ........................................................................................................81 
x 
 
2.5. Acknowledgements ...........................................................................................86 
2.6. Materials and Methods ......................................................................................87 
CHAPTER 3 ..................................................................................................................97 
3.1. Abstract ............................................................................................................98 
3.2. Introduction .......................................................................................................99 
3.3. Results............................................................................................................ 103 
3.3.1. Homozygous Vps33abf allele in melan-bf cells. ..................................... 103 
3.3.2. Melan-bf cells are hyperpigmented and contain enlarged, mature 
melanosomes. ................................................................................................ 106 
3.3.3. Melan-bf melanosomes have an increase in intralumenal vesicles that 
correlates with their increased size. ................................................................ 109 
3.3.4. Melanosomal genes and proteins are decreased in melan-bf cells........ 111 
3.3.5. Pigment granules contain TYRP1 but a proportion of TYRP1 is present 
in a distinct compartment in melan-bf cells. ..................................................... 113 
3.3.6. The endocytic pathway is normally segregated from melanosomes in 
melan-bf cells. ................................................................................................ 117 
3.3.7. Knockdown of endogenous VPS33A and overexpression of human 
VPS33A does not replicate the melan-bf phenotype. ...................................... 119 
3.4. Discussion ...................................................................................................... 126 
3.5. Materials and Methods .................................................................................... 136 
CHAPTER 4: DISCUSSION ........................................................................................ 147 
4.1. Data Summary ................................................................................................ 147 
4.2. Future Directions ............................................................................................ 150 
4.2.1. Is there a functional role for SLC45A2 punctate structures? .................. 150 
xi 
 
4.2.2. How does SLC45A2 traffic to melanosomes? ....................................... 153 
4.2.3. What is the role of sugar in the melanosome? ...................................... 158 
4.2.4. How to further investigate the differences between SLC45A2 
localization and OCA2 localization on melanosomes? .................................... 160 
4.2.5. How to measure melanosomal pH? ...................................................... 163 
4.2.6. How do other ion transport proteins regulate melanosome pH and 
melanogenesis?.............................................................................................. 166 
4.2.7. How to investigate VPS33A functions in the melanosomal pathway? .... 170 
4.2.8. How to assess GPR143 pathway in melan-bf cells? ............................. 173 
4.3. Concluding remarks ................................................................................. 174 
APPENDIX .................................................................................................................. 176 
Appendix A: VPS33A ............................................................................................. 176 
Appendix B: MELOPS ........................................................................................... 180 




LIST OF FIGURES 
Figure 1.1: Melanin synthesis pathway. .........................................................................13 
Figure 1.2: Ion transport channels in melanosome biogenesis ......................................31 
Figure 1.3: Trafficking pathways to melanosomes. ........................................................38 
Figure 2.1: HA-SLC45A2 functionally restores pigmentation in Slc45a2-deficient 
underwhite melanocytes. ...............................................................................................64 
Figure 2.2: HA-SLC45A2 localizes to melanosomes when expressed in SLC45A2-
deficient melan-uw melanocytes. ...................................................................................66 
Figure 2.3: HA-SLC45A2 localizes to melanosomes upon transient transfection in WT 
melanocytes. .................................................................................................................67 
Figure 2.4: HA-SLC45A2 expressed in HeLa cells localizes to lysosomes and 
neutralizes lysosomal pH. ..............................................................................................68 
Figure 2.5: SLC45A2 and OCA2 occupy partially distinct melanosome subsets. ...........71 
Figure 2.6: SLC45A2 is required for melanosomes to progress from stage III to stage 
IV ...................................................................................................................................73 
Figure 2.7: OCA2 overexpression compensates for loss of SLC45A2-dependent 
melanosome neutralization in melanocyte pigmentation. ...............................................75 
Figure 2.8: The human light skin-associated SLC45A2-F374 variant is expressed in 
melanosomes at lower levels than the dark variant........................................................77 
Figure 2.9: The F374 variant is less stable than the L374 variant and is degraded by a 
proteasome-dependent endolysosomal pathway. ..........................................................79 
Figure 2.10: Early phase of rapid SLC45A2-F374 degradation is blocked by vATPase 
inhibition. .......................................................................................................................80 
Figure 3.1: Melan-bf cells are homozygous for Vps33abf allele ................................... 105 
Figure 3.2: Melan-bf cells are hypopigmented and contain enlarged, mature 
melanosomes .............................................................................................................. 109 
Figure 3.3: Melan-bf cells contain increased ILVs per melanosome due to increased 
melanosome area ........................................................................................................ 111 
Figure 3.4: TYRP1 and VPS33A protein expression is decreased in melan-bf cells .... 113 
Figure 3.5: Most pigment granules contain TYRP1 but a majority of TYRP1 does not 
localize to pigment granules ........................................................................................ 116 
xiii 
 
Figure 3.6: The endocytic pathway is segregated from melanosomes in melan-bf cells
 .................................................................................................................................... 119 
Figure 3.7: Expression of VPS33A variants in Vps33a knockdown cells does not 
phenocopy melan-bf cells ............................................................................................ 125 
Figure 4.1. Model of SLC45A2 function in melanosome pH regulation ........................ 149 
Figure 4.2: Annotated human SLC45A2 amino acid sequence and aligned sequence 155 
Appendix Figure 1: Decreased expression of melanosomal genes and Vps33a in 
melan-bf cells .............................................................................................................. 176 
Appendix Figure 2: Low levels of LAMP2 colocalize to pigment granules .................... 177 
Appendix Figure 3: Overexpression of human VPS33A and knockdown of endogenous 
Vps33a does not phenocopy melan-bf cells at 14 days post-selection ........................ 178 
Appendix Figure 4: Overexpression of human WT VPS33A or variants does not 
phenocopy melan-bf cells ............................................................................................ 179 
Appendix Figure 5: MELOPS localizes to TYRP1-containing melanosomes ................ 181 
Appendix Figure 6: MELOPS indicates a low melanosome pH .................................... 182 
Appendix Figure 7: pH curve in LAMP1-GFP/MELOPS-expressing HeLa cells ........... 183 
Appendix Figure 8: MELOPS measurements of HA-OCA2 and HA-SLC45A2 effects 














LIST OF TABLES 
Table 1.1: Selected Ion transporters with known or putative effects on melanogenesis
 ......................................................................................................................................35 
Table 1.2: Non-syndromic Albinism ...............................................................................50 
























CHAPTER 1: INTRODUCTION 
Humans display a broad spectrum of pigmentation in the skin, hair, and eyes. 
Melanin, the major determinant of human pigmentation, serves a variety of purposes, 
including protection from DNA damage, protection from folate degradation, and a role in 
retinal development. Melanin is synthesized in melanosomes, specialized organelles 
generated in melanocytes and pigmented epithelial cells, primarily in the skin, hair and 
eyes. A complex network of genes and proteins coordinates melanin synthesis, storage, 
transport, transfer, and degradation, all of which influence the degree of pigmentation. 
Much of our understanding of these processes has come from studying pigmentation 
variants and defects in animal models, particularly in mice, rats, zebrafish, and drosophila. 
Approximately 130 genes have been identified that influence hair color in mice (Bennett 
and Lamoreux, 2003; Steingrimsson et al., 2006), making the mouse model system 
critically important for the identification and study of pigmentation genes. Despite this, our 
understanding of how many of these genes function in the establishment and maintenance 
of human pigmentation is relatively limited. Further investigation is required to better 
understand the basic cellular mechanisms underlying human pigmentation in both normal 
and disease states.  
 
1.1. Specialized cells generate melanin: Epidermal, follicular, and uveal 
melanocytes and pigmented epithelial cells 
In humans, melanin is produced by epidermal, follicular, and uveal melanocytes 
and pigmented epithelial cells. Melanoblasts, the undifferentiated precursor of 
melanocytes, arise from the neural crest and migrate to the epidermis and hair follicles, 
2 
 
where they give rise to epidermal melanocytes in the skin, melanocyte stem cells in the 
hair follicle bulge, and follicular melanocytes in the hair follicle (Vandamme and Berx, 
2019). Melanoblasts also migrate into the uvea, where they differentiate into uveal 
melanocytes of the choroid, the iris, and the ciliary body at 7-8 months gestation (Hu et 
al., 2008; Nickla and Wallman, 2010). Pigmented epithelial cells arise from the optic 
neuroepithelium and migrate to the posterior eye to form the retinal pigment epithelium 
(RPE), the iridial pigment epithelium, and the ciliary pigment epithelium, of which the RPE 
has been the most well studied (Hu et al., 2002). Both epidermal and follicular melanocytes 
transfer their melanosomes, the organelles that make and store melanin, to neighboring 
keratinocytes, thereby providing pigment to skin and hair. On the other hand, uveal 
melanocytes and pigmented epithelial cells retain their melanosomes. 
1.1.1. Epidermal melanocytes 
Epidermal melanocytes, sometimes called interfollicular melanocytes, are located 
at the basal layer of the epidermis adjacent to the basement membrane. Although 
melanocytes are relatively rare in the epidermis compared to other cells, primarily 
keratinocytes, they are the source of all pigmentation in the epidermis. Melanocytes 
accomplish this through their dendritic shape. Each melanocyte is estimated to contact 
and transfer melanin to 36 keratinocytes on average, forming the epidermal-melanin unit. 
While melanocytes remain on the basal layer of the epidermis, keratinocytes migrate 
upwards over the course of their lifetime, transporting pigment to the upper layers of the 
skin, where it can provide protection from ultraviolet radiation (UVR). Crosstalk between 
keratinocytes and melanocytes stimulates melanocyte proliferation, survival, 
melanogenesis, and melanin secretion (Weiner et al., 2014).  
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Diversity in human pigmentation is most apparent in human skin, which evidence 
suggests was under strong natural selection during human evolution and migration 
(Jablonski and Chaplin, 2017). In comparison, pigmentation in the eyes and hair do not 
seem to have been under natural selection in humans. The factors influencing skin 
pigmentation, particularly UVR, and the role of melanin in modulating UVR’s effect on skin 
and human health will be discussed in a later section.  
1.1.2. Follicular melanocytes 
In humans, hair growth occurs in an asynchronous and stochastic life cycle that 
can be categorized into four phases: anagen, the active growth phase of hair within a 
follicle; catagen, a transition phase during which time cells of the hair bulb undergo 
apoptosis and hair growth stops; telogen, when the hair shaft prepares to be shed; and 
neogen, when the dermal papilla reconnects with stem cells to generate a new hair and a 
new cycle can begin (Koch et al., 2020; Stenn and Paus, 2001). The timing of the hair 
cycle depends on the type and length of hair. Human scalp hairs are longer and thus have 
extended anagen phases that can last for years (Park et al., 2018). In contrast, shorter 
hairs such as eyelashes have short anagen phases that last only days (Paus et al., 2016).  
During anagen, melanocytes reside at the base of the hair follicle in the hair bulb 
where they can transfer melanosomes to keratinocytes that generate the hair shaft, 
providing pigment to the hair as it grows (Koch et al., 2020). During catagen, the follicular 
melanocytes undergo apoptosis; however, their population is replenished by the 
melanocyte stem cells in the hair bulge (Lin and Fisher, 2007; Vandamme and Berx, 
2019). Differentiated melanocytes migrate from the hair bulge to the hair bulb adjacent to 
the dermal papilla, a region of densely packed fibroblasts that determines hair shaft 
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diameter and length and anagen duration (Schneider et al., 2009). Thus, another round of 
pigmented hair growth can occur. 
A similar hair cycle occurs in other mammals, but the timing varies depending on 
the animal. In mice, for example, the hair cycles over weeks not years (Muller-Rover et 
al., 2001). Interestingly, the backs of mice do not contain epidermal melanocytes and the 
pigmentation of these regions of their skin is dependent on follicular melanocytes 
(Nishimura, 2011; Stenn and Paus, 2001). However, the hairless regions of mice, 
particularly the ears and tail, contain epidermal melanocytes that are often cultured and 
used in studies. Analyses of these melanocytes translate well to human epidermal 
melanocytes, making the obvious diversity in mouse coat colors and easily cultured 
immortalized mouse melanocytes a powerful system for studying pigmentation genes. 
1.1.3. Uveal melanocytes 
Whereas epidermal and follicular melanocytes have been studied extensively both 
in situ and in culture, the pigment producing cells of the eye, the biogenesis and turnover 
of their melanosomes, and the roles of ocular melanin are less well understood. The uvea 
is a layer of the eye that consists of the iris, the ciliary body, and the choroid (Hu et al., 
2008). The iris is the colored part of the eye and helps regulate the amount of light entering 
the eye. Melanocytes comprise about 65% of the iris stroma, and iris color is determined 
by the structure of melanosomes in the stroma, the quantity of melanin synthesized, and 
the ratio of eumelanin to pheomelanin (two types on melanin that will  be discussed in 
Chapter 1.3) (Eagle, 1988; Hu et al., 2008; Wakamatsu et al., 2008; Wilkerson et al., 
1996). Melanin in the iris and RPE plays a role in photoprotection, protecting the retina 
from excess light and from light reflection (d'Ischia et al., 2015). Uveal melanoma and age-
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related macular degeneration are both correlated with lower pigmentation of the iris, which 
is likely due to decreased UVR protection and potentially increased oxidative stress in the 
cases of high pheomelanin levels (Wakamatsu et al., 2008). The ciliary body is a structure 
containing melanocytes, muscle, connective tissue, and blood vessels and arteries and is 
located behind the iris. The ciliary body produces the aqueous humor and contracts to 
change the shape of the lens when the eye focuses (Delamere, 2005). Melanin generated 
by melanocytes in this tissue likely contributes to photoprotection but other roles have not 
been identified (Hu et al., 2008). The choroid is a vascular structure containing a network 
of arteries, veins, and capillaries, which serves this tissue’s primary function of supplying 
blood and oxygen to the outer retina (Nickla and Wallman, 2010). Surrounding this 
network are various cell types, including melanocytes, that comprise the stroma. Adjacent 
to this vascular layer of the choroid is the lamina fusca, which is composed of layers of 
compacted melanocytes and fibroblast-like cells (Nickla and Wallman, 2010). The role of 
melanocytes in the choroid is thought to be in light absorption and reactive oxygen species 
(ROS) scavenging to protect the vasculature (Nickla and Wallman, 2010; Peters et al., 
2006). While uveal melanocytes are not directly involved with vision, they are critically 
important for supporting and maintaining the ocular tissues that receive and transmit visual 
information; therefore, uveal melanocytes are necessary for normal vision.  
1.1.4. Pigmented epithelial cells 
The ocular pigment epithelium is comprised of the iris pigment epithelium, the 
ciliary pigment epithelium, and the RPE (Hu et al., 2002). Retinal pigment epithelial cells 
generate the retinal pigment epithelium, a monolayer adjacent to the photoreceptor layer 
in the eye (Hu et al., 2002). The RPE is important for ocular homeostasis and its functions 
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include phagocytosis of shed photoreceptors, operating as a blood-retinal barrier, and 
producing cytokines and growth factors (Hu et al., 2002). The RPE is densely pigmented 
and contains mostly eumelanin (Hu et al., 2002; Hu et al., 2008; Istrate et al., 2020). 
Melanogenesis in the RPE is mostly inactive after gestation, with the majority of melanin 
synthesis occurring early in fetal development and little to no melanin synthesis occurring 
in adult RPE cells (d'Ischia et al., 2015; Hu et al., 2008; Istrate et al., 2020).  
While retinal melanin is photoprotective and can absorb stray light, the RPE’s 
location at the posterior region of the eye suggests that this is a minor role. Likely a more 
important role for retinal melanin is in its antioxidant effects in reducing ROS and 
scavenging free radicals. The RPE accumulates lipofuscin over time, which is 
autofluorescent material associated with high oxidative stress that, in RPE cells, is thought 
to be a product of incomplete lysosomal digestion of shed photoreceptor fragments. 
Lipofuscin can generate ROS and free radicals which can be counterbalanced by melanin. 
Melanosomes in RPE cells may also closely interact with phagocytosed photoreceptors 
and lipofuscin-containing compartments. There is evidence that phagosomes and 
lipofuscin fuse with melanosomes (Kayatz et al., 2001; Schraermeyer and Heimann, 1999; 
Schraermeyer et al., 1999), and although the function of this process is unclear, it has 
been speculated that these fusion events occur in RPE in response to high oxidative stress 
of the cellular environment. 
Over time, the melanin content of RPE cells decreases and lipofuscin accumulates 
(Weiter et al., 1986), which may play a role in age-related macular degeneration (d'Ischia 
et al., 2015). While the RPE has been the most well studied tissues of the ocular pigment 
epithelium, it is likely that the iris pigment epithelium and ciliary pigment epithelium play 
similar roles in blocking stray light and UV and in antioxidant responses. Similar to uveal 
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melanocytes, ocular pigment epithelial cells are necessary for normal vision due to their 
protective effects on other ocular tissues. 
 
1.2. Evolution of human pigmentation diversity 
Human evolution from primates is marked by loss of the primate hair coat, which 
is hypothesized to occur due to natural selection to improve thermoregulation in the high 
temperature conditions in equatorial Africa (Jablonski and Chaplin, 2017). This loss of 
body hair left the exposed skin vulnerable to UVR. Genomic evidence indicates that the 
loss of body hair in humans coincided with a gain of dark, melanin-rich skin, which is 
thought to be a protective, adaptive response to high UVR (Jablonski, 2012; Jablonski and 
Chaplin, 2017, 2018; Lucock et al., 2017; Lucock et al., 2018b).  
1.2.1. UVR effects on metabolism 
UVR is comprised of UVA radiation (320-400 nm) and UVB radiation (290-320 nm) 
(Diffey, 2002). While UVA radiation is constant globally, UVB radiation varies according to 
latitude, season, and time of day; therefore, total UVR is highest at the equator and UVR 
is generally lower and seasonal outside of the equator due to decreased UVB radiation 
(Jablonski and Chaplin, 2010).  UVR has both beneficial and harmful effects on human 
health.  
UVB radiation stimulates the synthesis of vitamin D, a fat-soluble compound that 
is necessary for human reproduction and life (Jablonski and Chaplin, 2018). UVB initiates 
the conversion of 7-dehydrocholesterol (7-DHC) in the skin into pre-vitamin D3 which is 
subsequently converted to vitamin D3. Vitamin D3 enters the circulation and subsequently 
undergoes a series of hydroxylation reactions in the liver and kidney to form 1,25-
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dihydroxyvitamin D3 (calcitriol), a hormone that binds to vitamin D receptors on many 
tissues to promote pleiotropic effects and that has an essential role in calcium absorption 
and skeletal health (Lips, 2006; Norman, 2008). Although vitamin D3 can be obtained 
through some dietary sources, the major source of vitamin D3 in most humans is through 
UVB-mediated synthesis in the skin. This can be a concern in certain regions or 
populations as evidence indicates that the presence of melanin in skin reduces vitamin D 
synthesis (Armas et al., 2007; Enechukwu et al., 2019; Harris and Dawson-Hughes, 1998; 
Young et al., 2020), likely due to melanin’s role in preventing UV penetration through the 
skin.  
Conversely, both UVA and UVB promote folate degradation (Branda and Eaton, 
1978; Lucock et al., 2017) and depletion (Lucock et al., 2018a) in the skin and blood 
stream. Folates are a large group of vitamins that function as coenzymes or cosubstrates 
in reactions that transfer one-carbon units into biosynthetic pathways, including for nucleic 
acid and protein synthesis; thus, low folate levels are associated with neural tube defects 
and other developmental and degenerative disorders and have major impacts on human 
reproductive health and life (Lucock, 2000). Folate is photolabile and UVR is able to cleave 
folate between its C9 and N10 bond, resulting in irreversible loss of bioactivity, and to 
generate ROS that oxidize and inactivate folate derivatives (Off et al., 2005; Williams et 
al., 2012). UVR-induced DNA damage also depletes folate levels due to the need for 
nucleotide biosynthesis for DNA repair (Lucock, 2000).  
Exposure to UVR is the most significant environmental risk factor for the 
development of skin cancers – i.e. squamous cell carcinoma, basal cell carcinoma, and 
melanoma (Narayanan et al., 2010). UVR stimulation induces DNA damage in all cells of 
the epidermis both directly through pyrimidine dimer formation upon DNA absorption of 
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UVR and indirectly through the generation of  ROS (Narayanan et al., 2010; Valejo Coelho 
et al., 2016). Unrepaired DNA damage can be mutagenic, and mutations arising from 
pyrimidine dimer formation and other nucleotide changes that are hallmarks of UV-induced 
DNA damage can be found in several genes commonly mutated in skin cancers (Valejo 
Coelho et al., 2016). These include the tumor suppressor gene p53, genes encoding 
proteins in the Hedgehog signaling pathway, and PTEN, CDKN2A, and BRAF genes 
(Valejo Coelho et al., 2016).  
1.2.2. Melanin as a defense against UVR 
Melanin, a ubiquitous biological polymer that is the major determinant of 
pigmentation in humans, serves as the skin’s first line of defense against the harmful 
effects of UVR. There is a drastically lower incidence of skin cancer in darkly pigmented 
skin compared to lightly pigmented skin (Agbai et al., 2014; Gloster and Neal, 2006). 
Melanin protects its surrounding tissues by absorbing and scattering UVR, which limits 
UVR penetrance into the skin (Kaidbey et al., 1979). Melanin also acts as a ROS 
scavenger and decreases the indirect DNA damage done by UVA. Therefore, melanin 
acts as a natural sunscreen, and the photoprotective effects of melanin account for the 
different tolerances to sun exposure in lightly pigmented versus darkly pigmented humans. 
Skin color is highly correlated with UVR (Chaplin, 2004; Roberts and Kahlon, 
1976). It is hypothesized that positive selective pressures resulted in the initial gain in 
pigmentation after the loss of body hair and that negative selective pressures resulted in 
decreasing pigmentation as humans migrated away from Africa (Jablonski and Chaplin, 
2000). Regions along the equator, which have the highest UV index in the world, have the 
highest population of darkly pigmented humans, corresponding to the protective nature of 
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pigmentation against UV-induced folate degradation and DNA damage (Chaplin, 2004). 
As humans migrated from Africa and the high UV index along the equator, UVB availability 
decreased and individuals with darkly pigmented skin had reduced capacity to synthesize 
vitamin D; this therefore served as a positive selective pressure for decreased skin 
pigmentation in order to increase vitamin D photosynthesis. Conversely, hair color and 
eye color do not seem to be under strong natural selection but rather may have been 
influenced by sexual selection (Jablonski and Chaplin, 2017). 
Human skin color is a polygenic trait and is determined by a complex architecture 
of genetic loci; however, some gene variants are strongly associated with changes in skin 
pigmentation and several genes seem to have played major roles in the evolution of 
human skin pigmentation (Quillen et al., 2019). Genomic evidence indicates that the 
acquisition of dark, melanin rich skin correlated with functional constraints at the 
melanocortin 1 receptor (MC1R) locus, with an increase in synonymous variants 
compared to the nonsynonymous variants found in primates (Quillen et al., 2019). Outside 
of equatorial Africa, non-synonymous MC1R polymorphisms can be found throughout 
Europe and East Asia with differing frequencies of variant alleles in the two regions 
(Quillen et al., 2019), indicating that the requirement for MC1R signaling (which is a critical 
regulator of melanocyte biology and melanin synthesis and will be discussed in Chapter 
1.3.3) was relaxed outside of high UVR regions. There is evidence that depigmented skin 
evolved independently multiple times in human history, presumably to increase vitamin D 
synthesis capabilities. Many of the polymorphisms associated with lighter skin in Europe 
are distinct from those associated with lighter skin in East Asia (Hider et al., 2013; Izagirre 
et al., 2006; Lao et al., 2007; McEvoy et al., 2006; Myles et al., 2007; Norton et al., 2007). 
Genes that are associated with selection in European populations include SLC24A5, 
11 
 
SLC45A2, and tyrosinase (TYR), and genes associated with selection in East Asian 
populations include dopachrome tautomerase (DCT), ADAM17, ADAMT20, and 
tyrosinase-related protein 1 (TYRP1). Polymorphisms in OCA2 correlating with lighter skin 
pigmentation have been observed in both populations. Although these handful of genes 
have been identified in multiple studies as being important for the adaptive transition from 
darkly pigmented skin to lightly pigmented skin in European and East Asian populations, 
there is also much evidence that many other genes play roles in human pigmentation 
variation within populations (Crawford et al., 2017; Martin et al., 2017).  
The genetic regulation of pigmentation in African populations has been severely 
understudied. The majority of large analyses of pigmentation genetics have, until recently, 
focused on European and European-derived populations. Many older studies of human 
pigmentation used genetic analyses of Black Americans or Black Europeans to make 
broad claims about Africa. However, Africa is a diverse continent with both genetic and 
pigmentation diversity. Recent data suggest that regions of Africa also underwent 
depigmentation while others acquired increased pigmentation and identified the 
SLC24A5, SLC45A2, TYRP1, KITLG, and SNX13 loci (Martin et al., 2017) and MFSD12, 
TMEM138, and DDB1 (Crawford et al., 2017) as correlating with these changes in skin 
color. These identified genes only explained a small portion of the phenotypic variance 
observed in African regions and populations, indicating that much more work needs to be 
done.  
The study of human pigmentation is a multidisciplinary field involving the study of 
human evolution, genomes, and cell biology. Although many genes have been correlated 
with human pigmentation, their functional relevance is unclear and more work needs to be 
done to identify: (1) whether the proteins encoded by these genes influence pigmentation 
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or whether the correlation is merely due to gene linkage; (2) how these proteins influence 
pigmentation; and (3) how they coordinate with other proteins to accomplish this. The 
mouse model and its derived cells have proved useful tools for dissecting these questions. 
Indeed, studying coat color mutations in mice has yielded many insights into the genes 
that have roles in pigmentation, how those genes function, and how their variants 
modulate pigmentation (Bennett and Lamoreux, 2003; Nakamura et al., 2002; 
Steingrimsson et al., 2006).  In the Marks lab, we use mouse models to study the function 
of proteins that influence human pigmentation and that cause pathogenic changes when 
mutated. 
 
1.3. Melanin synthesis 
There are two types of melanins in humans – eumelanin and pheomelanin. 
Eumelanin comprises brown and black pigments and is composed of crosslinked 5,6-
dihydroxyindole (DHI),  5,6-dihydroxyindole-2-carboxylic acid (DHICA), and their oxidized 
forms (D'Alba and Shawkey, 2019) (Figure 1.1). The structure of eumelanin has not been 
completely resolved due to its insolubility. Attempts to study eumelanin structure have 
been made using synthetic melanin but the structures of the product vary because they 
are strongly dependent on reaction conditions and starting materials (D'Alba and 
Shawkey, 2019). Based on experiments using X-ray diffraction, atomic force microscopy, 
and scanning tunneling microscopy, the favored model of eumelanin structure proposes 
that four monomers comprising any combination of DHI, DHICA, or their oxidized forms 
are covalently linked to form a planar unit or protomolecule. These protomolecules are 
stacked vertically via noncovalent interactions to make eumelanin (Cheng et al., 1994a; 
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Cheng et al., 1994b; Clancy and Simon, 2001; Diaz et al., 2005; Gallas et al., 1999; 
Kaxiras et al., 2006; Liu and Simon, 2003a, b; Meng and Kaxiras, 2008a, b; Mondal et al., 
2018; Thathachari and Blois, 1969; Zajac et al., 1994). Pheomelanin comprises red and 
yellow pigments and is composed of benzothiazine intermediates (Ito and Wakamatsu, 
2003, 2008). Pheomelanin has been understudied compared to eumelanin. Currently, the 
only way to reliably quantify pheomelanin content in samples is by high-performance liquid 
chromatography (HPLC), which is done by  Shosuke Ito, PhD and Kazumasa Wakamatsu, 
PhD at Fujita Health University in Japan (Ito and Wakamatsu, 2003; Wakamatsu and Ito, 
2002).  
Figure 1.1: Melanin synthesis pathway. Tyrosinase (TYR) oxidizes tyrosine directly to 
dopaquinone. (Right) Dopaquinone in the presence of cysteine preferentially is converted to 
5-S-cysteinyldopa or 2-S-cysteinyldopa which undergo spontaneous rearrangements to forms 
cysteinyldopaquinone. Cysteinyldopaquinone undergoes a series of rearrangements to form 
benzothiazine intermediates and pheomelanin, which are red and yellow pigments. (Left) In 
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the absence of cysteine, dopaquinone spontaneously forms cyclodopa. Cyclodopa reacts with 
dopaquinone to form dopachrome. 3,4-dihydroxyphenylalanine (dopa) is a byproduct of this 
reaction and can be converted to dopaquinone by TYR. Dopachrome can spontaneously 
rearrange to form 5,6-dihydroxyindole (DHI) or can be oxidized by DCT to form  5,6-
dihydroxyindole-2-carboxylic acid (DHICA). DHI, DHICA, and their oxidized forms can 
crosslink to form eumelanin, which are black and brown pigments. TYR is the only enzyme in 
this pathway that is required for melanin synthesis. DCT modulates but is not required for 
eumelanin synthesis. The role of TYRP1 (not shown in the schematic) in the eumelanin 
synthesis pathway is unknown. Adapted from (Ito and Wakamatsu, 2008) . 
 
 
Aside from color and composition, a major difference between eumelanin and 
pheomelanin is in their reactions to UV radiation. While melanin as a whole is considered 
photoprotective, these properties can be attributed to eumelanin specifically, not 
pheomelanin. Eumelanin functions as a barrier against UVR to block its surrounding 
tissues (e.g. keratinocytes in the skin or ocular tissues in the eye) from UV penetration 
and it also actively scavenges free radicals to reduce ROS (Bustamante et al., 1993; 
Cesarini, 1988; Kobayashi et al., 1998a). Conversely, UV stimulation of pheomelanin 
generates ROS. UVR results in photolysis of pheomelanin to produce hydroxyl radicals 
and superoxide anions, which can cause DNA breaks (Cesarini, 1988; Chedekel et al., 
1980; Chedekel et al., 1978).  
Both eumelanin and pheomelanin require the enzyme tyrosinase (TYR) for the 
initial step of melanin synthesis (Fig 1.1) (Evans and Raper, 1937; Mason, 1948; Raper, 
1926, 1927; Raper and Speakman, 1926; Raper and Wormall, 1923; Solano, 2018). TYR 
catalyzes the oxidation of tyrosine to dopaquinone (Cooksey et al., 1997; Evans and 
Raper, 1937; Mason, 1948; Ramsden and Riley, 2014; Raper, 1926, 1927; Raper and 
Speakman, 1926; Raper and Wormall, 1923). Dopaquinone serves as the branch point 
for synthesis of either eumelanin or pheomelanin. In the presence of high amounts of 
cysteine, cysteinyldopaquinones, precursors to pheomelanin, are formed; in the absence 
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of excess cysteine, eumelanin is synthesized (Figure 1.1). All subsequent reactions from 
dopaquinone to eumelanin or from dopaquinone to pheomelanin can occur 
spontaneously. However, although other enzymes are not required for eumelanin 
synthesis, they may play roles in either stabilizing tyrosine or influencing the composition 
or chemical structure of eumelanin.  
Pathogenic mutations that prevent proper melanin synthesis cause albinism 
(discussed in more detail in Chapter 1.7), which is characterized by decreased 
pigmentation in skin, hair, and eyes and is associated with visual defects and increased 
risk for skin cancers (Montoliu et al., 2014).  By genetic analysis of individuals with albinism 
and by studying coat color mutations in mice, some of which are bona fide models of 
albinism, genes with proven and putative roles in the melanin synthesis pathway have 
been identified.  
1.3.1. The TYR family of proteins 
TYR, tyrosinase-related protein 1 (TYRP1), and dopachrome tautomerase (DCT 
a.k.a. TYRP2) comprise the tyrosinase family of enzymes, which all feature a cysteine-
rich domain, two metal-binding sites, a single transmembrane domain, and a short 
cytosolic C-terminal tail (Solano, 2018). TYR is the most well-characterized member of the 
family. It is a copper-binding enzyme, and binding two Cu2+ ions and an oxygen molecule 
allows it to function as an oxidative enzyme to convert tyrosine to dopaquinone (Ramsden 
and Riley, 2014; Solano, 2018). Mutations in any one member of the tyrosinase family of 
enzymes results in oculocutaneous albinism (OCA), a group of autosomal recessive 
disorders characterized by decreased melanin in the skin, hair, and eyes. Loss of TYR 
function in OCA type 1A results in severe hypopigmentation due its requirement for the 
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synthesis of both eumelanin and pheomelanin. Mutations in TYRP1 and DCT cause milder 
forms of OCA, suggesting that although they are not required for melanin synthesis, they 
have a role in modulating the pigmentary system (Boissy et al., 1996; Oetting and King, 
1994a, b; Pennamen et al., 2020b; Tomita et al., 1992). 
DCT is a zinc ion-binding enzyme and catalyzes the isomerization of dopachrome 
to DHICA. Its activity is therefore responsible for determining the ratio of DHICA to DHI, 
the latter of which is spontaneously formed from the decarboxylation of dopachrome 
(Olivares and Solano, 2009; Solano et al., 1996; Tsukamoto et al., 1992) (Fig 1.1). 
Experiments comparing eumelanin formed solely by DHI monomers and melanin formed 
solely by DHICA monomers determined that the antioxidant properties of eumelanin were 
due solely to the scavenging capabilities of DHICA; DHI is pro-oxidant alone but is 
neutralized when mixed with DHICA (Jiang et al., 2010). The authors also show that in 
Dct-/- mice, which have mild hypopigmentation compared to wild-type (WT) mice, chronic 
exposure to UVA resulted in increased ROS, sunburn, and cell death (Guyonneau et al., 
2004; Jiang et al., 2010). These data suggest that, while DCT is not required for eumelanin 
synthesis, it is important for determining the composition and antioxidant properties of the 
final eumelanin product.  
The role of TYRP1 is controversial and has been difficult to determine, potentially 
because of differing roles in humans and mice. Mice with loss-of-function mutations in 
Tyrp1 have a brown coat color as opposed to a black coat color, suggesting that TYRP1 
contributes to full and proper eumelanin synthesis. In mice, TYRP1 has been shown to 
catalyze the oxidation of DHICA, although TYRP1 in humans does not appear to have this 
function (Boissy et al., 1998; Jimenez-Cervantes et al., 1994; Kobayashi et al., 1994). 
Early studies of TYRP1 have also indicated that it may have tyrosine hydroxylase activity, 
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dopa oxidase activity, or hydroperoxidase activity; however, none of these results have 
been substantiated, which are possibly due to artifacts from TYR copurifying with TYRP1, 
and they would need to be repeated with purified human TYRP1 (Boissy et al., 1998; 
Halaban and Moellmann, 1990; Jimenez-Cervantes et al., 1993; Jimenez et al., 1991). 
The crystal structure of the intralumenal domain of human TYRP1 has recently been 
described and sheds some light on possible TYRP1 functions (Lai et al., 2017). While 
there has been controversy about whether TYRP1 binds copper, zinc, or iron, the crystal 
structure shows that human TYRP1’s metal binding site contains zinc ions, which lack 
redox activity, further supporting the model that human TYRP1 cannot function as an 
oxidative enzyme (Furumura et al., 1998; Lai et al., 2017; McCall et al., 2000; Williams, 
1987). Studies have also suggested that the main function of TYRP1 is to chaperone TYR. 
Orlow et al. showed by gel-filtration HPLC that a proportion of TYRP1, DCT, and TYR 
could be found in a high-molecular weight complex and confirmed this by 
immunoprecipitating TYRP1 or DCT and assaying the bound fraction for TYR activity 
(Orlow et al., 1994). Their data also show that TYR activity in the high molecular weight 
complex was decreased compared to monomeric TYR, suggesting a role for TYRP1 and 
DCT in regulating TYR activity (Orlow et al., 1994). Another group showed that in mouse 
cells lacking TYRP1, TYR was degraded more quickly than in WT cells and that this was 
rescued by expression of WT TYRP1 (Kobayashi et al., 1998b). Taken together, these 
data suggest a model where TYRP1 could form a complex with TYR and DCT to both 
regulate TYR activity and to protect TYR from degradation. However, the accuracy of this 
model has not been tested and several questions remain. (1) These studies were 
performed in mouse melanocytes with mouse TYRP1 and TYR, so are these results 
applicable to the human forms of the proteins? (2) Some evidence suggests that, whereas 
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TYRP1 is primarily localized to the limiting membrane (Raposo et al., 2001), TYR is 
partially localized to internal membranes (Theos et al., 2005). If this is the case, only the 
cohort of TYR at the membrane would interact with TYRP1, so what are the different 
functions, if any, of these two cohorts of TYR? (3) Additionally, is TYR degradation in the 
absence of TYRP1 due to loss of a specific interaction between the two proteins or is it 
because the system is not functional? For example, TYR is also less stable in several 
models where proteins in the pigmentary pathway are mutated (Chintala et al., 2005; 
Costin et al., 2003; Toyofuku et al., 2002). Researchers then concluded that these proteins 
have a direct role in TYR stabilization; however, further studies have failed to uncover 
direct interactions between these proteins and TYR. Rather, it is possible that these 
findings reflect sensitivity of TYR to degradation in the absence of melanin. Two groups 
have independently shown that loss of TYRP1 in human and mouse melanocytes causes 
cell death and that this was dependent on pigment production, suggesting that the 
synthesis of melanin itself in the absence of TYRP1 is cytotoxic (Johnson and Jackson, 
1992; Luo et al., 1994; Rad et al., 2004). Considering that DHI-melanin has prooxidant 
properties and that DHICA-melanin is an effective ROS scavenger, it is possible that 
TYRP1 plays a similar role as DCT and functions in the synthesis of DHICA or its 
downstream intermediates to prevent the formation of a toxic form of eumelanin. Although 
the role of TYRP1 is unclear, the fact that pathological mutations in the enzyme cause 
OCA3 in humans and coat color phenotypes in mice indicates that it modulates eumelanin 
synthesis in some way. 
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1.3.2. Melanin subtypes: Eumelanin and pheomelanin  
While eumelanin and pheomelanin are typically considered separately, overall 
human pigmentation is determined by the ratio of eumelanin to pheomelanin. In almost all 
humans, pigmentation is a product of mixed melanins consisting of both eumelanin and 
pheomelanin (Ito and Wakamatsu, 2003). Shosuke Ito and his colleagues have been at 
the forefront of pheomelanin research and have greatly contributed to our understanding 
of the synthesis of pheomelanin and its physiological relationship to eumelanin. Using 
HPLC, they analyze the degradation products of melanin and can therefore differentiate 
between and estimate eumelanin and pheomelanin in their samples (Prota, 1995; 
Wakamatsu and Ito, 2002). Specifically, they measure pyrrole-2,3,5-tricarboxylic acid 
(PTCA) and aminohydroxyphenylalanine (AHP), which are degraded from DHICA-derived 
eumelanin and from pheomelanin, respectively (Wakamatsu and Ito, 2002). Using this 
method, they and their colleagues have shown that human skin and hair contain both 
eumelanin and pheomelanin at various ratios, but that eumelanin is the predominant 
melanin type in human skin in most cases (Ito and Wakamatsu, 2003; Wakamatsu et al., 
2006).  
Studies of cultured human melanocytes show that, although both eumelanin and 
pheomelanin are present, eumelanin is more closely correlated with visible pigmentation. 
In one study rigorously comparing the visual phenotype (the observed pigmentation of the 
skin or of cultured cells by light microscopy), melanin content, and eumelanin and 
pheomelanin content of human skin and primary human melanocytes, the authors show 
that the ratio of eumelanin to pheomelanin widely varied in their samples and that 
eumelanin content correlated more with visual pigmentation (Wakamatsu et al., 2006). For 
example, skin and cultured melanocytes with a higher ratio of pheomelanin to eumelanin 
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could be more darkly pigmented than other samples if they contained more total 
eumelanin. If pheomelanin is toxic and only a determinant of pigmentation in rare cases 
(i.e. red hair), then why is it always present? The intrinsic reactive properties of 
dopaquinone, which can be converted to either a pheomelanin precursor or a eumelanin 
precursor, partially explain why eumelanin and pheomelanin are always found together. 
Dopaquinone is highly reactive and will preferentially form cysteinyldopa in the presence 
of cysteine, a reaction that occurs rapidly (Ito and Wakamatsu, 2008). Conversely, the 
conversion of dopaquinone to cyclodopa is much slower. Based on this, a model for mixed 
melanogenesis has been proposed: (1) dopaquinone is rapidly and preferentially 
converted to cysteinyldopa in the presence of cysteine and pheomelanin production 
occurs; (2) upon cysteine depletion, dopaquinone undergoes the relatively slower 
cyclization to cyclodopa and eumelanin production occurs (Ito and Wakamatsu, 2008; 
Wakamatsu et al., 2006). Additionally, the conversion rate of dopaquinone to cyclodopa 
is reduced in acidic pH; cyclodopa formation is reduced 100-fold when the pH decreases 
from 8.6 to 5.6 (Ito and Wakamatsu, 2008; Thompson et al., 1985). This means that, in 
acidic pH, dopaquinone is much less likely to form cyclodopa before cysteine can 
accumulate and react with dopaquinone to form cysteinyldopa. A low pH would also 
decrease TYR activity and therefore dopaquinone production, increasing the likelihood 
that pheomelanin would be synthesized in excess of eumelanin due to preferential 
conversion of dopaquinone to cysteinyldopa in the presence of cysteine (Ito and 
Wakamatsu, 2008). Indeed, increasing pH in melanocytes preferentially increases the 
production of eumelanin (Ancans et al., 2001b). 
Thus, the amounts of pheomelanin and eumelanin synthesized are dependent on 
cysteine availability for the preferential generation of pheomelanin and on pH for its effect 
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on (1) TYR activity and the generation of dopaquinone and (2) the rate of dopaquinone to 
cyclodopa conversion. If there is low TYR activity, low pH, and high cysteine availability, 
pheomelanin is likely to be the major melanin produced. If there is high TYR activity, high 
pH, and low cysteine availability, eumelanin is likely to be the major melanin produced. It 
is postulated that this stepwise generation of pheomelanin and eumelanin allows 
eumelanin to surround pheomelanin as it is being produced, creating a pheomelanin core 
encased by eumelanin and sequestering the prooxidant effects of pheomelanin (Ito and 
Wakamatsu, 2008).  
1.3.3. The melanocortin-1 receptor 
The melanocortin-1 receptor (MC1R) plays a major role in regulating eumelanin 
and pheomelanin synthesis and is a central component of the crosstalk between 
epidermal melanocytes and keratinocytes. Activation of this pathway stimulates 
eumelanogenesis while inhibition of this pathway stimulates pheomelanogenesis 
(Robbins et al., 1993). MC1R is a Gs-protein coupled receptor (GPCR) expressed on the 
surface of pigment producing cells (melanocytes and pigmented epithelial cells) (Chhajlani 
and Wikberg, 1992; Mountjoy et al., 1992). -melanocortin stimulating hormone (-MSH) 
and adrenocorticotropic hormone (ACTH) are MC1R agonists and are secreted by both 
melanocytes and keratinocytes for autocrine and paracrine signaling (De Luca et al., 1993; 
Donatien et al., 1992; Slominski et al., 2004). Activation of MC1R results in pleiotropic 
effects due to powerful downstream regulators and pathway crosstalk (Hemesath et al., 
1998; Herraiz et al., 2017). The major downstream pathway that mediates the most well-
characterized effects of MC1R activation involves classical GPCR signaling.  
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Ligand binding to MC1R induces a conformational change that induces the alpha 
subunit (Gs) of its associated heterotrimeric G-protein to exchange GDP for GTP, 
resulting in the dissociation of both Gs and the beta/gamma dimeric subunits from MC1R 
(Wolf Horrell et al., 2016b). Dissociated Gs stimulates adenylyl cyclase activity to 
increase cyclic AMP (cAMP) synthesis.  Increased cAMP levels can stimulate multiple 
downstream signaling pathways, including a major pathway initiated by protein kinase A 
(PKA) activation. Activated PKA phosphorylates and activates multiple proteins, including 
the transcription factor cAMP responsive‐element‐binding protein (CREB). CREB in turn 
promotes transcription of microphthalmia-associated transcription factor (MITF), a master 
regulator of melanocyte and pigmented epithelial cell biology. MITF belongs to the MITF-
TFE family of basic helix-loop-helix-leucine zipper (bHLH-Zip) transcription factors, and it 
upregulates expression of a network of melanogenic genes, including TYR, TYRP1, and 
DCT, to promote eumelanogenesis (Aksan and Goding, 1998; Bentley et al., 1994; 
Bertolotto et al., 1996; Fang and Setaluri, 1999; Opdecamp et al., 1997; Yasumoto et al., 
1995; Yasumoto et al., 1994). MITF also increases the expression of Rab27a (Chiaverini 
et al., 2008; Hoek et al., 2008), a small G-protein that is required for the transport of mature 
melanosomes to the cell periphery to position melanosomes for transfer to keratinocytes.  
Both keratinocytes and melanocytes secrete -MSH and ACTH upon UVR as a 
cellular response to DNA damage (Chakraborty et al., 1996; Rousseau et al., 2007; 
Schauer et al., 1994). This UV-stimulated signaling to MC1R and the subsequent increase 
in eumelanin is, at least in keratinocytes, dependent on functional P53 (Cui et al., 2007). 
P53 is stabilized upon UVR and transcribes the proopiomelanocortin (POMC) gene, 
encoding the precursor to -MSH and ACTH. Thus, the tanning response to UV is a 
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crosstalk between keratinocytes and melanocytes and is likely a protective mechanism 
against further UVR-induced damage. Downstream of MC1R, MITF also upregulates the 
expression of genes involved in reducing oxidative stress and in the DNA damage 
response pathway (Kadekaro et al., 2012; Swope et al., 2014). Therefore, activation of 
MC1R stimulates a broad host of protective effects that are both dependent on and 
independent of pigment production. Conversely, binding of agouti signaling protein (ASIP), 
an MC1R antagonist, decreases melanogenic enzyme expression and total melanin 
synthesis and shifts the ratio of melanin towards pheomelanin (Miller et al., 1993; Suzuki 
et al., 1997). Several SNPs in ASIP are associated with increased risk of skin cancers 
(Gudbjartsson et al., 2008; Helsing et al., 2012; Lin et al., 2011; Maccioni et al., 2013). 
There is some evidence that MC1R has ligand-independent basal activity (Bennett and 
Lamoreux, 2003; Sanchez-Mas et al., 2004), suggesting a model in which MC1R 
maintains basal levels of melanogenesis but, that upon stimulation (e.g. UVR), binds 
available ligand and increases signaling as a protective response. 
MC1R is highly polymorphic, with >200 nonsynonymous variants reported (Garcia-
Borron et al., 2014). Many variants are associated with skin and hair color phenotypes 
and thus are a major contributor to the normal variation of human pigmentation (Rees, 
2003). Additionally, MC1R is dimeric and evidence suggests that dimerization occurs in 
the endoplasmic reticulum (ER) before MC1R can traffic to the plasma membrane (Wolf 
Horrell et al., 2016a). This adds an additional layer of complexity to MC1R regulation and 
signaling because (1) dominant negative alleles can sequester WT MC1R in the ER or 
inhibit signal transduction at the plasma membrane, and (2) heterozygous mutations can 
modulate signaling of the WT protein.  
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 Loss-of-function, hypomorphic, and dominant negative MC1R variants result in 
increased pheomelanin synthesis and many of these variant alleles are associated with 
red hair, fair skin, and freckles (Duffy et al., 2004; Frandberg et al., 1998; Herraiz et al., 
2009; Newton et al., 2005; Ringholm et al., 2004; Sanchez-Laorden et al., 2009; Sanchez-
Laorden et al., 2006; Schioth et al., 1999; Valverde et al., 1995). Individuals with MC1R 
variants display increased sun sensitivity, resulting in increased risk for sun damage and 
skin cancers. This is likely a consequence of decreased eumelanin, increased 
pheomelanin, an inefficient tanning response, and a decrease in the MITF-mediated 
expression of antioxidant and DNA damage response genes (Bastiaens et al., 2001; 
Raimondi et al., 2008; Scherer and Kumar, 2010; Williams et al., 2011).  
Studying the coordination of eumelanogenesis and pheomelanogenesis is critically 
important for understanding human health and disease. Questions remain about whether 
pheomelanin is synthesized in the same melanosome as eumelanin, whether a separate 
pheomelanosome exists, or a combination of both. Unfortunately, few tools exist to study 
pheomelanin synthesis and there are no markers specific for this pathway. Most cell 
biology studies, including this work, center on eumelanin biology. In the rest of this work, 
melanin refers specifically to eumelanin, unless stated otherwise. 
 
1.4. Melanosomes serve as the site for melanin synthesis and storage 
Melanin synthesis occurs in melanosomes, specialized organelles that are found 
in melanocytes and pigmented epithelial cells.  The term melanosome was coined in 1961 
after work involving fractionation experiments and electron microscopy (EM) determined 
that TYR activity and melanin synthesis took place in a so-called “ultramicroscopic 
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compartment” (Lerner et al., 1949; Seiji et al., 1961). Researchers were able to isolate 
these compartments biochemically and, by EM, could visualize membrane-bound 
structures that contained lamellae or that were filled with dense particles. They proposed 
that melanin synthesis in these compartments was a gradual process with melanin 
depositing on the lamellae until they could no longer be seen (Barnicot and Birbeck, 1958; 
Birbeck et al., 1956). These works served as the basis for the study of melanosome 
biogenesis and maturation. 
Melanosomes mature in four morphologically distinct stages from stage I to stage 
IV (Seiji et al., 1961).  Stage I melanosomes derive from early endosomes, are 
unpigmented, and resemble maturing multivesicular bodies (MVBs) which have 
intralumenal vesicles (ILVs) and PMEL fibrils. Stage II melanosomes contain organized 
fibrillar sheets. In stage III, melanin is synthesized and deposited onto the PMEL fibrils, 
and by stage IV, the melanosome is completely dark and filled with melanin.  
Stage I melanosomes are maturing early endosomes that are accessible to 
endocytic cargo and harbor known early endosomal constituents such as EEA1 but, in 
addition, contain the melanosomal protein PMEL. PMEL is an integral membrane 
glycoprotein that can be observed both on the limiting membrane and on ILVs by 
immunogold-labeled EM (Berson et al., 2001; Hurbain et al., 2008; Kikuchi et al., 1996; 
Raposo et al., 2001). Few other melanosomal proteins are present, with only a negligible 
number of TYRP1 gold-labeled particles at this stage, suggesting that other melanosomal 
proteins are transported to maturing melanosomes (Raposo et al., 2001).  
Although they remain unpigmented, stage II melanosomes can be clearly identified 
in electron micrographs by the presence of long internal striations, which are composed 
of lumenal fragments of PMEL (Berson et al., 2001; Berson et al., 2003; Raposo et al., 
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2001; Seiji et al., 1961; Seiji et al., 1963; Theos et al., 2006a). PMEL is composed of a 
long lumenal N-terminal domain, a single transmembrane domain, and a short cytoplasmic 
C-terminal domain (Adema et al., 1994; Kwon et al., 1987; Maresh et al., 1994a). The 
lumenal domain of PMEL is cleaved in stage I melanosomes to generate a soluble M 
form and a membrane-bound Mβ form (Berson et al., 2001; Berson et al., 2003; Maresh 
et al., 1994b). The M form is amyloidogenic and, after further cleavage and processing 
steps, assembles into the fibrillar structure necessary for proper melanosome formation 
(Berson et al., 2003; Fowler et al., 2006; Hee et al., 2017; Hurbain et al., 2008; Leonhardt 
et al., 2013; Rochin et al., 2013). Loss of PMEL fibril formation results in a disorganized 
melanosomal matrix, uneven melanin deposition, and a circular rather than ovoid 
melanosome shape (Berson et al., 2003; Hellström et al., 2011; Theos et al., 2006a; Theos 
et al., 2006b). Thus, PMEL fibril formation is initiated in stage I and completion of the 
PMEL melanosomal matrix marks the transition of the melanosome to stage II. Antibodies 
to full-length and the various PMEL fragments can be used to visualize stage I and II 
melanosomes by immunofluorescence microscopy (IFM); although the cleaved, fibrillar 
M fragments exist in stage III and IV melanosomes, their epitopes become buried by 
melanin and are inaccessible (Donatien and Orlow, 1995; Raposo et al., 2001). Stage II 
melanosomes also contain low levels of TYR, TYRP1, and DCT (Kushimoto et al., 2001; 
Raposo et al., 2001), but because melanosome maturation and cargo trafficking to 
melanosomes are dynamic processes, these markers cannot be used to reliably 
differentiate between stage I and stage II melanosomes. The most reliable method for 
distinguishing between stages is by EM, by which the fibrillar matrix of stage II 
melanosomes is easily seen. Additionally, stage II melanosomes are fully segregated from 
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early endosomes, so unlike stage I melanosomes, stage II melanosomes do not 
accumulate endocytosed cargo (Raposo et al., 2001). 
In stage III melanosomes, melanin is synthesized and deposited onto PMEL fibrils. 
TYRP1, TYR, and DCT continue to accumulate and are most prevalent in these maturing 
melanosomes (Kushimoto et al., 2001; Raposo et al., 2001). Antibodies to TYRP1 or TYR 
are commonly used to visualize stage III and IV melanosomes by IFM as the majority of 
TYRP1-positive or TYR-positive structures are pigmented (Benito-Martinez et al., 2020). 
As melanin accumulates, the PMEL fibrils become obscured until only pigment can be 
seen, generating a stage IV melanosome.  
ILVs, formed by the invagination of the limiting membrane, within melanosomes 
are important for melanosome maturation. In stage I melanosomes, ILVs serve as the site 
of PMEL fibril initiation and growing fibrils can be found adjacent to ILVs (Berson et al., 
2001; Hurbain et al., 2008). Indeed, PMEL sorting to ILVs is required for fibril formation 
(Theos et al., 2006b). Additionally, evidence suggests TYR is present both on limiting 
membranes of stage III and IV melanosomes and on ILVs of stage III melanosomes 
(Theos et al., 2005). This may allow increased coverage of the enzyme throughout the 
melanosome for even melanin synthesis; however, this has not been tested. Protein 
localization to ILVs may also be a mechanism to regulate protein activity. For example, 
the GPCR GPR143 localizes to melanosomes and can be found on the limiting membrane 
and sometimes on ILVs (Samaraweera et al., 2001; Schiaffino et al., 1996), likely as a 
regulatory mechanism to sequester GPR143 from its downstream effectors. 
The fate of a stage IV melanosome depends on the cell type in which it resides. In 
epidermal and follicular melanocytes of the skin and hair, respectively, the mature 
melanosome is transported to the cell periphery where it is secreted to be taken up by 
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keratinocytes (Bahadoran et al., 2001; Hume et al., 2001; Koch et al., 2020; Wilson et al., 
2000). This requires the small GTPase Rab27a, the adaptor protein melanophilin, and the 
actin-based motor myosin Va. The mechanism of melanosome transfer is a topic of debate 
and four possible modes of transfer have been posited: cytophagocytosis, membrane 
fusion, shedding-phagocytosis, and exocytosis-endocytosis (Van Den Bossche et al., 
2006; Wu and Hammer, 2014). In the cytophagocytosis model, melanosomes are 
transported to the dendritic tips of melanocytes where keratinocytes can reach out and 
pinch off the tip to phagocytose the mature melanosomes (Birbeck et al., 1956; Cohen 
and Szabo, 1968; Cruickshank and Harcourt, 1964; Mottaz and Zelickson, 1967; Okazaki 
et al., 1976). The membrane fusion model proposes that melanocytes and keratinocytes 
undergo localized membrane fusion to generate a pore or channel through which 
melanosomes can travel (Scott et al., 2002). The shedding-phagocytosis model suggests 
that melanosomes are packaged into vesicles, which are exocytosed by the melanocyte 
and phagocytosed by a neighboring keratinocyte (Ando et al., 2012; Ando et al., 2011; 
Aspengren et al., 2006; Cerdan et al., 1992; Singh et al., 2010; Wu et al., 2012). In the 
exocytosis-endocytosis model, the melanosomal membrane fuses with the plasma 
membrane of melanocytes to exocytose naked melanin, which is then endocytosed by 
keratinocytes (Quast et al., 2003; Swift, 1964; Tarafder et al., 2014; Virador et al., 2002). 
There is little current evidence to indicate that melanosome transfer occurs via 
cytophagocytosis or membrane fusion. It is more likely that the mechanism of 
melanosome transfer involves shedding-phagocytosis, exocytosis-endocytosis, or both. 
While debate exists about how melanosomes are transferred to keratinocytes, the field 
agrees that transfer involves close contact between melanocytes and keratinocytes, at 
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sites similar to an immunological synapse, and that protease-activated receptor-2 (PAR-
2), a GPCR on the plasma membrane of keratinocytes, is required (Seiberg et al., 2000). 
 
1.5. pH regulation of melanosomes 
The regulation of pH in melanosomes is critically important for proper melanosome 
biogenesis and maturation. Vacuolar-type H(+)-ATPase (V-ATPase) localizes to the 
plasma membrane, trans Golgi network, and all endosomal organelles, including 
melanosomes, where it uses energy from ATP hydrolysis to drive proton transport into the 
lumen of their resident organelle, resulting in acidification (Bhatnagar and Ramalah, 1998; 
Cotter et al., 2015; Tabata et al., 2008). An acidic pH is required in stage I and II 
melanosomes for PMEL processing into M and Mβ forms by a proprotein convertase 
(Berson et al., 2001; Berson et al., 2003). However, Mα remains linked to Mβ via disulfide 
bond (Berson et al., 2001) until cleavage by beta site APP cleaving enzyme-2 (BACE2) 
releases Mα to allow its oligomerization into fibrils (Rochin et al., 2013).  BACE2 activity 
is pH-dependent, with maximal activity at low pH and decreasing activity as the pH 
approaches 6 (Abdul-Hay et al., 2012). Loss of BACE2 activity results in a disorganized 
melanosomal matrix and mild hypopigmentation due to lack of PMEL processing (Rochin 
et al., 2013). Therefore, an acidic pH is required for the proper formation of stage I and II 
melanosomes; however, as melanosomes mature, neutralization of the melanosome must 
occur. 
The enzymatic activity of TYR is related to pH, with maximal TYR activity at neutral 
pH and decreased activity at acidic pH (Ancans et al., 2001b; Fuller et al., 2001; Saeki 
and Oikawa, 1985). Consequently, treatment with V-ATPase inhibitors (e.g. bafilomycin 
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A1 and concanamycin A1), membrane-permeant basic molecules (e.g chloroquine and 
ammonium chloride), or ionophores (e.g. monensin) to inhibit or reverse acidification 
results in increased TYR activity and melanin content (Ancans and Thody, 2000; Oikawa 
et al., 1987; Saeki and Oikawa, 1983, 1985). These data directly disproved the hypothesis 
that melanosomes became more acidic as they matured (Bhatnagar et al., 1993; Puri et 
al., 2000). 
Studies to identify the cellular mechanisms underlying human pigmentation 
variances have focused on TYR because it is the rate-limiting enzyme for melanin 
synthesis. In melanocytes derived from lightly pigmented Caucasian skin and from darkly 
pigmented Black skin, TYR protein and mRNA levels did not correlate well with skin color 
but TYR activity did (Iozumi et al., 1993). Incubating these melanocytes in ammonium 
chloride to increase pH resulted in a 5-20-fold increase in TYR activity in Caucasian 
melanocyte cell lines but not in Black melanocyte cell lines, indicating that the 
melanosomes in Caucasian melanocytes are more acidic and prevent maximal TYR 
activity and melanin synthesis (Ancans et al., 2001b; Fuller et al., 2001). Therefore, a shift 
from acidic pH to neutral pH promotes the transition from PMEL fibril formation in stage I 
and II melanosomes to melanin synthesis in stage III and IV melanosomes. This was 
confirmed using the acidotropic pH indicator, N[3-[(2,4-dinitrophenyl)amino]propyl]-N-(3-
aminopropyl)methylamine dihydrochloride (DAMP), which selectively accumulates in 
acidic compartments by becoming protonated and thus no longer able to cross the lipid 
bilayer. Assessing DAMP accumulation in melanosomes using immunogold-labeled EM 
showed that DAMP accumulated to a much higher degree in stage I and II melanosomes 
than in stage III and IV melanosomes (Raposo et al., 2001). 
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The regulation of pH in the melanosome is an intriguing topic of investigation. 
Currently, only a few proteins involved in ion transport in melanosomes have been 
characterized. However, it is likely that the ion transport system in melanosomes is 
complex and highly coordinated, so there is much more to learn about how pH is regulated 
in this system (Figure 1.2). Ion transport proteins include ion pumps, channels, and 
transporters, and they function relative to the electrochemical gradient. Whereas ion 
channels allow passive diffusion of an ion or substrate along its concentration gradient, 
ion pumps and transporters use energy from ATP hydrolysis or from the electrochemical 
gradient to drive transport against an ion or substrate’s concentration gradient (Alberts et 
al., 2002). While V-ATPase mediates H+ influx in melanosomes to generate an acidic 
lumen in early stage melanosomes, it is unclear how this is counteracted in maturing 
melanosomes to generate a neutral environment.   
 
Figure 1.2: Ion transport channels in melanosome biogenesis. A schematic of ion transport 
proteins that affect pigmentation. ATP7A is an ATP-dependent copper transporter on 
melanosomes, the Golgi, and endosomes. Its activity is required to provide copper for TYR function. 
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V-ATPase on melanosomes uses ATP hydrolysis to pump protons into the lumen to acidify the 
melanosome. TPC2 is a cation channel on melanosomes that allows sodium and/or calcium cation 
efflux and promotes melanosome acidification by increasing membrane potential, which would 
putatively increase V-ATPase actiivty. OCA2 is a chloride-selective anion channel on 
melanosomes that allows chloride efflux from the melanosomes and promotes melanosome 
deacidification by decreasing membrane potential, which would putatively decrease V-ATPase 
activity. SLC45A2 functions as a proton/sugar co-transporter and it is hypothesized to localize to 
melanosomes but this is unclear. SLC24A5 localizes primarily to the Golgi and is a calcium/sodium 
antiporter. The function of MFSD12 is unknown but it localizes to lysosomes in melanocytes and 
its knockdown results in increased pigmentation. ClC7 is a proton/chloride antiporter that localizes 
to lysosomes in non-pigmented cells but its localization in pigmented cells has not been shown. 
Black question marks signify proteins with unknown localization. Red question marks signify 
proteins with unknown function. 
 
 
The protein oculocutaneous albinism type 2 (OCA2 a.k.a. p-protein) is a chloride-
selective anion channel localized to melanosomes that allows Cl- ions to flow from the 
melanosomal lumen to the cytoplasm (Bellono et al., 2014; Sitaram et al., 2009). Loss-of-
function mutations in OCA2 in humans result in OCA type 2 (OCA2), characterized by 
moderate-to-severe hypopigmentation of the skin, hair, and eyes (Brilliant, 2001; Getting 
and King, 1994; Manga and Orlow, 1999). Mice with loss-of-function mutations in the Oca2 
gene (pink-eyed dilution mice) or melanocytes cultured from those mice (melan-p1 cells) 
are also hypopigmented (Sviderskaya et al., 1997). Treatment of melan-p1 cells with 
bafilomycin A1, monensin, or ammonium chloride resulted in a 4-5-fold increase in 
melanin content, indicating that loss of OCA2 results in an aberrantly acidic organelle 
(Ancans et al., 2001a). Indeed, OCA2 expressed in AD-293 cells, derivatives of the 
HEK293 cell line, localizes to late endosomes/lysosomes and increases pH in the 
organelles to which they localize (Bellono et al., 2014). This is dependent on OCA2’s Cl- 
transport function as a mutation that inhibits Cl- transport does not change the pH in these 
organelles (Bellono et al., 2014). One model for how OCA2 neutralizes pH is that Cl- efflux 
reduces melanosome membrane potential, resulting in decreased V-ATPase activity and 
fewer or no protons being pumped into the melanosomal lumen (Bellono et al., 2014).  
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Additionally, Cl- efflux may be necessary for the action of one or multiple transporters that 
actively pumps protons out of the melanosome; however, if this is the case, the 
transporter(s) has not yet been identified.  
Two-pore channel 2 (TPC2) is a voltage-independent cation channel localized to 
melanosomes where, upon binding its ligand phosphatidylinositol 3,5-bisphosphate 
(PtdIns(3,5)P2), a pore opens to allow Na2+ efflux from the melanosomal lumen (Ambrosio 
et al., 2016; Bellono et al., 2016; Wang et al., 2012). While it has been proposed that 
nicotinic acid adenine dinucleotide phosphate (NAADP) is a TPC2 ligand and that Ca2+ 
transport is also mediated by TPC2 (Ambrosio et al., 2016; Lin-Moshier et al., 2014),  patch 
clamp data indicate otherwise (Bellono et al., 2016; Wang et al., 2012). Overexpression 
of TPC2 results in decreased melanosomal pH and hypopigmentation, which is dependent 
on TPC2 channel activity (Ambrosio et al., 2016; Bellono et al., 2016; Lin-Moshier et al., 
2014). Conversely, knockdown of TPC2 results in increased pH and increased melanin 
content (Ambrosio et al., 2016; Bellono et al., 2016). Therefore, TPC2 promotes acidic 
melanosomal pH and is a negative regulator of melanin production. Current clamp 
recordings of melanosomes show that TPC2 activity increases melanosome membrane 
potential (Bellono et al., 2016). Therefore, a model for how TPC2 activity achieves an 
acidic pH is that the increase in membrane potential from TPC2 activity increases V-
ATPase activity and proton influx. In this model, TPC2 and OCA2 would counterbalance 
each other to alter membrane potential. Understanding how each protein localizes to and 
is active within each melanosome maturation stage will provide important insight into one 
mechanism of how pH regulation is coordinated in melanosomes.   
A major question remains: if OCA2 activity decreases membrane potential and V-
ATPase activity, how are protons removed from the lumen to deacidify melanosomes? 
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One candidate protein is solute carrier family 45 member 2 (SLC45A2 a.k.a. MATP, AIM1, 
OCA4). Pathologic mutations in SLC45A2 result in OCA type 4 (OCA4), characterized by  
moderate-to-severe hypopigmentation of the skin, hair, and eyes (Gronskov et al., 2007; 
Marcon and Maia, 2019; Martinez-Garcia and Montoliu, 2013; Montoliu et al., 2014). When 
expressed in yeast cells, mouse SLC45A2 functions as a sugar/proton-symporter that 
imports protons into the cytosol (Bartolke et al 2014), indicating that it could mediate proton 
transport out of the melanosome. However, while it has been proposed to reside on 
melanosomes (Bin et al 2015), its localization and function in mammalian cells has not 
been clearly defined. This is the focus of Chapter 2.  
Many other ion transport proteins play a role in melanosome pH regulation (Table 
1.1). RNA-sequencing data of human epidermal melanocytes from Haltaufderhyde and 
Oancea (2014) list numerous abundantly expressed ion transport proteins 
(Haltaufderhyde and Oancea, 2014). Among them are OCA2, TPC2, and SLC45A2; they 
also include members of the TRPM family of cation channels, members of the chloride 
intracellular channel (CLIC) family, and members of the chloride channel voltage-sensitive 
(CLCN) family (Haltaufderhyde and Oancea, 2014). This is a wide field of study as it is 
necessary to identify not only the localization and function of each of these proteins in 
melanocytes but also how they crosstalk with each other and with the other ion transport 




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1.6. Cargo delivery: Trafficking to and from melanosomes 
Melanosomes are a type of lysosome-related organelle (LRO), a class of cell type-
specific subcellular organelles that are often distinct from lysosomes but derive from the 
endosomal pathway and share some features including acidic pH and certain lysosomal 
proteins at some point in their maturation (Bowman et al., 2019; Raposo and Marks, 2002; 
Raposo and Marks, 2007; Raposo et al., 2007). LROs play specialized roles that confer 
unique properties to their resident cell type (e.g. melanosomes generating pigment in 
melanocytes and pigmented epithelial cells; platelet dense granules as the storage site 
for small molecule mediators in platelets; lamellar bodies synthesizing pulmonary 
surfactant in alveolar type II (AT2) cells; etc.) (Bowman et al., 2019). An organizational 
problem for all organelle biogenesis and maturation, but especially for cells that contain 
LROs, is how to maintain organelle identity. After synthesis, folding, and modifications in 
the ribosome, ER and Golgi, proteins must be accurately directed to their final 
destinations. Therefore, trafficking needs to be tightly spatiotemporally regulated. A 
dedicated system of proteins exists for cargo protein trafficking to LROs. Mutations in the 
gene encoding some of these proteins result in Hermansky-Pudlak syndrome (HPS), 
which is a group of autosomal recessive diseases with pleiotropic effects due to defective 
LRO biogenesis (Bowman et al., 2019). Hypopigmentation of the skin, hair, and eyes is 
always associated with HPS, reflecting the requirement for these proteins for melanosome 
maturation. Therefore, melanosomes serve as a model system for studying LRO 
trafficking mechanisms and have provided much insight into how cells accurately transport 
cargo proteins.   
In previous sections, the functions of melanosomal cargo proteins have been 
discussed but not how they are transported to melanosomes. All known melanosomal 
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proteins are integral membrane glycoproteins and are synthesized in the endoplasmic 
reticulum (ER) and modified by glycosidases and glycotransferases in the Golgi. They 
then are transported to melanosomes either directly from the Golgi or via endosomal 
intermediates, in some cases after delivery to and internalization from the plasma 
membrane. As discussed earlier, PMEL-containing stage II melanosomes diverge from 
maturing vacuolar early endosomes by mechanisms that are not understood (Raposo et 
al, 2001). Once they are segregated, they then mature to stage III and IV by the delivery 
of additional cargos – including TYR, TYRP1, DCT, and transporters such as OCA2 and 
ATP7A – by membrane trafficking pathways (Delevoye et al 2019; Bowman et al 2019). 
There are three known pathways for cargo transport to maturing melanosomes: 
the aforementioned pathway from the trans Golgi network, which utilizes vesicle-mediated 
trafficking; a vesicular pathway from early endosomes; and a tubulovesicular pathway 
from early endosomes  (Figure 1.3) (Bowman et al., 2019). Currently, it is known that two 
proteins (DCT and MART-1 a.k.a. melan-a) are transported to maturing melanosomes 
directly from the Golgi (Patwardhan et al., 2017); one, TYR, is transported via vesicles 
from endosomes (Theos et al., 2005); and three, TYRP1, OCA2, and APT7A, are 
transported via tubules from endosomes (Setty et al., 2008; Setty et al., 2007; Sitaram et 
al., 2012). The two pathways from the early endosome to melanosomes utilize multimeric 
protein complexes that are targeted by mutations in HPS variants. Many melanosomal 
cargo proteins contain either dileucine-based or tyrosine-based sorting sequences in their 
cytoplasmic domains that allow them to be targeted for sorting and transport 
(Blagoveshchenskaya et al., 1999; Calvo et al., 1999; Robila et al., 2008; Simmen et al., 






Figure 1.3: Trafficking pathways to melanosomes. Cargo of mature melanosomes traffic to 
melanosomes in one of three pathways. (1) Melanosomal proteins (e.g. TYR) on endosomes can 
be sorted by the coat protein AP-3 and transported to melanosomes via vesicles. (2) Melanosomal 
proteins (e.g. TYRP1 and ATP7A) on endosomes can be sorted by AP-1 or AP-3 into tubules which 
transport cargo to melanosomes. These tubules require BLOC-1 for initiation and elongation by 
coupling tubules to the microtubule motor protein KIF13A via AP-1 and they require BLOC-2 for 
engagement with melanosomal membranes. The v-SNARE VAMP7 engages unknown t-SNAREs 
at the melanosome to drive membrane fusion, allowing for cargo transfer. (3) Melanosomal proteins 
(e.g. DCT and MART-1) can also be transported to melanosomes directly from the Golgi via RAB6-
mediated vesicles. (4) Non-resident proteins (e.g. VAMP7) are recycled from melanosomes 
through a retrograde pathway that requires BLOC-3 – a GEF for RAB32/28 – and VARP – an 
effector for RAB32/38. Figure copied with permission from (Bowman et al., 2019). 
 
1.6.1. Function of AP-1 and AP-3 in sorting melanosomal cargo 
Adaptor proteins 1 and 3 (AP-1 and AP-3) are heterotetrameric cytoplasmic 
complexes that bind to either dileucine-based or tyrosine-based sorting sequences and 
that function as coat proteins primarily from early endosomes through their interactions 
with early endosomal markers (Robinson and Bonifacino, 2001). Whereas AP-1 appears 
to function only in the tubulovesicular pathway to melanosomes by recruiting the 
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microtubule motor KIF13A (Delevoye et al 2009), AP-3 can mediate sorting into both 
vesicles and tubules. TYR contains a dileucine-based motif that preferentially binds AP-3 
but can also bind AP-1 (Theos et al., 2005); therefore, TYR is transported from the early 
endosome primarily via vesicle-mediated trafficking but also a minor cohort can be 
transported via tubules. Conversely, TYRP1 contains a dileucine sorting signal that 
interacts only with AP-1 (Theos et al., 2005), which packages TYRP1 into tubules that 
extend from the early endosome to the melanosome (Delevoye et al., 2009a; Dennis et 
al., 2016; Dennis et al., 2015; Raposo et al., 2001). OCA2 can interact with both AP-1 and 
AP-3 through its dileucine-based sorting signal, but uses solely the tubulovesicular 
pathway to traffic to melanosomes (Sitaram et al., 2012; Sitaram et al., 2009). ATP7A 
interacts with AP-1 to enter the tubulovesicular pathway to melanosomes (Alsaif et al., 
2019; Hartwig et al., 2019; Holloway et al., 2013; Setty et al., 2008; Yi and Kaler, 2015). 
Thus, AP-1 and AP-3 are critical mediators of melanosomal cargo sorting.  
1.6.2. BLOC function in the tubulovesicular pathway 
Central to the proper function of the tubulovesicular pathway to melanosomes are 
the biogenesis of lysosome-related organelles complex-1, -2, and -3 (BLOC-1, BLOC-2, 
and BLOC-3) (Fig 1.3). These multisubunit protein complexes coordinate tubule initiation 
and elongation, membrane engagement, and recycling (Bowman et al., 2019). BLOC-1 
promotes the extension of tubules at least in part by coordinating the function of the kinesin 
motor protein KIF13A to pull tubules along microtubule motors (Delevoye et al., 2016; 
Delevoye et al., 2009a). Additionally, negative stain EM of recombinant BLOC-1 shows 
that the complex adopts a flexible linear shape, often curved (Lee et al., 2012). BLOC-1 
associates with tubulovesicular regions (Di Pietro et al., 2006), which contain highly curved 
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membrane, and knockdown of BLOC-1 results in loss of tubule formation despite the 
emergence of buds at endosomes (Delevoye et al., 2016). Together, these data suggest 
that BLOC-1 may also be involved in the initiation of tubules, potentially by promoting 
membrane curvature. 
BLOC-2 functions downstream of BLOC-1 and facilitates stable contacts between 
tubules and the melanosome; however, the mechanism by which BLOC-2 accomplishes 
this is unclear (Dennis et al., 2015; Di Pietro et al., 2006). BLOC-3 is a guanine nucleotide 
exchange factor (GEF) for RAB32 and RAB38 and functions in a retrograde transport 
pathway from melanosomes, which is required to ensure that proteins that mediate 
trafficking are recycled to the endosome and available for another round of anterograde 
transport (Dennis et al., 2016). BLOC-3, RAB32 and RAB38 might also function in 
anterograde transport (Bultema et al., 2012; Ohishi et al., 2019; Wasmeier et al., 2006). 
1.6.3. Fusion of transport intermediates with melanosomes 
Both vesicles and tubules must undergo membrane fusion to transport cargo, but 
how are docking and fusion coordinated to occur at the appropriate target? Membrane 
fusion specificity is dictated by soluble N-ethylmaleimide-sensitive factor attachment 
protein receptors (SNARE) proteins and by small GTPases that signal to effector proteins. 
Effectors include Sec1/Munc18 (SM) family members and tethering proteins (Ohbayashi 
and Fukuda, 2018; Stenmark, 2009).  
SNARE proteins function essentially as molecular zippers to facilitate membrane 
fusion. In order to drive fusion, SNARE proteins on opposite membranes assemble into a 
coiled-coil four-helix bundle called a SNARE complex, which generates enough force to 
overcome the energy barrier to membrane fusion (Sudhof and Rothman, 2009). SNARE 
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proteins can be subdivided into R-SNAREs, or Qa-, Qb, or Qc-SNAREs. This designation 
is given by the amino acid (either an arginine or a glutamine) at the highly conserved 
central position of the SNARE motif and by the SNARE motif’s position within the SNARE 
complex (Fasshauer et al., 1998; Kloepper et al., 2007; Sutton et al., 1998). Also called 
the zero-layer residues, these arginine and glutamines of the R-SNARE, Qa-SNARE, Qb-
SNARE, and Qc-SNARE form hydrogen bonds which align these SNARE proteins in 
relation to each other for proper SNARE complex formation (Yoon and Munson, 2018). 
Every SNARE complex is comprised of an R-SNARE, Qa-SNARE, Qb-SNARE, and Qc-
SNARE. A more generalized classification of SNARE proteins is based on their 
localizations on apposing membranes – v-SNAREs (typically an R-SNARE) on vesicular 
membranes and t-SNAREs (typically Q-SNAREs) on target membranes (Sudhof and 
Rothman, 2009). Alignment of the zero-layer residues of the R-SNARE and Qa-, Qb-, and 
Qc-SNAREs and helical zippering completes the formation of the SNARE complex to drive 
membrane fusion. 
 Although in vitro experiments indicate that the physical interactions between 
SNARE proteins can be promiscuous, SNARE proteins in vivo are highly regulated and a 
v-SNARE interacts only with its cognate t-SNAREs to form specific SNARE complexes 
and to provide specificity in membrane fusion reactions (Sudhof and Rothman, 2009). In 
tubulovesicular transport to melanosomes, the v-SNARE has been identified as VAMP7 
(Dennis et al., 2016); however, the v-SNARE on vesicles destined for melanosomes and 
the t-SNAREs on melanosomes are unknown.  
For a v-SNARE and t-SNAREs to promote fusion, their resident membranes must 
be in close proximity. This is accomplished by tethering proteins, which bind apposing 
membranes and serve as a bridge to connect them. Tethering proteins bind membranes 
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and achieve specificity through their interactions with small GTPases, primarily of the Rab 
superfamily (Ungermann and Kummel, 2019; van der Beek et al., 2019; Yu and Hughson, 
2010). A tethering protein in the endosome-to-melanosome trafficking pathway has not 
yet been identified, but the homotypic fusion and vacuole protein sorting (HOPS) complex 
is a strong candidate.  
1.6.4. HOPS, VPS33A, and the buff mouse 
HOPS is composed of 6 subunits – VPS41, VPS16, VPS33A, VPS18, VPS11, and 
VPS39 – organized in a seahorse shape (Balderhaar and Ungermann, 2013; Brocker et 
al., 2012). VPS41 and VPS39 exist on opposite ends of the complex and bind to the small 
GTPases and Rab adaptors, and simultaneous binding of VPS41 and VPS39 to these 
proteins on different membranes allows HOPS to bind and tether apposing membranes. 
VPS41 can bind the small GTPase ARL8B (Garg et al., 2011; Khatter et al., 2015), the 
RAB7 adaptor pleckstrin homology and RUN domain containing M1 (PLEKHM1) (McEwan 
et al., 2015), and the RAB7 effector Rab interacting lysosomal protein (RILP) (Lin et al., 
2014; van der Kant et al., 2013); and VPS39 can bind the ARL8B effector SKIP (Khatter 
et al., 2015) and PLEKHM1 (Marwaha et al., 2017; McEwan et al., 2015). Through these 
interactions, HOPS is able to mediate tethering between late endosomes, lysosomes, and 
autophagosomes. In yeast, Vps41 and Vps39 can bind directly to Ypt7 (Brocker et al., 
2012; Ho and Stroupe, 2015; Seals et al., 2000), the RAB7 ortholog; however, in 
mammalian systems, these interactions do not occur directly (Khatter et al., 2015). 
Additionally, one report suggests that yeast Vps39 acts as a guanine nucleotide exchange 
factor (GEF) for Ypt7 (Wurmser et al., 2000), but mammalian VPS39 does not show this 
activity (Peralta et al., 2010). In addition to late endosomes and lysosomes, RILP also 
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localizes to melanosomes, indicating that HOPS could potentially interact with 
melanosomes through RILP (Matsui et al., 2012; Ohbayashi et al., 2012). However, 
whether HOPS localizes to or mediates tethering at melanosomes is unknown.  
Based on the known interactions between VPS39 or VPS41 and small GTPases 
and their adaptors, HOPS does not bind early endosomes; instead, a similar complex, the 
class C core vacuole/endosome tethering (CORVET) complex tethers early endosomes 
during fusion (Amaya et al., 2016; Balderhaar et al., 2013; Balderhaar and Ungermann, 
2013; Chou et al., 2016; Marwaha et al., 2017; Perini et al., 2014b; van der Beek et al., 
2019; Van Der Kant et al., 2015). CORVET is predicted to have a similar structure as 
HOPS, with which it shares 4 subunits – VPS11, VPS18, VPS33A, and VPS16 – but 
CORVET has VPS3 and VPS8 on opposite sides of the seahorse shape to mediate 
interactions with the small GTPase Rab5 on early endosomes (Lachmann et al., 2014; 
Peplowska et al., 2007; Perini et al., 2014a; Van Der Kant et al., 2015). Even though a 
role for endosome-melanosome tethering has not been described for HOPS, it is more 
likely that HOPS rather than CORVET is required for melanosome biogenesis because 
mutations in HOPS-specific but not CORVET-specific subunits have been associated with 
pigmentation defects in mice, Drosophila melanogaster, Caenorhabditis elegans, and 
zebrafish (Delahaye et al., 2014; Grant et al., 2016; Hermann et al., 2005; Huizing et al., 
2001; Pulipparacharuvil et al., 2005; Sadler et al., 2005; Sevrioukov et al., 1999; Suzuki 
et al., 2003; Takats et al., 2014; Warner et al., 1998).  
VPS33A, a subunit of both HOPS and CORVET, plays a critically important role in 
SNARE complex formation as a member of the Sec1/Munc18 (SM) family of proteins 
(Baker et al., 2013; Baker et al., 2015; Graham et al., 2013; Lobingier and Merz, 2012; 
Seals et al., 2000). SM proteins chaperone SNARE complex assembly, but the exact 
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mechanism by which this occurs may differ depending on the SM protein (Baker and 
Hughson, 2016). Structural data from Vps33 bound to the Qa-SNARE Vam3 and the R-
SNARE Nyv1, all purified from the thermophilic fungus Chaetomium thermophilum, has 
led to a model where Vps33  templates SNARE complex assembly by binding to R- and 
Q-SNAREs and aligning them for proper formation of the four-helix bundle (Baker et al., 
2015). A mutation in VPS33A has been identified in the buff mouse line, a mouse model 
of HPS characterized by hypopigmentation and bleeding diathesis, indicating that 
VPS33A plays a role in trafficking to LROs including melanosomes (Suzuki et al., 2003). 
Like HPS, the phenotype observed in mice is recessive. Intriguingly, the mice are not 
reported to have any major general defects in the endosomal/lysosomal system despite 
that fact that HOPS has a well characterized role in regulating fusion of late endosomes 
with lysosomes and with autophagosomes. Data from one group indicated that the buff 
mutation – VPS33A-D251E – results in increased interaction between the SM protein and 
SNARE proteins (Zhen and Li, 2015). However, it is unlikely that a mutation that 
sequesters HOPS and prevents its function would be a recessive mutation. Additionally, 
data from their sucrose gradient experiment indicate that HOPS is only present in the 
same fraction as lysosomes but not with late endosomes, which contradicts evidence that 
HOPS associates with both lysosomes and late endosomes (Balderhaar and Ungermann, 
2013; Bowman et al., 2019; Lin et al., 2014; Marwaha et al., 2017; Pols et al., 2013a; 
Solinger and Spang, 2013; van der Beek et al., 2019; Wartosch et al., 2015; Zhen and Li, 
2015). How VPS33A functions in melanosome biogenesis is unknown and is of major 
interest because it could (1) reveal more about melanosome dynamics and interactions 
with other organelles, and (2) identify how VPS33A confers specificity even though it 




1.7. Molecular basis of albinism 
Mutations resulting in defective melanosome biogenesis result in albinism, a rare, 
heterogeneous disorder characterized by hypopigmentation of the skin, hair, and eyes. 
The prevalence of albinism is estimated to be approximately 1:17,000 to 1:20,000 
(Santiago Borrero et al., 2006; Witkop et al., 1990), although it is more common in certain 
populations due to founder effects. The decrease in pigmentation may vary from individual 
to individual, but ocular defects due to hypopigmentation of the eyes must be present for 
a diagnosis of albinism (Gronskov et al., 2007; Kirkwood, 2009; Marcon and Maia, 2019; 
Martinez-Garcia and Montoliu, 2013; Montoliu et al., 2014).  
Characteristic ocular symptoms include: hypopigmentation of the iris resulting in 
iris transillumination; reduced pigmentation of the retinal pigment epithelium resulting in 
foveal hypoplasia; abnormal decussation (abnormal crossing of the optic nerve fibers); 
congenital nystagmus (involuntary eye movement); strabismus (misalignment of eyes); 
photophobia (light sensitivity); refractive errors (i.e. far-sightedness, near-sightedness, 
and astigmatism); and poor vision (Gronskov et al., 2007; Montoliu et al., 2014). The ocular 
defects are broad and severe due to a requirement for melanin synthesis in ocular 
melanocytes and pigmented epithelial cells during development (Levin and Stroh, 2011). 
The fovea is a region of the retina that is responsible for visual acuity. Therefore, foveal 
hypoplasia, which is the loss of the foveal pit, is the major cause of poor vision in albinism. 
Additionally during development, optic nerve fibers, composed of retinal ganglion cell 
(RGC) axons, emerge from the ventro-temporal retina and migrate towards the optic 
chiasm where they either cross to the contralateral brain hemisphere or continue straight 
to the ipsilateral brain hemisphere. This decussation, or crossing of the optic nerve fibers, 
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allows each brain hemisphere to receive visual cues from both eyes, which is necessary 
for binocular vision (Reese, 2011). During normal development, approximately 55% of the 
optic nerve fibers cross to the contralateral side, but this percentage is increased to 75-
85% in individuals with albinism and is associated with reduced binocular vision and 
strabismus (Levin and Stroh, 2011).  This is due to a requirement for L-DOPA, an 
intermediate in the melanin biosynthesis pathway, during embryological development. The 
presence of L-DOPA is required to coordinate the timing of RGC cell entry at the optic 
chiasm, which promotes ipsilateral crossing early and contralateral crossing later. The loss 
of L-DOPA leads to RGC cells reaching the optic chiasm later and more cells being sent 
to the contralateral side (Ather et al., 2019; Ilia and Jeffery, 1999; Kralj-Hans et al., 2006). 
These clinical criteria for the diagnosis of albinism can be tested by an ophthalmologist. 
While there are no treatments for albinism and most individuals with albinism are legally 
blind, some of the associated visual defects can be somewhat managed (Levin and Stroh, 
2011). For instance, prescription corrective lenses or telescopic lenses may slightly 
improve vision; tinted glasses can dampen photophobia; and, while rarely performed for 
albinism, surgery on optical muscles may decrease nystagmus and strabismus.  
Although albinism does not affect life expectancy, reduced or absent melanin 
makes individuals with albinism more vulnerable to the harmful effects of UVR. Individuals 
with albinism are at increased risk for sun damage, sunburns, and skin cancers, 
particularly squamous cell carcinoma and basal cell carcinoma (Marcon and Maia, 2019; 
Martinez-Garcia and Montoliu, 2013). Those with albinism are recommended to use 
sunscreen liberally, to avoid the sun, and to see a physician regularly to check for 
malignant lesions.  
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Aside from one type of albinism (ocular albinism type 1 (OA1), which is X-linked 
and primarily affects the eyes), all albinism is autosomal recessive and results in 
decreased pigmentation of the skin, hair, and eyes. Albinism can be divided into non-
syndromic albinism or syndromic albinism. In non-syndromic albinism, gene mutations 
affect only pigmented cell types; therefore, albinism is the only systemic disorder. In 
syndromic albinism, additional systemic disorders are observed due to defects in non-
pigmented cell types. 
1.7.1. Non-syndromic albinism 
The types of non-syndromic albinism identified thus far are oculocutaneous 
albinism types 1-8 (OCA1-OCA8) and ocular albinism type 1 (OA1) (Table 1.2) (Marcon 
and Maia, 2019; Martinez-Garcia and Montoliu, 2013; Pennamen et al., 2020b). With the 
exception of OCA5 and OCA7, mouse models of OCA subtypes and OA1 exist and are 
also hypopigmented (Table 1.2).  OCA1, OCA2, OCA3, and OCA4 are the most common 
subtypes of OCA, although the prevalence of each subtype varies by region. As discussed 
earlier, the genes mutated in OCA1, OCA2, and OCA8 – TYR, OCA2 and DCT – have 
been well studied and have known roles in melanin synthesis and melanosome biogenesis 
(Table 1.2). Mutations in TYRP1 cause OCA3 and while the exact function of TYRP1 has 
not been unequivocally determined, TYRP1 localizes to the mature melanosome limiting 
membrane and influences melanin synthesis and melanosome structure; this can be seen 
in brown mice, the OCA3 mouse model, which have smaller, rounder melanosomes than 
their WT counterparts (Hirobe et al., 2014).The role of SLC45A2, which is mutated in 
OCA4, is hypothesized to be in ion transport at the melanosome (Bin et al., 2015) but this 
has not clearly been shown. Elucidating the structure and function of SLC45A2 is the focus 
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of Chapter 2. The gene mutated in OCA5, which has only been reported in 1 Pakistani 
family, has not been identified (Kausar et al., 2013). OCA6 has been found in 6 unrelated 
families and is caused by mutations in SLC24A5, which encodes a potassium-dependent 
sodium-calcium exchanger (Ginger et al., 2008; Morice-Picard et al., 2014; Wei et al., 
2013). SLC24A5 does not appear to localize to melanosomes but rather has been 
reported to localize to the trans-Golgi network and perhaps to mitochondria, indicating that 
it affects melanosome biogenesis indirectly (Ginger et al., 2008; Rogasevskaia et al., 
2019; Zhang et al., 2019). OCA7 has been identified in 1 Lithuanian patient and 5 
unrelated individuals from the Faroe Islands (Gronskov et al., 2013). It is caused by 
mutations in the leucine-rich melanocyte differentiation associated (LRMDA) protein. The 
function of LRMDA is unknown, but it is hypothesized to play a role in melanocyte 
differentiation due to the decreased number of melanocytes found in adult tissues 
compared to fetal tissues upon knockdown of the gene in zebrafish (Gronskov et al., 
2013). OCA8 has recently been described in 2 patients and is caused by mutations in DCT 
(Pennamen et al., 2020b).  
OA1 is an X-linked form of non-syndromic albinism that affects primarily the eyes, 
resulting in the ocular defects seen in OCA but without severe hypopigmentation of the 
skin or hair (O'Donnell et al., 1976). It is caused by mutations in the G-protein-coupled 
receptor GPR143 (OA1) (Innamorati et al., 2006), which is expressed in all pigment-
producing cells (Bassi et al., 1996; Bassi et al., 1995; Newton et al., 1996). Individuals 
with OA1 have macromelanosomes in both skin and eye melanocytes. However, skin 
pigmentation is normal in these individuals. Conversely, RPE cells have decreased 
pigmentation, likely because melanin is not evenly dispersed throughout the cell and is 
instead accumulated in a few giant melanosomes (Garner and Jay, 1980; Wong et al., 
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2009). GPR143 localizes to late endosomes/lysosomes and melanosomes, primarily to 
the ILVs (Basrur et al., 2003; Giordano et al., 2009; Samaraweera et al., 2001; Schiaffino 
et al., 1996; Schiaffino et al., 2002; Schiaffino and Tacchetti, 2005). Evidence suggests 
that GPR143 expression prevents fusion between multivesicular bodies and lysosomes 
when ectopically expressed in HeLa cells (Burgoyne et al., 2013); this suggests that in 
pigmented cells, GPR143 may be involved in segregating maturing melanosomes from 
lysosomes. GPR143 also has putative roles in controlling the rate of melanosome 
biogenesis and controlling melanosome size (Cortese et al., 2005), inducing transcription 
of MITF target genes (Chen et al., 2016; Falletta et al., 2014) and regulating melanosome 
mobility and transport (Palmisano et al., 2008). These broad effects of GPR143 signaling 
are mediated by GPCR signaling. 
 The putative ligand-binding site for OA1 is on the lumenal side of membranes, so 
signaling from the melanosomal or endosomal membrane would induce downstream 
signaling in the cytosol to regulate melanosome biogenesis (Schiaffino and Tacchetti, 
2005). One report suggests that the ligand for GPR143 is L-DOPA (Lopez et al., 2008), 
which should be abundant in a normal melanosome during melanin synthesis, but the 
conclusion is controversial (De Filippo et al., 2017).  
The downstream effectors of GPR143 are an area of interest as uncovering this 
signal transduction pathway will reveal how GPR143 achieves its broad effects. Data 
indicate that GPR143 is a Gi/o-coupled receptor (Innamorati et al., 2006; Young et al., 
2008). Broadly, G proteins belong to one of four families: Gi/o, Gq/11, Gs, and G12/13 
(Syrovatkina et al., 2016). Each of these families is associated with different downstream 
signaling pathways. The Gi/o family of proteins inhibits adenylyl cyclase activity.  One 
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group identified guanine nucleotide binding protein, alpha inhibiting activity polypeptide 3 
(Gi3) as the specific Gi protein through which GPR143 signals, and RPE cells and tissue 
from mice with loss of Gai3 phenocopy those of mice with loss of Gpr143  (Young et al., 
2011; Young et al., 2008). However, further work needs to be done to identify the function 
of Gi3 in pigmented cells. 
 
1.7.2. Syndromic albinism 
Syndromic albinism is comprised of either HPS or Chediak-Higashi syndrome 
(CHS) (Table 1.3). HPS is a rare, autosomal recessive syndrome that affects trafficking 
pathways utilized by LROs, resulting in effects on multiple cell types. All subtypes of HPS 
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are characterized by oculocutaneous albinism and excessive bleeding and bruising due 
to defective trafficking to melanosomes and platelet dense granules. Some HPS subtypes 
have additional effects on other LROs. HPS patients have mutations in subunits of the 
multisubunit complexes described in Chapter 1.6.1 and 1.6.2 to regulate melanosome 
biogenesis – AP-3, BLOC-1, BLOC-2 and BLOC-3 (Bowman et al., 2019). Therefore, the 
HPS subtypes can be grouped by mutations in members of the same complex. HPS7, 
HPS8, HPS9, and HPS11 result from mutations in four of the eight known subunits of 
BLOC-1 (DTNBP1, BLOC1S3, BLOC1S6, and BLOC1S5, respectively) (Table 1.3) 
(Bowman et al., 2019; Pennamen et al., 2020a). Patients with these subtypes do not 
appear to exhibit consistent deficiencies other than the hypopigmentation and bleeding 
defects common to all HPS. Mutations in BLOC-2 subunits cause HPS3, HPS5 and HPS6. 
Like BLOC-1 disease, patients with BLOC-2 display only hypopigmentation and bleeding 
defects, although a subset of these patients also suffer from a form of inflammatory bowel 
disease; the physiological basis for this is not understood, but is also observed in HPS5 
model mice (Itoh et al., 2016). Mutations in BLOC-3 subunits cause HPS1 and HPS4, 
which are severe forms of HPS and unfortunately the most common. In addition to OCA 
and excessive bleeding, HPS1 and HPS4 cause severe lung fibrosis and, in a minority of 
individuals, severe granulomatous colitis, a form of inflammatory bowel disease. The lung 
fibrosis is due to defective cargo trafficking to lung lamellar bodies in alveolar epithelial 
type 2 cells, impairing the production and/or secretion of surfactant. The cause of the 
granulomatous colitis is unknown. HPS2 and HPS10 are caused by mutations in the beta 
and delta subunits, respectively, of the heterotetrameric AP-3 complex and are also 
severe forms of HPS with multiple symptoms. In addition to albinism and excessive 
bleeding, individuals with HPS2 and HPS10 suffer from pulmonary fibrosis and recurrent 
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bacterial and viral infections, which are due to a requirement for AP-3 in trafficking in a 
number of innate and adaptive immune cell types including conventional dendritic cells, 
plasmacytoid dendritic cells, cytotoxic T cells, and natural killer cells. Individuals with 
HPS10 also have neurological symptoms (Ammann et al., 2016; Mohammed et al., 2019). 
CHS is a rare autosomal recessive disorder that is characterized by OCA, bleeding 
diathesis, immune system dysregulation, and mild neuropsychological impairment 
(Bowman et al., 2019; Shirazi et al., 2019). Affected cell types have enlarged lysosomes 
and LROs, including melanosomes, platelet dense granules, and cytolytic granules, 
preventing them from being secreted. CHS is caused by mutations in the lysosomal 
trafficking regulator (LYST) gene; however, the function of LYST in LRO biogenesis and 
regulation is unknown. 
 Mouse models exist for CHS and every HPS subtype (Table 1.3) and these mice 
phenocopy the human disease in all ways except for differences in how lungs are affected 
in those subtypes with lung fibrosis. However, additional mouse models of HPS exist with 
affected genes that have not yet been identified in human disease. For example, both 
gunmetal mice and subtle gray mice exhibit hypopigmentation and prolonged bleeding. 
They are caused by mutations in Rabggta, a gene encoding a subunit of the Rab 
geranylgeranyltransferase (RABGGTA), and Slc7a11, a gene encoding the cysteine 
transporter SLC7A11, respectively. Additionally, a mutation in the CORVET/HOPS 
subunit VPS33A has been identified in buff mice, a putative HPS model with 
hypopigmentation and bleeding defects (Suzuki et al., 2003). While studying these mouse 
models has improved our understanding of how BLOCs, AP3, and other putative HPS-
associated proteins function in LRO biogenesis, we still do not know how VPS33A works 




Row colors indicate subunits that belong to the same complex. 
 
There is much still to be learned about the genes that have been identified in OCA, 
OA1, HPS, and CHS. The gene mutated in OCA5 has not been identified and it is not 
known how LRMDA and LYST function in melanosome biogenesis or activity. However, 
more genes are likely associated with albinism. Of the individuals with albinism, 27% do 
not have mutations in any of the known albinism genes (Pennamen et al., 2020b). While 
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some of this percentage may be accounted for by noncoding mutations that impact gene 
expression, the abundance of mouse models with a hypopigmentation phenotype and the 
recent identification this year of two new forms of OCA and HPS (OCA8, HPS11) 
(Pennamen et al., 2020a; Pennamen et al., 2020b) indicate that there are more proteins 
yet to be identified that are required for melanosome and LRO biogenesis in humans.  
 
1.8. Dissertation Aims 
Melanosomes are LROs within melanocytes and pigmented epithelial cells that are 
responsible for producing melanin for photoprotection, antioxidation, and retinal 
development. Defective melanosome biogenesis results in albinism, including OCA and 
HPS. Our studies of OCA and HPS have greatly expanded our understanding of (1) 
melanosome formation and function and (2) trafficking pathways to transport cargo 
specifically to melanosomes. However, many questions remain. SLC45A2, mutated in 
OCA4, has a putative role in the pH regulation of melanosomes. One report indicates that 
SLC45A2 localizes to and deacidifies melanosomes, but the data are inconclusive and 
unconvincing. It is also unknown when SLC45A2 functions and how it coordinates its 
actions with other ion transport proteins. Additionally, the buff mouse model, an HPS-like 
mouse model with a mutation in VPS33A, suggests that VPS33A and HOPS may play a 
role in trafficking to melanosomes and other LROs. However, it is unclear where, when, 





Question 1: What is the localization and function of SLC45A2 in melanocytes? While 
published data indicate that SLC45A2 localizes to melanosomes, the conclusion is based 
on low resolution microscopy that cannot clearly differentiate between organelles, an 
unvalidated antibody that appears to be non-specific, and poorly controlled data. 
Additionally, the function of SLC45A2 in melanocytes is unclear. While experiments in 
zebrafish show that its expression is required for pigmentation and that treatment of 
zebrafish with the V-ATPase inhibitor bafilomycin A1 rescues pigmentation in the absence 
of slc45a2, its role in melanocytes and its relationship to acidification has not been 
characterized in a controlled cellular system. I hypothesize that SLC45A2 localizes to 
melanosomes where its activity as a sugar-proton symporter enhances OCA2’s function 
to neutralize the melanosomal lumen. In chapter 2, I show through widefield and 
fluorescence microscopy that SLC45A2 localizes to mature melanosomes and by electron 
microscopy that loss of SLC45A2 results in hypopigmentation that is not as severe as loss 
of OCA2. Experiments done by collaborators show that expression of SLC45A2 increases 
pH. 
 
Question 2: What is the phenotype of melanocytes derived from buff mice? 
Mutations in HPS-related genes have allowed us to study and understand the role of these 
proteins in specialized trafficking pathways used to generate LROs. In one mouse model 
of HPS, buff (bf) mice contain a missense mutation in Vps33a (D251E), encoding a subunit 
of both CORVET and HOPS. CORVET and HOPS function in all cells in the early 
endosomal and late endosomal/lysosomal systems, respectively, by binding to apposing 
membranes to promote SNARE complex formation and consequent fusion. The subunit 
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VPS33A directly binds to SNARE proteins and accelerates SNARE zippering, thereby 
facilitating fusion. Interestingly, the buff mouse is not reported to have apparent 
generalized endolysosomal defects, but rather selectively impairs LRO biogenesis in 
certain cell types such as skin melanocytes; however, how CORVET/HOPS function 
specifically in the biogenesis of cell-type specific LROs is unknown.  Additionally, detailed 
studies of the function of the CORVET/HOPS in mammalian systems have been limited 
due to the ubiquitous requirement for these complexes in endolysosomal maturation. In 
chapter 3, I characterize melanosome biogenesis defects in buff mice and test whether 
they reflect a hypomorphic function of VPS33A. My data show that melanosome 

























This chapter appeared as a peer-reviewed article titled “SLC45A2 protein stability and 
regulation of melanosome pH determine melanocyte pigmentation” by Linh Le, Iliana E. 
Escobar, Tina Ho, Ariel J. Lefkovith, Emily Latteri, Kirk D. Haltaufderhyde, Megan K. 
Dennis, Lynn Plowright, Elena V. Sviderskaya, Dorothy C. Bennett, Elena Oancea, and 




SLC45A2 encodes a putative transporter expressed primarily in pigment cells. 
SLC45A2 mutations cause oculocutaneous albinism type IV (OCA4) and polymorphisms 
are associated with pigmentation variation, but the localization, function, and regulation of 
SLC45A2 and its variants remain unknown. We show that SLC45A2 localizes to a cohort 
of mature melanosomes that only partially overlaps with those expressing the chloride 
channel OCA2. SLC45A2 expressed ectopically in HeLa cells localizes to lysosomes and 
raises lysosomal pH, suggesting that in melanocytes, SLC45A2 expression, like OCA2 
expression, results in the deacidification of maturing melanosomes to support melanin 
synthesis. Interestingly, OCA2 overexpression compensates for loss of SLC45A2 
expression in pigmentation. Analyses of SLC45A2- and OCA2-deficient mouse 
melanocytes show that SLC45A2 likely functions later during melanosome maturation 
than OCA2. Moreover, the light skin-associated SLC45A2 allelic F374 variant restores 
only moderate pigmentation to SLC45A2-deficient melanocytes due to rapid proteasome-
dependent degradation resulting in lower protein expression levels in melanosomes than 
the dark skin-associated allelic variant. Our data suggest that SLC45A2 maintains 
melanosome neutralization initially orchestrated by transient OCA2 activity to support 
melanization at late stages of melanosome maturation, and that a common variant imparts 
reduced activity due to protein instability.    
 
2.2. Introduction 
Melanins are the main source of pigmentation in the skin, hair, and eyes of 
mammals and other vertebrates. In humans, melanins serve as a barrier to the harmful 
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effects of ultraviolet radiation and play an important role in the development and 
functioning of the retina (d'Ischia et al., 2015). Melanin synthesis takes place in skin and 
eye melanocytes and in ocular pigment epithelia within specialized organelles called 
melanosomes (Hearing, 2005; Marks and Seabra, 2001; Seiji et al., 1963). Heritable 
defects in melanin synthesis underlie the various forms of oculocutaneous albinism (OCA), 
characterized by impaired vision and increased susceptibility to skin and ocular cancers 
(Montoliu et al., 2014). To date, non-syndromic OCA has been linked to inactivating 
mutations in eight different genes (Montoliu et al., 2014; Pennamen et al., 2020b). 
Sequence variation at the loci for some of these genes has been linked to variability in 
skin, hair and eye color among humans (Adhikari et al., 2019a; Branicki et al., 2008; 
Crawford et al., 2017; Han et al., 2008; Lamason et al., 2005a; Liu et al., 2015; Martin et 
al., 2017; Stokowski et al., 2007). Nevertheless, the molecular function of the majority of 
the OCA genes has not yet been fully characterized. 
OCA type 4 (OMIM #606574) represents 3-12% of total OCA patients in population 
studies (Gronskov et al., 2009; Lasseaux et al., 2018a; Mauri et al., 2017; Wei et al., 2010; 
Wei et al., 2015) and is due to mutations in the SLC45A2 gene encoding the putative 
transmembrane transporter SLC45A2 (a.k.a. membrane associated transporter protein, 
MATP or antigen isolated from immuno-selected melanoma-1, AIM1) (Newton et al., 
2001). Mutations in the homologous gene underlie pigment dilution in a number of 
vertebrate species, including gorilla, several breeds of dog, tigers, horses, mice, shrew, 
chickens, pigeons, quail, frogs, fish and perhaps cattle (Caduff et al., 2017; DeLay et al., 
2018; Domyan et al., 2014; Dooley et al., 2013; Fukamachi et al., 2001; Gunnarsson et 
al., 2007; Mariat et al., 2003; Minvielle et al., 2009; Newton et al., 2001; Prado-Martinez 
et al., 2013; Rothammer et al., 2017; Tsetskhladze et al., 2012; Tsuboi et al., 2009; 
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Wijesena and Schmutz, 2015; Winkler et al., 2014; Xu et al., 2013), and polymorphisms 
at the SLC45A2 locus are associated with skin tone differences and skin aging in several 
human population studies (Adhikari et al., 2019a; Branicki et al., 2008; Cerqueira et al., 
2014; Fracasso et al., 2017; Han et al., 2008; Jonnalagadda et al., 2016; Law et al., 2017; 
Liu et al., 2015; Lopez et al., 2014; Soejima and Koda, 2007; Stokowski et al., 2007; Yuasa 
et al., 2006). OCA4 patients have very low levels of pigmentation and phenotypically 
resemble OCA2 patients who lack the melanosomal chloride channel, OCA2 (Bellono et 
al., 2014), suggesting that SLC45A2 plays an important role in melanogenesis (Montoliu 
et al., 2014). Moreover, primary melanocytes from mice carrying the inactivating 
underwhite (uw) mutation of Slc45a2 (Du and Fisher, 2002; Newton et al., 2001) are 
severely hypopigmented (Costin et al., 2003), indicating a melanocyte-intrinsic defect; this 
would be consistent with the known restriction of SLC45A2 expression to pigment cells 
and a few other cell types (Baxter and Pavan, 2002; Bin et al., 2015; Harada et al., 2001; 
Loftus et al., 2002). However, while the 12-transmembrane domain SLC45A2 protein 
bears weak homology to sucrose transporters in plants and Drosophila (Lemoine, 2000; 
Meyer et al., 2011; Newton et al., 2001), its function in melanocytes is not understood.  
When expressed in yeast, mouse SLC45A2 functions at the plasma membrane as 
an acid-dependent importer of sugars (sucrose, glucose, or fructose) into the cytosol 
(Bartölke et al., 2014), suggesting that if SLC45A2 localized to acidic organelles it might 
facilitate export of a sugar and protons from the lumen to the cytosol. Neutralization of 
acidic early stage melanosomes is a critical process for melanogenesis (Bellono et al., 
2014; Raposo et al., 2001), as the key enzyme in melanogenesis, Tyrosinase (TYR), is 
minimally active at pH < 6 (Ancans et al., 2001b; Halaban et al., 2002).  Consistent with a 
function in proton export and neutralization of acidic organelles, pigmentation of a 
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zebrafish Slc45a2 mutant was rescued upon inhibition of endolysosomal and 
melanosomal acidification by treatment with bafilomycin A1 or by knockdown of the atp6v1 
subunit of the vacuolar ATPase (Dooley et al., 2013), and knockdown of SLC45A2 in a 
pigmented melanoma cell line was reported to result in increased acidification of early 
stage melanosomes (Bin et al., 2015). However, despite limited evidence for SLC45A2 on 
melanosomes (Bin et al., 2015), the localization of SLC45A2 within melanocytes has not 
yet been firmly established and it is not clear whether the effects of SLC45A2 mutants 
reflect a direct effect of SLC45A2 function on the lumenal environment of melanosomes 
or an indirect effect due to impaired function of other organelles during melanosome 
maturation, as appears to be the case for the endolysosomal transporter MFSD12 
(Crawford et al., 2017). Moreover, if SLC45A2 indeed functions to neutralize melanosome 
pH, its function must be coordinated with that of OCA2, a major regulator of melanosomal 
pH (Bellono et al., 2014). While mice lacking expression of either SLC45A2 or OCA2 each 
have dramatic coat color dilution (Dickie, 1964b; Sweet et al., 1998), mice with 
hypomorphic mutations in both Slc45a2 and Oca2 are more severely hypopigmented than 
either mutant alone (Lehman et al., 2000), suggesting that the encoded proteins have 
distinct functions.  
Differences in skin and hair pigmentation among European, Chinese, South 
American and South Asian human populations have been ascribed to a single genetic 
variant in SLC45A2 associated with the SNP rs16891982 (c.1122G>C). This results in a 
missense mutation p.Leu374Phe (ClinVar ID: 194990) and is correlated with lighter skin, 
hair, and eyes (Adhikari et al., 2019a; Branicki et al., 2008; Cerqueira et al., 2014; Han et 
al., 2008; Jonnalagadda et al., 2016; Liu et al., 2015; Lopez et al., 2014; Soejima and 
Koda, 2007; Stokowski et al., 2007; Yuasa et al., 2006). The SLC45A2-F374 variant is 
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nearly fixed in light-skinned human populations (Soejima and Koda, 2007). Residue 374 
lies within the 8th predicted transmembrane domain of SLC45A2 (Newton et al., 2001). 
When introduced into a homologous plant sucrose transporter, the amino acid 
corresponding to SLC45A2-F374 resulted in a 90% decrease in transporter activity without 
influencing the affinity for substrate (Reinders and Ward, 2015a), and slc45a2 with an 
introduced F374 mutation was unable to rescue pigmentation in a slc45a2 mutant 
zebrafish (Tsetskhladze et al., 2012). However, the mechanism underlying the decreased 
activity of the SLC45A2-F374 variant is not understood. 
Analyses of SLC45A2 localization and function in pigment cells have been 
hindered by the lack of suitable specific antibodies. Here we assess the localization and 
function of SLC45A2-L374 and -F374 variants in melanosome biogenesis by analyzing 
epitope-tagged human SLC45A2 expressed in wild-type melanocytes, Slc45a2-deficient 
melanocytes from underwhite mice, and HeLa cells, and by comparing the phenotypes of 
underwhite and OCA2-deficient pink-eyed dilute melanocytes. We show that expression 
of SLC45A2, like of OCA2, increases the pH of lysosomes and/or late endosomes when 
expressed ectopically in HeLa cells and that in melanocytes SLC45A2 localizes to 
melanosomes, where it likely neutralizes the melanosome lumen. We also show that 
OCA2 and SLC45A2 localize to distinct subsets of melanosomes and that the F374 variant 
accelerates SLC45A2 degradation but does not alter its localization. Our data indicate that 
melanosome neutralization is a critical process for the maintenance of eumelanin 





2.3.1. Functionality of HA-SLC45A2. 
Available antibodies to SLC45A2 were not suitable in our hands for 
immunolocalization analyses. Therefore, we used epitope-tagging to investigate SLC45A2 
localization in melanocytes. Human SLC45A2 was tagged at the N- or C-terminus with 
either the HA11 epitope tag or EGFP and cloned into a retroviral vector. To determine 
whether the tagged transgenes were functional, they were expressed by recombinant 
retroviral infection in Slc45a2-deficient melan-uw cells from underwhite mice (Dickie, 
1964b). The Slc45a2uw allele encodes a non-functional truncated SLC45A2 protein and 
an undetectable transcript (Du and Fisher, 2002; Newton et al., 2001). Consequently, 
underwhite mice (Dickie, 1964b; Lehman et al., 2000; Sweet et al., 1998) and primary 
melanocytes derived from them (Costin et al., 2003) are severely hypopigmented. 
Likewise, melan-uw cells are very pale compared to “wild-type” (WT) immortalized 
melanocytes (melan-Ink4a) from C57BL/6-Ink4a-/- mice (Sviderskaya et al., 2002) (Figure 
2.1a, b). While expression of the EGFP-tagged proteins failed to consistently restore 
pigmentation in melan-uw cells (data not shown), expression of the N-terminally HA-
tagged human SLC45A2 (HA-SLC45A2) restored partial or full pigmentation in a 
substantial fraction of cells by 48-72 h post-infection, whereas pigmentation was not 
restored by expression of a similarly tagged unrelated polytopic protein - the putative 
sugar-nucleotide transporter, SLC35D3, which plays no role in pigmentation (Chintala et 
al., 2007b) (Figure 2.1c-g). Additionally, quantitative analysis of melanin content in melan-
uw cells stably expressing HA-SLC45A2 showed pigmentation at levels comparable to 
those of melan-Ink4a cells (see Figure 2.5f). These data indicate that HA-SLC45A2 is 
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fully functional in melanocytes, and therefore validate its use in defining the localization 
and biosynthesis of SLC45A2. 
 
Figure 2.1: HA-SLC45A2 functionally restores pigmentation in Slc45a2-deficient underwhite 
melanocytes. Wide field microscopy with bright field illumination of melan-Ink4a (a) and melan-uw 
(b) cells to visualize pigmentation. Scale bar, 10 m. Mouse melan-uw cells were transiently 
transfected with plasmids encoding human SLC45A2 with an N-terminal HA epitope (HA-
SLC45A2) or with a comparably HA-tagged control polytopic protein, SLC35D3 (HA-SLC35D3). 
48-72 h after transfection, HA-expressing cells were scored for their level of pigmentation. c-e, 
examples of unpigmented (c, like untransfected cells), partially pigmented (d) and fully pigmented 
(e) cells. Scale bar, 10m. f, g, quantification of the percentage of HA-expressing cells with partial 
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(gray) or full (black) pigmentation at 48 (f) or 72 (g) h after transfection. Note that all cells except 
melan-Ink4a were treated with 200 pM cholera toxin. Data represent mean ± SEM from 3 
independent experiments and the following total sample sizes: 234 (HA-SLC45A2) and 109 (HA-
SLC35D3) at 48 h, 173 (HA-SLC45A2) and 108 (HA-SLC35D3) at 72 h. ***, p < 0.001; ****, 
p<0.0001 by unpaired two-tailed t-test. 
 
2.3.2. HA-SLC45A2 localizes to the limiting membrane of pigmented melanosomes 
and is partially enriched in a membrane subdomain.   
To define SLC45A2 localization in melanocytes, HA-SLC45A2 was expressed 
either stably from recombinant retroviruses in melan-uw cells or by transient transfection 
in WT melan-Ink4a melanocytes. Cells were then fixed and processed for 
immunofluorescence microscopy with image deconvolution (dIFM) using antibodies to the 
HA tag and to endogenous markers. In Slc45a2-deficient melan-uw cells, HA-SLC45A2 
localized primarily to pigment granules (Figure 2.2a, b, d) often in a ring pattern around 
the granule (Figure 2.2b), in two to three puncta associated with the granule exterior 
(Figure 2.2a), or both (Figure 2.2c). The distinct patterns did not correlate with SLC45A2 
expression levels. The melanosomes labeled by HA-SLC45A2 overlapped with those 
harboring the melanosomal enzymes Tyrosinase (TYR) and Tyrosinase-related protein-1 
(TYRP1) (Figure 2.2a, b, d; overlap was  82.7 ± 1.3% with TYR and 79.2 ± 2.5% with 
TYRP1). By contrast, HA-SLC45A2-labeled structures overlapped poorly with LAMP2, a 
membrane protein of lysosomes but not melanosomes, which are distinct organelles in 
eumelanin-generating melanocytes (Berson et al., 2001) (Figure 2.2c, d; overlap was 
34.4% ± 2.9% with LAMP2). Essentially identical results were observed for HA-SLC45A2 
transiently expressed in melan-Ink4a cells (Figure 2.3), which express endogenous 
SLC45A2. The degree of HA-SLC45A2 labeling on punctate subdomains vs. the 
melanosome limiting membrane was similar in transiently transduced melan-Ink4a and 
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stably transduced melan-uw cells. Together, these data indicate that SLC45A2 localizes 
to mature melanosomes, where it is often enriched in subdomains associated with the 
limiting membrane. 
Figure 2.2: HA-SLC45A2 localizes to melanosomes when expressed in SLC45A2-deficient 
melan-uw melanocytes.  (a-c) Melan-uw cells stably expressing HA-tagged SLC45A2 were fixed, 
labeled for HA (green) and for TYRP1 (a), TYR (b), or LAMP2 (c) (magenta), and analyzed by dIFM 
and bright field (BF) microscopy to visualize melanin. Insets of boxed regions are magnified 7.5 
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times. Scale bar, 10 m. SLC45A2 that localized to TYRP1- or TYR-labeled compartments (white 
arrows) or SLC45A2 (cyan arrowheads) and LAMP2 (white arrowheads) on separate 
compartments are indicated. (d) The percentage of compartments with both markers in a-c was 
quantified by manual counting of at least 13 cells each from 3 separate experiments. Colocalization 
is represented as mean ± SEM of label 1 vs label 2, in which the number of compartments 
containing both label 1 and label 2 is presented as a percentage of the total number of 
compartments containing label 2. The % colocalization between TYRP1 and LAMP2 was quantified 
as a negative control. Data are from 3 independent experiments with the following total sample 
sizes: 13 (TYRP1 vs HA; HA vs TYRP1; LAMP2 vs HA; HA vs TYRP1; TYRP1 vs LAMP2; LAMP2 
vs TYRP1) and 17 (TYR vs HA; HA vs TYR; HA vs Pigment; Pigment vs HA). Statistical significance 
was determined using one-way ANOVA with Tukey post hoc test for multiple comparisons; only 
significant differences are indicated. *, p < 0.05; **, p < 0.01; ****, p < 0.0001.  
 
 
Figure 2.3: HA-SLC45A2 localizes to melanosomes upon transient transfection in WT 
melanocytes. Transiently transfected WT melan-Ink4a cells expressing HA-SLC45A2 were fixed, 
labeled for HA (green) and either TYRP1 (a-e, magenta), TYR (f-j, magenta) or LAMP2 (k-o, 
magenta), and analyzed by dIFM and by bright field microscopy. Shown are individual bright field 
(BF) or labeled panels (a-c, f-h, and k-m), merged dIFM images (d, I, n) or merged HA and bright 
field images (e, j, o; bright field is pseudocolored blue); boxed regions are magnified 7.5X in insets. 
Scale, 10 m. 
 
2.3.3. SLC45A2 localizes to lysosomes and regulates lysosomal pH when 
ectopically expressed in HeLa cells. 
When expressed in non-melanocytic cells, many melanosomal proteins localize to 
late endosomes and lysosomes (Ambrosio et al., 2016; Bellono et al., 2016; Berson et al., 
2001; Bouchard et al., 1989; Calvo et al., 1999; Piccirillo et al., 2006; Simmen et al., 1999; 
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Sitaram et al., 2009; Vijayasaradhi et al., 1995). Indeed, when expressed in HeLa cells 
and analyzed by dIFM, HA-SLC45A2 was detected on LAMP1-containing lysosomes in 
distinct punctate microdomains associated with the limiting membrane (Figure 2.4a), 
similar to the distribution in some melanosomes in melanocytes. This indicates that 
SLC45A2 localizes to lysosomes when expressed ectopically in HeLa cells and retains its 
ability to accumulate in a membrane subdomain. 
Figure 2.4: HA-SLC45A2 expressed in HeLa cells localizes to lysosomes and neutralizes 
lysosomal pH. a. HeLa cells transiently transfected with HA-SLC45A2 were fixed, labeled for HA 
(green) and the lysosomal protein LAMP1 (magenta), and analyzed by dIFM. Merged image is at 
right. Insets of boxes are magnified 5-fold. Scale bar, 10 m. b. HeLa cells transiently transfected 
with LAMP1-mCherry alone, mCherry-OCA2, or HA-SLC45A2 and LAMP1-mCherry were 
incubated with Lysosensor DND-160, and analyzed by fluorescence microscopy with excitation 
wavelength 405. The W1/W2 emission ratio for mCherry-labeled endolysosomes was calculated 
and compared to that from a standard curve to define pH as described in Materials and Methods. 
Data represent mean ± SEM from 3 independent experiments with the following total sample sizes: 
319 LAMP1-mCherry+ endolysosomes, 391 OCA2-mCherry+ endolysosomes, and 299 HA-
SLC45A2/LAMP1-mCherry+ endolysosomes.  Statistical significance was determined using 
Welch’s ANOVA with Games-Howell test for multiple comparisons; only significant differences are 
indicated. ****, p < 0.0001. 
 
SLC45A2 was predicted to be a transmembrane transporter that influences 
melanosome pH (Bin et al., 2015; Newton et al., 2001). We have been unable to directly 
assess melanosomal pH in melanocytes using common cellular probes for lysosomal pH 
such as Lysotracker and Lysosensor because in our hands melanocytes fail to accumulate 
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these probes intracellularly. However, we previously showed that the OCA2 chloride 
channel expressed in HeLa cells localizes to lysosomes and neutralizes their lumenal pH, 
paralleling its role in neutralizing the lumenal pH of melanosomes to enhance TYR activity 
and melanogenesis in melanocytes (Bellono et al., 2014). We therefore tested whether 
SLC45A2 expression affects lysosomal acidification in HeLa cells using the pH-sensitive 
ratiometric dye Lysosensor DND-160. HeLa cells were transfected with either LAMP1-
mCherry alone as a negative control, mCherry-OCA2 as a positive control, or LAMP1-
mCherry and HA-SLC45A2 together to identify HA-SLC45A2-expressing cells by live 
imaging (cotransfection efficiency measured by immunostaining was >90%). Cells 
preincubated with Lysosensor DND-160 were imaged at two emission wavelengths, and 
an average emission ratio was calculated for individual mCherry-LAMP1-positive 
compartments (see Materials and Methods). The corresponding pH for the average 
emission ratio was determined using a pH curve generated in each experiment by 
incubation in buffers with different pH values. Our results show that the average pH of 
lysosomes containing HA-SLC45A2 was nearly one pH unit higher than the pH of control 
cells and similar to the pH of mCherry-OCA2-containing lysosomes (Figure 2.4b). These 
data indicate that, like OCA2, SLC45A2 can function to raise organellar pH, and suggest 
that in melanocytes SLC45A2 functions physiologically to raise melanosomal pH. 
2.3.4. SLC45A2 and OCA2 function at distinct stages of melanosome maturation. 
The similar function of SLC45A2 and OCA2 in neutralizing organellar pH led us to 
ask whether these transporters function at the same or distinct stages of melanosome 
maturation. We first used dIFM to compare the distribution of HA-SLC45A2 and HA-OCA2 
to melanosomes labeled by the mature melanosome marker TYRP1 in transiently 
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transfected melan-Ink4a cells. HA-SLC45A2 and TYRP1 were largely present in the same 
compartments (86.58 ± 1.25% of HA-SLC45A2 in TYRP1-containing structures, and 89.17 
± 1.32% of TYRP1 in HA-SLC45A2-containing structures; Figure 2.5a, e), and the 
fluorescence signal intensity within positive compartments was highly correlated (Figure 
2.5c). By contrast, although TYRP1 and OCA2 each primarily localize to subsets of 
pigment granules (Berson et al., 2001; Sitaram et al., 2012; Sitaram et al., 2009; 
Vijayasaradhi et al., 1991; Vijayasaradhi et al., 1995), they label only partially overlapping 
populations (58.57 ± 4.87% of HA-OCA2 in TYRP1-containing compartments, and 48.66 
± 5.32% of TYRP1 in OCA2-containing compartments; Figure 2.5b, e). Moreover, within 
those overlapping compartments, the fluorescence signal intensities of HA-OCA2 and 
TYRP1 over background correlated substantially less well than those of HA-SLC45A2 and 
TYRP1 (Figure 2.5d). These data suggest that OCA2 and SLC45A2 are enriched in 
melanosomes of distinct maturation stages, with SLC45A2 present in largely the same 
subset of mature melanosomes as TYRP1, while OCA2 occupies a partially different 
subset of melanosomes. 
The distinct localization patterns for OCA2 and SLC45A2 suggest that they might 
regulate the lumenal pH and pigmentation of melanosomes at different maturation stages. 
We therefore tested for potential differences in melanosome pigmentation in melan-uw 
cells and immortalized melan-p1 melanocytes from OCA2-deficient pink-eyed dilute mice. 
Electron microscopy can be used to define four stages of melanosome maturation based 




Figure 2.5: SLC45A2 and OCA2 occupy partially distinct melanosome subsets. (a, b) melan-
Ink4a cells transiently expressing either HA-SLC45A2 (a) or HA-OCA2 (b) were fixed, labelled for 
HA (green) and TYRP1 (magenta), and analyzed by dIFM and bright field microscopy. Insets of 
boxed regions are magnified 7.5 times. Scale bar, 10 m. White arrows, colocalization of HA-
SLC45A2 or HA-OCA2 to TYRP1-containing compartments at comparable relative intensities; 
white arrowhead, compartments with high HA-OCA2 and low TYRP1; cyan arrowhead, 
compartments with low HA-OCA2 and high TYRP1. (c, d) Quantification of the object-based 
fluorescence intensity of HA-SLC45A2 versus TYRP1 (c) or HA-OCA2 versus TYRP1 (d) in 10 
cells each from 3 independent experiments. Correlation coefficients (r2) of fluorescent intensities 
for each pair of markers is indicated.  (e) Manual quantification (mean ± SEM) of the % 
colocalization between TYRP1 and either HA-SLC45A2 or HA-OCA2 and TYRP1, shown as a 
percentage of total TYRP1-, SLC45A2-, or OCA2-containing compartments. Values are presented 
as label 1 vs label 2, in which compartments containing both label 1 and label 2 is indicated as a 
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percentage of total compartments containing label 2. Data are quantified from 3 independent 
experiments with the following total sample sizes: 13 (HA-SLC45A2) and 14 (HA-OCA2). Statistical 
significance was determined using Welch’s ANOVA with Dunnett T3 test for multiple comparisons; 
only significant differences are indicated. ****, p < 0.0001. 
 
Stages I and II lack pigment but are distinguished by the presence of disorganized 
intralumenal fibers (stage I) or well-organized fibrils in parallel intralumenal sheets (stage 
II). Stage III is defined by the appearance of pigment on the fibrils and stage IV by pigment 
throughout the organelle. Electron microscopy analyses showed that relative to either WT 
melan-Ink4a or "rescued" melan-uw cells stably expressing HA-SLC45A2 (melan-uw:HA-
SLC45A2), both melan-uw and melan-p1 cells harbored melanosomes of similar size and 
number, but with more stage III melanosomes and fewer stage IV melanosomes (Figure 
2.6a-e). However, only melan-p1 cells contained significantly more stage I/II 
melanosomes than the controls (Figure 2.6e). Moreover, although we could not quantify 
it, the amount of pigment on the fibrils in stage III melanosomes in melan-p1 cells 
consistently appeared to be lower than in melan-uw cells (Figure 2.6, panels b vs. c). 
Accordingly, quantitative melanin content assays showed that while both melan-uw and 
melan-p1 had dramatically lower melanin content than melan-Ink4a or melan-uw:HA-
SLC45A2 cells, the melanin content of melan-p1 cells was significantly lower than that of 
melan-uw (Figure 2.6f). These data indicate that loss of SLC45A2 results in a milder 
phenotype than loss of OCA2. Taken together with the data showing that SLC45A2 and 
OCA2 are found on different subsets of melanosomes (Figure 2.5), the most likely 






Figure 2.6: SLC45A2 is required for melanosomes to progress from stage III to stage IV. (a-
d) melan-Ink4a (a), melan-uw (b), melan-p1 (c), and melan-uw cells stably expressing HA-
SLC45A2 (melan-uw:HA-SLC45A2; d) were fixed and analyzed by conventional transmission 
electron microscopy. Insets of boxed regions on the left were magnified 4.5 times on the right. I/II, 
stage I/II melanosomes; III, stage III melanosomes; IV, stage IV melanosomes. Scale bars, 500 nm 
(left) and 200 nm (right). (e) The number of stage I/II, stage III, and stage IV melanosomes per cell 
was quantified for each of the cell lines and is shown as a percentage of total counted melanosomes 
per cell. For each stage, data represent the mean  SEM from the following number of independent 
experiments, cells, and melanosomes: melan-Ink4a (2, 54, 717), melan-uw (3, 49, 1292), melan-
p1 (2, 27, 626), and melan-uw:HA-SLC45A2 (3, 76, 1927). Statistical analyses were performed by 
Welch’s ANOVA with multiple comparisons to melan-Ink4a for each stage and Dunnett T3 test for 
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multiple comparisons. (f) Melanin content in cell lysates was determined by spectrometry relative 
to total protein content. Plat-E cells are included as a non-pigmented cell control. The data are 
presented as a percentage normalized to melanin content in melan-uw samples ± SEM and 
represent  at least 3 independent experiments performed in duplicate or triplicate. Statistical 
significance was determined by Welch’s ANOVA with Dunnett T3 test for multiple comparisons. 
Except where indicated, statistical comparisons were made relative to melan-uw. Note that all cells 
except melan-Ink4a and Plat-E were treated with 200 pM cholera toxin. **, p < 0.01; ***, p < 0.001; 
****, p < 0.0001; ns, no significant difference. 
 
2.3.5. OCA2 overexpression partially compensates for loss of SLC45A2 expression. 
Given that both OCA2 and SLC45A2 are capable of raising lysosomal pH when 
expressed in HeLa cells, we tested whether overexpression of either protein could 
compensate for the loss of the other. HA-SLC45A2, HA-OCA2, or HA-SLC35D3 as a 
negative control (see Figure 2.1) were transiently expressed by transfection in either 
Slc45a2-deficient melan-uw melanocytes or Oca2-deficient melan-p1 melanocytes, and 
the fraction of HA-positive cells that were pigmented after 3 days was quantified. As 
expected, very few melan-uw cells expressing HA-SLC35D3 were pigmented above 
background (19.88 ± 5.76%) whereas most HA-SLC45A2 expressing cells were 
pigmented (70.7 ± 5.85%; Figure 2.7a, b, g). Surprisingly, a large fraction of HA-OCA2-
expressing melan-uw cells were also pigmented (46.37 ± 6.29%; Figure 2.7c, g), 
suggesting that OCA2 overexpression can compensate for the loss of SLC45A2. By 
contrast, whereas HA-OCA2 expression restored pigmentation to melan-p1 cells (93.17 ± 
4.97%), HA-SLC45A2 expression was as ineffective at restoring pigmentation as the 
negative control HA-SLC35D3 (Figure 2.7d-f, h). Thus, overexpression of SLC45A2 
cannot compensate for the loss of OCA2. These data are consistent with a model in which 
sequential function of OCA2 and then SLC45A2 is required to modulate and maintain a 




Figure 2.7: OCA2 overexpression compensates for loss of SLC45A2-dependent 
melanosome neutralization in melanocyte pigmentation. SLC45A2-deficient melan-uw cells or 
OCA2-deficient melan-p1 cells were transiently transfected with negative control HA-SLC35D3 (a, 
d), HA-SLC45A2 (b, e), or HA-OCA2 (c, f), and fixed and labelled for HA (not shown). Bright field 
microscopy was used to visualize pigmented melanosomes within HA-positive cells. Scale, 10 m. 
(g, h) The number of HA-containing pigmented cells was quantified and is depicted as a mean 
percentage of total HA-containing (HA+) cells  SEM. Quantification is from the following 
independent experiments and total sample sizes: melan-uw + HA-SLC35D3 (3, 67), melan-uw + 
HA-SLC45A2 (9, 320), melan-uw + HA-OCA2 (9, 308), melan-p1 + HA-SLC35D3 (3, 62), melan-
p1 + HA-SLC45A2 (4, 137), melan-p1 + HA-OCA2 (4, 90). Statistical significance was determined 
using one-way ANOVA with Holm-Sidak’s test for multiple comparisons. *, p < 0.05; ***, p < 0.001; 





2.3.6. The light skin-associated SLC45A2-F374 variant protein is expressed at lower 
levels than the dark skin-associated SLC45A2-L374 variant. 
The major human SLC45A2 allele associated with light skin tone encodes a 
phenylalanine (F) instead of a leucine (L) at amino acid position 374, within the eighth 
transmembrane domain of the predicted 12-transmembrane domain-containing protein 
(Figure 2.8a). How does this single amino acid substitution impact pigmentation? We 
reasoned that the F374 variant could affect either protein folding/stability, localization to 
melanosomes, or transporter function within melanosomes. To begin to distinguish 
between these possibilities, we generated stable melan-uw cells expressing the HA-
tagged dark skin-associated L374 variant (as used in Figures 2.1-2.7), the HA-tagged 
F374 variant, or HA-SLC35D3 as a control (CTRL). Bright field microscopy analysis 
revealed that cells expressing HA-SLC45A2-F374 were darker than control cells but 
lighter than cells expressing HA-SLC45A2-L374 (Figure 2.8b), consistent with published 
results (Cook et al., 2009b). The observed phenotype was confirmed by quantitative 
melanin content assay, in which cells expressing HA-SLC45A2-F374 harbored 
significantly more pigment than control cells but less than cells expressing HA-SLC45A2-
L374 (Figure 2.8c). The lower level of pigmentation in cells expressing HA-SLC45A2-
F374 did not reflect reduced SLC45A2 mRNA expression, as quantitative RT-PCR 
analyses showed that melan-uw cells expressing HA-SLC45A2-F374 had 1.25-fold more 
SLC45A2 mRNA than the wild-type HA-SLC45A2-L374-expressing cells (Figure 2.8d). 
However, immunoblotting analyses of cell lysates for the HA-tagged proteins revealed that 
the HA-SLC45A2-L374 stable cell line expressed two-fold more HA-SLC45A2 than cells 
stably expressing the HA-SLC45A2-F374 variant (Figure 2.8e, f). These data indicate that 
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the reduced pigmentation conferred by the F374 variant is reflected by a post-translational 
reduction in SLC45A2 protein content.  
 
Figure 2.8: The human light skin-associated SLC45A2-F374 variant is expressed in 
melanosomes at lower levels than the dark variant.  (a) Schematic diagram of human SLC45A2 
primary structure, with transmembrane (gray cylinders), luminal and cytosolic domains (gray lines) 
indicated. An asterisk indicates the position of L/F374. (b) Stably transfected melan-uw cells 
expressing HA-SLC45A2-L374 (left), HA-SLC45A2-F374 (center), or HA-SLC35D3 as a negative 
control (right) were imaged by bright field microscopy to emphasize pigmentation levels. Bar, 10 
m.  (c-f) Stably transfected melan-uw cells expressing HA-SLC45A2-L374, HA-SLC45A2-F374, 
or HA-SLC35D3 (CTRL) were analyzed for (c) melanin content by quantitative spectroscopy assay, 
(d) SLC45A2 mRNA expression by quantitative RT-PCR, or (e, f) HA protein expression by 
immunoblotting relative to tubulin as a loading control. A representative immunoblot is shown in e; 
quantification of HA expression normalized to tubulin levels over three experiments is shown in f. 
All values are normalized to 100% for cells expressing HA-SLC45A2-L374. Each experiment was 
repeated at least three times. Statistical analyses were determined by Welch’s ANOVA with 
Dunnett T3 test for multiple comparisons (c, d) or one-way ANOVA with Dunnett’s test for multiple 
comparisons (f).  ns, no significant difference; *, p < 0.05; ***, p < 0.001; ****, p < 0.0001. 
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To test whether the reduced protein content of the F374 variant reflected increased 
protein degradation, we assessed the protein stability of each variant over time in stably 
transduced melan-uw cells. Cells were treated with cycloheximide (CHX) to block new 
protein synthesis, and the amount of HA-SLC45A2 remaining in cell lysates at different 
time points was assessed by immunoblotting. While the levels of both variants were 
substantially reduced by 32 h following CHX treatment, HA-SLC45A2-F374 was degraded 
at a higher rate than HA-SLC45A2-L374 (L374 half-life, 53.2 h; F374 half-life, 8.5 h) and 
was nearly completely eliminated by 32 h (Figure 2.9a, c). To determine whether the rapid 
decline in the HA-SLC45A2-F374 variant protein levels were dependent on proteasomal 
degradation, cells were treated with the proteasome inhibitor MG132 during the CHX 
chase. MG132 treatment nearly completely blocked the gradual disappearance of HA-
SLC45A2-L374, and also blocked the rapid degradation of HA-SLC45A2-F374 at early 
chase times (Figure 2.9b, c). MG132 treatment did not, however, block the slow 
degradation of HA-SLC45A2-F374 at later time points (Figure 2.9b, c). These data 
indicate that normal turnover of L374 and of the labile fraction of F374 requires 
proteasome activity, but that degradation of F374 occurs by a proteasome-independent 
mechanism. To test for the role of endolysosomal degradation, cells were treated with the 
vacuolar ATPase inhibitor bafilomycin A1 (BafA1) during the CHX chase. BafA1 treatment 
caused significant cell death by 24 h, but within the first 16 h blocked degradation of both 
HA-SLC45A2-L374 and -F374, suggesting that degradation was largely mediated in 
endolysosomes (Figure 2.10). Importantly, dIFM analysis showed that HA-SLC45A2-
F374 colocalized with TYRP1 to a similar extent as HA-SLC45A2-L374 (Figure 2.9d, e), 
indicating that the cohort of non-degraded HA-SLC45A2-F374 variant localizes properly 
to melanosomes where it retains some function in supporting elevated pH.   
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Taken together, these data suggest that the light skin-associated SLC45A2-F374 
variant is less stable than the dark skin-associated SLC45A2-L374 variant due to 
endolysosomal proteolysis that is proteasome-dependent, resulting in lower SLC45A2 
activity in melanosomes. 
Figure 2.9: The F374 variant is less stable than the L374 variant and is degraded by a 
proteasome-dependent endolysosomal pathway. (a, b) Melan-uw cells stably expressing either 
HA-SLC45A2-L374 (L374; a, b, top) or -F374 (F374;  a, b, bottom) were cultured with cycloheximide 
(CHX; 25 g/ml) alone (a) or combined with proteasome inhibitor MG132 (25 M; b) for the 
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indicated times in hours. At the indicated times, cells were harvested and whole cell lysates were 
fractionated by SDS-PAGE and analyzed by immunoblotting for HA and for vinculin as a loading 
control. Relevant regions of the gels are shown. (c) Band intensities for HA-SLC45A2 were 
quantified over three independent experiments, normalized to vinculin band intensities, and 
presented as a percentage of the signal observed at time 0 +/- SEM. (d) Band intensities for HA-
SLC45A2 after treatment for 8 h with CHX alone or with MG132 or 25 nM Bafilomycin A1 (BafA1; 
blots are shown in Expanded View Figure EV2) were quantified over three independent 
experiments, normalized to vinculin band intensities, and presented as a percentage of the signal 
for each isoform at time 0 ± SEM. Statistical significance of values relative to those at time 0 was 
determined using ordinary one-way ANOVA with Dunnett post-hoc test for multiple comparisons. 
Only statistically significant differences are noted. (e, f) Melan-uw cells stably expressing either HA-
SLC45A2-L374 (e, top) or HA-SLC45A2-F374 (e, bottom) were fixed, labeled for HA (green) and 
TYRP1 (magenta), and analyzed by dIFM and by bright field microscopy. Merged HA/TYRP1 image 
is at right; insets of boxed regions are magnified 7.5 times. HA-SLC45A2 and TYRP1 localizing to 
the same compartments are indicated with arrows. Scale, 10 m. (f) The degree of TYRP1 and 
SLC45A2 localization to the same compartments was quantified manually from 14 cells over 2 
independent experiments, and is presented as label 1 vs label 2, in which the colocalization 
between label 1 and label 2 is a percentage of total label 2. Quantification is from 2 independent 
experiments with 14 cells counted per sample. Statistical significance was determined using 
Kruskal-Wallis test with Dunn’s post hoc test for multiple comparisons. ns, no significant difference; 
*, p < 0.05. 
 
Figure 2.10: Early phase of rapid SLC45A2-F374 degradation is blocked by vATPase 
inhibition. (a) Melan-uw cells stably expressing either HA-SLC45A2-L374 (L374; a, left) or -F374 
(F374;  a, right) were cultured with cycloheximide and the vATPase inhibitor bafilomycin A1 (BafA1; 
25 nM) for the indicated times (h). Cells were then harvested and whole cell lysates were 
fractionated by SDS-PAGE and analyzed by immunoblotting for HA and for vinculin as a loading 
control. Relevant regions of the gels from a representative experiment are shown. (b) Band 
intensities for HA-SLC45A2 were quantified over three independent experiments, normalized to 
vinculin band intensities, and presented as a percentage of the signal observed at time 0 +/- SEM. 





SLC45A2 is a critical determinant of skin and eye pigmentation, but until now its 
localization and functional role in melanogenesis have not been clearly delineated. Using 
a functional epitope-tagged form of SLC45A2 expressed in immortalized SLC45A2-
deficient epidermal mouse melanocytes, we show here that SLC45A2 localizes to a subset 
of mature melanosomes marked by TYR and TYRP1 expression, where it partially 
accumulates in subdomains of the organelle outer membrane. When expressed 
ectopically in HeLa cells, SLC45A2 localizes to subdomains of the lysosomal membrane 
and functions to increase lysosomal pH, supporting a previously proposed role in 
neutralizing melanosomes (Bin et al., 2015). Although the melanosomal chloride channel 
OCA2 also functions to neutralize melanosome pH (Bellono et al., 2014), SLC45A2 
localizes to a partially distinct cohort of melanosomes, and SLC45A2-deficient 
melanocytes harbor melanosomes that are more pigmented than OCA2-deficient cells – 
together suggesting that SLC45A2 functions at a later melanosome maturation stage than 
OCA2. Accordingly, overexpression of OCA2 in SLC45A2-deficient melanocytes 
compensated for SLC45A2 deficiency in pigment production, whereas SLC45A2 
overexpression could not compensate for OCA2 deficiency. Although it is possible that 
these data reflect the distinct abilities of the OCA2 channel and the SLC45A2 transporter 
to modulate pH on the same melanosome subsets, the localization of these two proteins 
to partially distinct subsets lead us to conclude that SLC45A2 functions to neutralize 
lumenal pH at a later stage of melanosome maturation than OCA2. We also identified the 
mechanism underlying the pigmentation phenotype of the light skin-associated F374 
variant of SLC45A2. Although SLC45A2-F374 localizes to melanosomes like the dark 
skin-associated L374 variant, SLC45A2-F374 is less stable and more rapidly degraded 
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than -L374, resulting in reduced SLC45A2-F374 protein levels at steady state. Together, 
our data (1) indicate that SLC45A2 regulates melanogenesis by controlling melanosome 
pH in a manner that is non-redundant with OCA2 and (2) uncover the mechanism by which 
a common genetic variant imparts light skin color.   
Our data indicate that SLC45A2 localizes to the melanosomal membrane, where 
we propose that it directly functions to increase lumenal pH. This is analogous to other 
proteins on the melanosome membrane, such as the chloride channel OCA2 and the 
cation channel TPC2, which also directly regulate melanosome pH through ion transport 
(Ambrosio et al., 2016; Bellono et al., 2014; Bellono et al., 2016; Sitaram et al., 2009), and 
contrasts with ion transporters/channels that may indirectly regulate melanosome pH 
through effects on other organelles. For example, the putative solute transporter MFSD12 
negatively regulates pigmentation from lysosomes (Crawford et al., 2017) and NCKX5 
encoded by SLC24A5, the gene deficient in OCA6, appears to positively regulate 
pigmentation from the trans Golgi network (Ginger et al., 2008; Rogasevskaia et al., 2019). 
Together, these observations suggest that melanosome pH is regulated both directly and 
indirectly via a complex network of putative channels/transporters. Further work is 
necessary to identify other regulators of melanosome pH and to understand how these 
proteins cooperate to fine-tune the lumenal pH of melanosomes, thereby controlling 
melanin synthesis. 
When expressed at the plasma membrane in yeast, SLC45A2 functions as a 
sucrose/proton symporter that transports sucrose from the extracellular space into the 
cytosol in a manner that requires a proton gradient and is maximal at a slightly acidic pH 
(Bartölke et al., 2014). Interestingly, SLC45A2 and other SLC45 family members can 
transport not only the disaccharide sucrose but also the monosaccharides glucose, 
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fructose, and mannose (Bartölke et al., 2014). If it were to function similarly in 
melanocytes, SLC45A2 would expel protons and sugar molecules from the melanosome 
lumen into the cytosol, hence increasing melanosome pH.  Whether sugars are substrates 
for SLC45A2 under physiological conditions in melanosomes remains to be determined, 
but given that lysosomal enzymes are present within maturing melanosomes (Berson et 
al., 2001; Diment et al., 1995b), it is possible that monosaccharides released from 
glycoproteins by lysosomal glycosidases in early stage melanosomes could serve as 
substrates for sugar/proton symporter activity. Our data show that expression of SLC45A2 
in lysosomes of HeLa cells is sufficient to increase pH, indicating that its proton-dependent 
symporter activity is sufficient to raise lumenal pH by counteracting the activity of the 
vacuolar ATPase (vATPase), which pumps protons into the lumen of both melanosomes 
and lysosomes in an ATP-dependent manner (Bhatnagar and Ramalah, 1998; Mindell, 
2012; Tabata et al., 2008). Sugar co-transport from the melanosome into the cytosol would 
also decrease the osmotic concentration inside the melanosome, requiring counter-ion 
transport to balance solute concentrations. Further investigation into the melanosomal 
channels, transporters, and exchangers is required to understand how the melanosome 
regulates not only its pH but also its osmolarity. 
Unlike melanosomal proteins such as TYRP1 that are detected relatively uniformly 
on the melanosome membrane by IFM, SLC45A2 is sometimes detected in a punctate 
pattern, corresponding to specific subdomains of the melanosome membrane. The nature 
of these subdomains and the mechanism by which SLC45A2 assembles into them 
remains unclear. The punctate localization is conserved on lysosomes upon ectopic 
expression of SLC45A2 in non-pigmented HeLa cells, suggesting that the assembly of 
SLC45A2 into subdomains does not require interactions with melanocyte-specific 
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proteins. Some cells expressing HA-SLC45A2 displayed a mixture of punctate and ring-
like SLC45A2 patterns on melanosomes. This might either reflect an artifact of 
overexpression or the consequence of a regulated process of aggregate assembly that 
may be influenced by melanosome contents or other features of melanosome maturation. 
The composition, regulation and function of these SLC45A2-containing structures 
warrants further investigation. 
The high colocalization between SLC45A2 and TYRP1 suggests that SLC45A2 is 
co-delivered with TYRP1 to maturing melanosomes, likely via BLOC-1-dependent 
membrane transport (Setty et al., 2008; Setty et al., 2007). In contrast, despite similar 
requirements for BLOC-1 for delivery to melanosomes (Sitaram et al., 2012), there is 
significantly less overlap between OCA2 and TYRP1, and in structures in which they 
overlap their abundance is inversely related. Moreover, the relative melanin content of 
SLC45A2- and OCA2-deficient melanocytes is different, such that SLC45A2-deficient 
melanocytes harbor more mature melanosomes and slightly higher pigmentation than 
OCA2-deficient melanocytes. While these latter data alone could be interpreted to reflect 
distinct activities of OCA2 and SLC45A2 in facilitating increased melanosomal pH, 
together with the localization data they suggest that OCA2 functions at an earlier 
melanosomal maturation stage compared to SLC45A2. This would imply either that the 
melanosome delivery of OCA2 and TYRP1/SLC45A2 is staggered or that OCA2 is cleared 
soon after delivery. The latter is supported by the short half-life of OCA2 (Sitaram et al., 
2009), the dependence of this half-life on melanization (Donatien and Orlow, 1995), and 
the accumulation of OCA2 on internal membranes in mature melanosomes (Sitaram et 
al., 2012). Based on these observations, we propose a model in which OCA2, SLC45A2, 
and TYRP1 are delivered together to maturing melanosomes – which harbor active 
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vATPase to acidify their lumen (Bhatnagar and Ramalah, 1998; Tabata et al., 2008). 
OCA2 would facilitate a rapid efflux of chloride ions, immediately reducing membrane 
potential and thereby slowing vATPase activity. As the melanosomes mature, OCA2 
clearance from the limiting membrane coupled with continued SLC45A2 arrival would 
support a slow but continued melanosome neutralization mediated by SLC45A2 proton 
export, counteracting residual vATPase activity. If this model were true, then OCA2 
overexpression, by prolonging exposure on the melanosomal membrane, would 
antagonize vATPase activity in a more sustained way, perhaps resulting in slow proton 
efflux from the melanosome through another means such as membrane recycling (Dennis 
et al., 2016). This model would thus explain our observation that OCA2 overexpression 
can compensate for SLC45A2 loss but that SLC45A2 overexpression – with its limited 
capacity for proton export – cannot compensate for OCA2 loss.   
The SLC45A2-F374 variant is the predominant allele in Northern Europe and is 
strongly associated with light skin and hair and blue eyes (Branicki et al., 2008; Cook et 
al., 2009a; Lao et al., 2007; Lopez et al., 2014; Lucotte et al., 2010; Lucotte and Yuasa, 
2013; Mukherjee et al., 2013; Sabeti et al., 2007; Soejima and Koda, 2007; Soejima et al., 
2006; Yuasa et al., 2006). However, the mechanism responsible for the reduced 
pigmentation associated with SLC45A2-F374 was previously unclear. We show here that 
compared to SLC45A2-L374, expression of SLC45A2-F374 in SLC45A2-deficient 
melanocytes results in a more meager increase in pigmentation, despite higher levels of 
SLC45A2 mRNA. Our results demonstrate that this is due to instability of the SLC45A2-
F374 protein, leading to a higher rate of degradation relative to SLC45A2-L374 through a 
proteasome- and vATPase-dependent mechanism. Nevertheless, the remaining cohort of 
SLC45A2-F374 localizes appropriately to melanosomes. Thus, we propose that the 
86 
 
reduced pigmentation associated with the F374 allele is due to insufficient levels of 
SLC45A2-F374 on the melanosomal membrane to maintain optimal neutral pH for 
maximal TYR activity, thus resulting in decreased melanin synthesis. Whether SLC45A2-
F374 is rapidly degraded following melanosomal delivery or is missorted for 
endolysosomal degradation remains to be determined.    
In conclusion, our data significantly advance our understanding of SLC45A2 and 
its function on melanosomes and begin to unravel the stepwise contributions of SLC45A2 
and OCA2 to lumenal pH regulation and proper melanosome maturation. We also reveal 
the molecular basis explaining why the SLC45A2-F374 variant is a hypomorphic allele 
and propose a mechanism by which this allele contributes to lighter pigmentation in 
humans. The regulation of melanosome pH through the coordinated function of 
transporters, channels, and other proteins requires further investigation.  
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2.6. Materials and Methods 
2.6.1. Reagents 
Unless otherwise specified, chemicals were obtained from Sigma-Aldrich (St. 
Louis, MO) and tissue culture reagents from Life Technologies/Thermo Fisher Scientific 
(Waltham, MA). Protease inhibitors were purchased from Roche Diagnostics (Rotkreuz, 
Switzerland), gene amplification primers from Integrated DNA Technologies (Coralville, 
IA), GoTaq DNA polymerase from Promega Corp. (Madison, WI), and restriction enzymes 
and T4 DNA ligase from New England Biolabs (Ipswich, MA).  
 
2.6.2. Cell Culture 
Immortalized melanocyte cell lines melan-p1 (OCA2 deficient) from C3H-
Oca2cp/25H (pink-eyed dilute) mice (Sviderskaya et al., 1997), and "wild-type" (WT) melan-
Ink4a-Arf1 (formerly called melan-Ink4a-1; referred to here as melan-Ink4a or WT) from 
C57BL/6J-Ink4a-Arf−/− (Cdkn2 null) mice (Sviderskaya et al., 2002) have been described 
and were derived from the skins of neonatal mice. Three immortal SLC45A2 deficient 
melanocyte lines, melan-uw-1, -2 and -3, were similarly derived from the skins of neonatal 
C57BL/6J- Ink4a-Arf-/- Slc45a2uw/uw (underwhite) mice. Mice were housed and interbred by 
Dr Lynn Lamoreux (Texas A&M University, College Station, TX, USA), and skins were 
shipped on ice to London.  Only the melan-uw-2 line (referred to here as melan-uw) was 
used here because they were more uniform in pigmentation both before and after stable 
expression of HA-SLC45A2. All cells were cultured at 37˚C and 10% CO2 in RPMI 1640 
medium supplemented with 10% FBS (Atlanta Biologicals) and 200 nM 12-O-
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tetradecanoylphorbol-13-acetate (TPA). Melan-uw cells grow poorly in the absence of 
adenylate cyclase activators, which also stimulate the transcription of melanogenic genes. 
In order to properly compare them, melan-uw cells, melan-p1 cells, and all stable cell lines 
derived from these cells were additionally supplemented with 200 pM cholera toxin. Melan-
Ink4a cell medium was not supplemented with cholera toxin, but we expect that this might 
contribute to underestimating the differences between Melan-Ink4a and the other cell lines 
due to the increased expression of melanogenic genes in the latter. Cell lines were 
authenticated by restoration of pigmentation upon expression of the wild-type form of their 
defective genes, and verified to be negative for mycoplasma every 2-3 months using the 
MycoAlert Mycoplasma Detection Kit (Lonza). 
Retrovirus production from transiently transfected Plat-E cells(Morita et al., 2000a) 
and retroviral transduction of melanocyte cell lines were carried out as described 
previously (Meng et al., 2012a; Setty et al., 2007). Briefly, Plat-E cells were transfected 
with retroviral DNA constructs using Lipofectamine 2000 (Thermo Fisher), and the medium 
was replaced the next day. Retrovirus-containing supernatants were collected 48 h later, 
filtered, and added to melan-Ink4a cells or melan-uw cells in a 1:1 ratio with fresh medium. 
The medium was replaced the next day, and pools of stable transductants were selected 
24 h later by adding 300 μg/ml hygromycin B to the medium. Stable transfectants were 
occasionally treated with 200 µg/ml hygromycin B for 2–3 d to maintain selective pressure 
for the transgene. For transient transfections, cells on glass coverslips were transfected 
with DNA constructs using Lipofectamine 3000 or Lipofectamine 2000 (Thermo Fisher), 
and the medium was replaced the next day. Cells were fixed using 4% formaldehyde/PBS 




2.6.3. DNA Constructs 
We first generated a GFP-SLC45A2 (L374) fusion protein by inserting human 
SLC45A2 cDNA, generated by RT-PCR of RNA isolated from darkly pigmented human 
epidermal melanocytes, into the BamHI/Xhol sites of pcDNA4/TO (Invitrogen/Life 
Technologies) in frame with GFP and a Gly-Ala-Gly-Ala linker previously inserted in the 
AflII/HindIII sites (sequence available upon request). To generate HA-tagged SLC45A2, 
the insert from pcDNA4/TO-GFP-SLC45A2 was amplified by PCR adding XhoI and NotI 
restriction sites at the 5' and 3' ends, respectively, and subcloned into the respective sites 
of pCI (Promega). An N-terminal Kozak consensus start site, HA tag, and Gly-Ser linker 
were subsequently added by PCR using a distinct forward primer (5’-
gcatatctcgagatgTACCCATACGATGTTCCAGATTACGCTggctcaggatctgggatgggtagcaac
agtgggc-3’) and the same reverse primer. The HA-SLC45A2 insert was subsequently 
subcloned as a XhoI-NotI fragment into pBMN-(XN)-IRES-hygro to generate the retroviral 
vector encoding HA-SLC45A2. The F374 variant was made by site-directed mutagenesis 
of the pBMN-(XN)-IRES-hygro-HA-SLC45A2 (L374) construct using the Clontech site-
directed mutagenesis kit. All recombinant plasmids were verified by sequencing by the 
University of Pennsylvania Cell Center, the Nucleic Acid/Protein Research Core Facility 
at the Children's Hospital of Pennsylvania, or Macrogen. 
The plasmid-based expression vector pCR3-OCA2-WT-HA-UTR2 and 
corresponding retroviral vector pBMN-OCA2-WT-HA-UTR2 encoding human OCA2 with 
an exofacial HA epitope were described in (Sitaram et al., 2009); pCDM8.1-HA-SLC35D3 
encoding human SLC35D3 with an N-terminal HA epitope tag was described in (Meng et 
al., 2012a); and human LAMP1-mCherry in pCDNA3.1 was a generous gift from Sergio 




2.6.4. Melanin Content Quantification 
Melanin quantification by spectroscopy was done essentially as described 
(Delevoye et al., 2009a). Briefly, melanocytes seeded on 6-cm dishes were trypsinized, 
pelleted, and sonicated in melanin buffer (50 mM Tris, 2 mM EDTA, and 150 mM NaCl, 
pH 7.4) supplemented with protease inhibitor cocktail (Roche). Insoluble material was 
pelleted for 15 min at 16,000 g (4°C), rinsed in ethanol/diethyl ether (1:1), and dissolved 
in 2 M NaOH/20% DMSO at 60°C. The optical density at 492 nm was measured to 
estimate melanin content and normalized to protein concentration as determined by BCA 
protein determination kit (Thermo Fisher). Plat-E cells, an unpigmented cell line, were 
used as a negative control. Statistical significance from at least 3 independent 




Primary antibodies used and their sources (listed in parentheses) include: mouse 
monoclonal antibody TA99/Mel5 to TYRP1 (American Type Culture Collection; Rockville, 
MD); rat monoclonal antibody 3F10 to the HA11 epitope (Sigma); mouse monoclonal 
antibody 16B12 to the HA11 epitope (Biolegend); mouse monoclonal antibody H4A3 to 
human LAMP1 (Developmental Studies Hybridoma Bank, Iowa City, IA); rabbit anti-
LAMP2 (Abcam; for mouse melanocytes); rabbit anti-TYR (Pep7h, to the C-terminal 17 
amino acids of human TYR (Calvo et al., 1999)); mouse monoclonal antibody to γ-Tubulin 
(Sigma); and rabbit antibody to vinculin (E1E9V; Cell Signaling). Species- and/or mouse 
isotype–specific secondary antibodies from donkey or goat and conjugated to Alexa Fluor 
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488 or Alexa Fluor 594 used in IFM or conjugated to Alexa Fluor 680 or Alexa Fluor 790 
for immunoblots were obtained from Jackson ImmunoResearch Laboratories (West 
Grove, PA). 
 
2.6.6. Bright Field Microscopy, Immunofluorescence Microscopy (IFM), and 
Colocalization Analyses 
 IFM analyses of fixed cells were done essentially as described (Dennis et al., 
2016). Briefly, cells were plated on Matrigel (BD)-coated coverslips, fixed with 4% 
formaldehyde (VWR) in PBS, labeled with primary and secondary antibodies diluted in 
PBS/0.02% saponin/0.01% BSA, mounted onto slides using Prolong Gold 
(ThermoFisher), and analyzed on a Leica DMI-6000 microscope equipped with a 40× or 
63× objective lens (Leica; 1.4 NA), a Hamamatsu Photonics ORCA-Flash4.0 sCMOS 
C11440-22CU digital camera, and Leica Application Suite X (LAS X) software. Images in 
sequential z planes (0.2 m step size) were deconvolved with Microvolution software and 
further analyzed using ImageJ (http://fiji.sc/Fiji; National Institutes of Health). 
Because SLC45A2 localized partially to subdomains on the melanosome 
membrane and thus did not fully overlap other melanosomal markers, previously used 
automated methods to quantify colocalization did not yield meaningful values; similarly, 
OCA2 localized largely to the interior of melanosomes(Sitaram et al., 2012; Sitaram et al., 
2009) and was thus partially distinct from the distribution of TYRP1 or TYR cytoplasmic 
domain on the melanosome membrane. Therefore, quantification of the degree of overlap 
between two channels on individual organelles was performed manually on deconvolved, 
Z-projected images of cells in ImageJ. In brief, single-channel images and a merged image 
were synchronized using “Analyze > Tools > Synchronize Windows;” signals that were 
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localized to the same organelle were counted using the “Multi-Point” tool; remaining signal 
in single channels were counted using the “Multi-Point” tool; and the total colocalized 
structures was calculated as a percentage of total structures for each channel. Statistical 
significance was determined using one-way ANOVA with Tukey’s multiple comparisons 
test, Welch’s ANOVA with Dunnett T3 post hoc test, or Kruskal-Wallis test with Dunn’s 
multiple comparisons test where appropriate.  
Scoring of pigmentation in transfected melan-uw and melan-p1 cells was done 
blinded. Fixed, stained coverslips were randomly assigned numbers and samples were 
revealed only after images were taken and scored. Statistical significance was determined 
using one-way ANOVA with Holm-Sidak’s test for multiple comparisons. 
 
2.6.7. Fluorescence Intensity Analyses 
Object-based fluorescence intensity was measured using ImageJ as described in 
https://www.unige.ch/medecine/bioimaging/files/1914/1208/6000/Quantification.pdf. 
Briefly, 8-bit, single-channel images were opened in ImageJ and brightness and contrast 
adjusted for each image. The image was duplicated and a threshold applied using “Image 
> Adjust > Auto Local Threshold.” To multiply binary images of the two channels of interest, 
we used “Process > Image Calculator > Multiply.” To redirect intensity measurements from 
binary image to fluorescent image, we used “Analyze > Set measurements” and pulled 
down the “Redirect to:” menu to choose the appropriate fluorescent image, making sure 
“Area” and “Integrated density” were also checked. With "binary image" clicked, we used 
“Analyze > Analyze Particles” to measure object intensity. This was repeated for each 
channel, and for each sample values were normalized to the highest integrated density 
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value in each channel. At least 10 cells from each of two independent experiments were 
analyzed. 
 
2.6.8. Lysosomal pH Measurements 
HeLa cells were transfected one day prior to imaging experiments with LAMP1-
mCherry alone, mCherry-OCA2 alone, or HA-SLC45A2 and LAMP1-mCherry to identify 
endolysosomes, and incubated with 1 μM LysoSensor-ND160 (Thermo Fisher) for 5 min. 
Lysosensor was excited at 405 nm and its emission detected at 417-483 nm (W1) and 
490-540 nm (W2). The ratio of LysoSensor W1/W2 emission in endolysosomes 
expressing LAMP1-mCherry was assigned a pH value based on a calibration curve 
generated prior to each experiment using solutions containing 125 mM KCl, 25 mM NaCl, 
24 μM Monensin, and varying concentrations of MES to adjust the pH to 3.5, 4.5, 5, 5.5, 
6.5, 7, or 7.5. The fluorescence ratio was linear from pH 5 - 7.0. Statistical significance 
was determined by Welch’s ANOVA with Games-Howell post hoc test for multiple 
comparisons. 
 
2.6.9. Electron Microscopy 
Melanocytes were cultured in 10-cm dishes and fixed in situ with Karnovsky's 
fixative [4% paraformaldehyde (VWR Scientific, Radnor, PA), 4 mM calcium chloride, 72 
mM sodium cacodylate, pH 7.4] containing 0.5% glutaraldehyde (Polysciences, 
Warrington, PA) for 1–2 h at room temperature. This solution was then removed and 
replaced with Karnovsky's fixative containing 2% glutaraldehyde, and the cells were fixed 
overnight at room temperature. Cells were collected by scraping using a cell scraper and 
centrifugation at 27 g for 5 min, resuspended in Karnovsky's fixative containing 0.5% 
94 
 
glutaraldehyde, and stored at 4°C until processing. After subsequent buffer washes, the 
samples were post-fixed in 2.0% osmium tetroxide with 1.5% K3Fe(CN)6 for 1 hour at room 
temperature, and then rinsed in deonized water prior to en bloc staining with 2% uranyl 
acetate. After dehydration through a graded ethanol series, the tissue was infiltrated and 
embedded in EMbed-812 (Electron Microscopy Sciences, Fort Washington, PA) at the 
Electron Microscopy Resource Laboratory (University of Pennsylvania). Thin sections 
were stained with uranyl acetate and SATO lead and examined with a JEOL 1010 electron 
microscope fitted with a Hamamatsu digital camera (Hamamatsu, Bridgewater, NJ) and 
AMT Advantage NanoSprint500 software (Advanced Microscopy Techniques, Woburn, 
MA). 
For melanosome staging, a combined total of at least 20 cells from at least two 
independent experiments and over 600 melanosomes were analyzed for each cell type 
and the analysis was done blinded. The number of stage I/II, stage III, and stage IV 
melanosomes were quantified, and the percentage of melanosomes at each stage was 
calculated for each cell. These data were analyzed and plotted using Prism 6 (GraphPad, 
La Jolla, CA), and statistical significance was determined by Welch’s ANOVA with multiple 




Melan-uw cells stably expressing HA-SLC45A2-L374, HA-SLC45A2-F374, or HA-
SLC35D3 cultured in 60 mm Petri dishes were treated with 25 µg/ml cycloheximide ± 25 
µM MG-132 or ± 25 nM bafilomycin A1 and collected for immunoblot every 8 h for 32 h. 
For each time point the cells were rinsed in cold PBS before pelleting by centrifugation. 
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After collection of all time points, cell pellets were  resuspended in 1X Laemmli buffer 
(Laemmli, 1970), lysed by sonication, and heated at 37°C for 5 minutes. Protein 
concentration for each sample was measured using the BCA assay (Pierce) according to 
the manufacturer's protocol. 20 µg protein from each sample was fractionated by SDS-
PAGE on 10% polyacrylamide gels, and transferred to PVDF membranes (Immobilon-FL, 
Millipore). Membranes were blocked with 5% milk in TBS, incubated overnight with 
antibodies to HA or vinculin diluted in TBS/0.5% Tween, washed with TBS/0.5% Tween, 
and analyzed using Alexa Fluor 680 or 790-conjugated secondary antibodies and 
Odyssey imaging system (LI-COR, Lincoln, NE). For immunoblotting without drug 
treatments, the method was the same except that cycloheximide, MG-132, and bafilomcin 
A1 were not added and antibodies to tubulin were used for the loading control. Statistical 
significance was determined using one-way ANOVA with Dunnett’s test for multiple 
comparisons. Protein half-lives were calculated using one phase decay. 
 
2.6.11. Quantitative RT-PCR 
Total RNA was extracted from melan-uw cells stably expressing either HA-
SLC45A2, HA-SLC45A2-F374 or HA- SLC35D3 as a control using the RNeasy Plus Kit 
(Qiagen), and 3 µg was reverse transcribed (RT) using the SuperScript III kit (Life 
Technologies). The resulting cDNA was used for qPCR. Primers were designed using 
Primer3 (http://bioinfo.ut.ee/primer3-0.4.0/) to span an exon-exon junction to avoid 
amplification of any contaminating genomic DNA and were as follows: SLC45A2 
(NM_016180.3) - F: CCCTGTACACTGTGCCCTTT and R: 
CTTCCCTCTCACGCTGTTGT. Reactions were prepared according to the manufacturer’s 
protocol using SYBR Select Master Mix (Invitrogen/ThermoFisher Scientific) and cycled 
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on a Real-Time PCR System (Biorad).  β-actin was used as an internal control and all 
reactions were run in triplicate. mRNA levels were quantified by calculating average 2-∆∆Ct 
values, where Ct is the cycle number for the control and target transcript at the chosen 
threshold. ∆Ct = Cttarget - Ctβ-actin was calculated by subtracting the average Ct of β-actin 
from the average Ct of the target transcript. The ∆Ctmean was calculated for the reference 
sample (L374) and ∆∆Ct = ∆Ct - ∆Ctmean was calculated by subtracting the ∆Ctmean from 
the ∆Ct. The relative mRNA expression of samples compared to L374 samples was 
calculated by 2-∆∆Ct. Statistical significance was determined using Welch’s ANOVA with 
Dunnett T3 test for multiple comparisons. 
 
2.6.12. Statistical Analyses 
Except where noted, we performed each experiment three times and sample sizes 
are as indicated in each figure legend. Statistical data are presented as mean ± SEM. 
Statistics were calculated in GraphPad Prism using ordinary unpaired Student’s t test, 
ordinary one-way ANOVA, Welsh’s ANOVA, or Kruskal-Wallis test with post hoc correction 
as specified. Welsh’s ANOVA or Kruskal-Wallis tests were used instead of ordinary one-
way ANOVA when the data displayed heteroscedasticity or did not display a normal 
distribution, respectively, which were determined using Graphpad Prism. Significant 
differences between control or experimental samples are indicated (****, p < 0.0001; ***, 




Characterization of melanocytes derived from the Hermansky-Pudlak 





VPS33A encodes a Sec1-Munc18 (SM) protein that is ubiquitously expressed and 
is a subunit of the HOPS and CORVET complexes that promote fusion between 
organelles in the endolysosomal and autophagosome systems. A mouse model, buff, with 
a VPS33A-D251E mutation only has apparent defects in lysosome-related organelles 
(LROs), suggesting that the functions of VPS33A in endolysosomal maturation and LRO 
biogenesis have distinct requirements. We show that, contrary to a previous report, melan-
bf cells, immortalized melanocytes derived from buff mice, have enlarged melanosomes, 
a shift towards mature melanosomes, and overall hyperpigmentation at steady state. By 
bright field microscopy, we observe that the melanosomal marker TYRP1 largely localizes 
properly to melanosomes and the lysosomal marker LAMP2 properly segregates from 
melanosomes; however, a proportion of TYRP1 is punctate and diffuse throughout the 
cytoplasm, suggesting that a cohort of this protein is mistrafficked. We attempted to 
determine whether the VPS33A-D251E mutation was causative for these phenotypes by 
stably expressing human HA-VPS33A-D251E in wild-type immortalized melanocytes and 
knocking down endogenous VPS33A with short hairpin RNAs. Although enlarged 
melanosomes were observed in some cells, no significant quantitative differences in 
melanosome morphology or cargo localization were observed between cells expressing 
wild-type or buff mutant VPS33A. Our data show that melanosomes in buff melanocytes 
have a mild defect in melanosome biogenesis reflected by partial cargo mislocalization. 
Our inability to phenocopy these cells by expressing the VPS33A-D251E variant in wild-
type melanocytes suggests that the mutation may not be causative for these phenotypes. 
Overall, we conclude that the VPS33A-D251E mutation is permissive for pigmentation and 
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that other genetic or environmental factors must influence pigmentation status of buff 
melanocytes. 
3.2. Introduction 
Melanin is a biopolymer that confers pigmentation to skin, hair, and eyes and offers 
photoprotection against ultraviolet radiation and folate degradation, provides antioxidant 
effects, and is required during retinal development (D'Alba and Shawkey, 2019; d'Ischia 
et al., 2015; Valejo Coelho et al., 2016). Melanin is synthesized in melanosomes, 
specialized lysosome-related organelles (LROs) generated in melanocytes and 
pigmented epithelial cells (Marks and Seabra, 2001; Seiji et al., 1961). Defects in 
melanosome contents or assembly result in oculocutaneous albinism, which is associated 
with poor vision, increased sensitivity to UV-induced DNA damage in the skin, and 
increased incidence of skin cancers. Oculocutaneous albinism is one feature of the 
Hermansky-Pudlak Syndromes (HPS), a group of genetic diseases in which melanosomes 
and other LROs are impaired due to defective trafficking of cargo required for maturation 
of these organelles (Bowman et al., 2019; Wei, 2006). HPS has been associated with 
pathological mutations in 11 genes, which encode ubiquitously expressed proteins in 
multisubunit complexes that have specialized roles in cells containing LROs (Bowman et 
al., 2019; Pennamen et al., 2020a). However, 27% of individuals with albinism, including 
syndromic forms like HPS, do not have mutations in any of the known albinism genes. 
Furthermore, several mouse models of HPS exist with mutations in genes that have not 
been identified among human HPS patients, suggesting that other genes may be critical 
specifically for trafficking to LROs (Bowman et al., 2019; Lasseaux et al., 2018b).  
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The homotypic fusion and vacuole protein sorting (HOPS) and class c core 
vacuole/endosome tethering (CORVET) complexes promote membrane tethering and 
fusion in the late endosomal/lysosomal pathway and the early endosomal pathway, 
respectively (Balderhaar et al., 2013; Balderhaar and Ungermann, 2013; Peplowska et al., 
2007; Pols et al., 2013a; Seals et al., 2000; Solinger and Spang, 2013; van der Beek et 
al., 2019). Both complexes consist of a core complex of VPS11, VPS18, VPS16, and 
VPS33A (Peplowska et al., 2007; Seals et al., 2000). The core complex associates with 
either the HOPS-specific subunits VPS39 and VPS41 or the CORVET-specific subunits 
VPS3 and VPS8 (van der Beek et al., 2019), which exist on opposite ends of the complex 
and confer specificity through their interactions with small GTPases and effector proteins 
(Balderhaar et al., 2013; Brocker et al., 2012; Garg et al., 2011; Khatter et al., 2015; Lin 
et al., 2014; Marwaha et al., 2017; McEwan et al., 2015; Peplowska et al., 2007; Peralta 
et al., 2010; van der Kant et al., 2013). Engagement of both subunits with membrane-
associated small GTPases or effector proteins brings donor and target membranes 
together. CORVET and HOPS promote fusion through the VPS33A subunit (Akbar et al., 
2009; Gengyo-Ando et al., 2016; Lobingier and Merz, 2012; Wartosch et al., 2015). 
VPS33A is a Sec1/Munc18 (SM) protein that binds and aligns  vSNARE and tSNAREs for 
SNARE complex assembly and protects SNARE complexes from premature disassembly 
(Baker et al., 2015; Lobingier and Merz, 2012; Lobingier et al., 2014; Seals et al., 2000). 
Null mutations of HOPS or CORVET subunits are lethal in higher eukaryotes, but 
hypomorphic alleles or conditional knockouts of HOPS or CORVET subunits are viable. 
Mutations in HOPS or CORVET subunits have been described to cause LRO defects, 
including gut granules in Caenorhabditis elegans, secretory lysosomes in Tetrahymena 
thermophila, and defects in pigmentation in medaka, zebrafish, Drosophila melanogaster, 
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and mice, suggesting that HOPS and/or CORVET plays a role in LRO biogenesis (Akbar 
et al., 2009; Delahaye et al., 2014; Hermann et al., 2005; Pulipparacharuvil et al., 2005; 
Sadler et al., 2005; Sevrioukov et al., 1999; Shestopal et al., 1997; Sparvoli et al., 2018; 
Suzuki et al., 2003; Warner et al., 1998; Yu et al., 2006). The majority of these defects 
have been ascribed to mutations in HOPS rather than CORVET; the exception is in 
Tetrahymena thermophila which does not have HOPS but has 8 paralogs of VPS8 that 
function throughout the endolysosomal pathway (Sparvoli et al., 2018). Indeed, the VPS8 
paralog that is required for formation of secretory lysosomes colocalizes with the late 
endosomal/lysosomal marker Rab7, suggesting that this paralog functions similarly to 
HOPS subunits (Sparvoli et al., 2018). Together, these data indicate that HOPS rather 
than CORVET is likely to be involved in LRO biogenesis. However, how HOPS functions 
in the LRO biogenesis pathway is unclear. It may involve several levels of specificity, 
including HOPS-specific subunits binding to proteins on the melanosomal membrane and 
VPS33A binding to the SNAREs involved in melanosomal fusion. 
The buff (bf) mouse model is an HPS-like mouse model that displays 
hypopigmentation and prolonged bleeding (Dickie, 1964a; Suzuki et al., 2003), as well as 
progressive neuropathy and motor defects (Chintala et al 2009). Suzuki et al. show that 
melanocytes cultured from the skin of buff mice (melan-bf (Samaraweera et al., 1999)) are 
hypopigmented, that choroidal and retinal pigment epithelial tissue have decreased and 
smaller melanosomes, and that platelets have fewer dense granules; by contrast, there is 
little effect on the activity of two lysosomal enzymes in the kidney (Suzuki et al., 2003). 
There is no reported effect on life span. A missense mutation causing an aspartic acid to 
glutamic acid substitution at the conserved residue 251 was identified in the Vps33a gene 
in buff mice. Consistent with a role for this mutation in the disease phenotype, stable 
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expression of the wild-type (WT) Vps33a gene in melan-bf cells restored normal 
pigmentation as assessed by low magnification bright field microscopy (Suzuki et al., 
2003). The D251E mutation lies in VPS33A domain 3a, which has been shown to interact 
directly with vSNAREs (Graham et al., 2013). Although VPS33A-D251E is a conservative 
mutation, it is hypothesized that it would disrupt a hydrogen bond between Asp-251 and 
Ile-256 (Graham et al., 2013). Therefore, it is possible that this mutation affects VPS33A 
binding to vSNAREs.  
A few groups have attempted to determine the mechanism underlying the buff 
phenotype (Lobingier and Merz, 2012; Zhen and Li, 2015). Expression of Vps33-D300E, 
the yeast analog of the buff mutation, had no effect on vacuole morphology or trafficking 
to vacuoles, and the mutant-expressing yeast cells had a wild-type phenotype by all 
assays tested (Lobingier and Merz, 2012). However, a more dramatic mutation, D300G, 
displayed partial trafficking defects to the vacuole. This suggested that this conserved 
residue is required for normal VPS33A function, but that a conservative mutation at this 
residue is not sufficient to cause a phenotype in yeast (Lobingier and Merz, 2012). Zhen 
et al. showed that buff mice have impaired autophagy, and biochemical data using 
cerebellar lysates and mouse embryonic fibroblasts (MEFs) derived from buff mice 
suggest that VPS33A-D251E has an increased interaction with the autophagosomal 
vSNARE syntaxin 17 (Zhen and Li, 2015). They also show that overexpression of 
VPS33A-D251E in HEK293T cells replicates these data, leading the authors to propose 
that an increased interaction between VPS33A and syntaxin 17 acts in a dominant 
negative manner to reduce the availability of VPS33A for further rounds of fusion (Zhen 
and Li, 2015). However, there are several weaknesses to this model, including that the 
data contradict published reports on HOPS localization and a dominant negative function 
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does not correspond to a recessive gene. Nevertheless, overall the published data 
suggest that buff mice have defects in LROs and autophagy (Suzuki et al., 2003; Zhen 
and Li, 2015). However, the defect in melanosome biogenesis in buff mice has not been 
well-characterized. 
To analyze melanocytes and melanosomes from buff mice, we obtained melan-bf 
cells from the Spritz lab (Suzuki et al., 2003). Here, we compare the phenotype of melan-
bf cells to melan-Ink4a cells, derived from “wild-type” (WT) C57BL/6J-Ink4a-Arf-/- mice that 
express WT VPS33A. We show that, despite the hypopigmentation in buff mice and the 
reported hypopigmentation of melan-bf as reported by Suzuki et al., melanosomes are 
enlarged in melan-bf cells with increased melanin content, indicating that the VPS33A-
D251E mutation does not necessarily impede melanosome biogenesis and that other 
genetic or environmental factors likely influence pigmentation in melan-bf cells. 
 
3.3. Results 
3.3.1. Homozygous Vps33abf allele in melan-bf cells.  
Melan-bf cells were generously provided by Richard Spritz, who sent sixteen 
numbered vials (i.e. melan-bf #1, melan-bf #2, etc) of immortalized melanocytes cultured 
from buff mice and single-cell clones derived from these cells (Dickie, 1964a; 
Samaraweera et al., 1999; Suzuki et al., 2003). All vials were thawed and qualitatively 
characterized by light microscopy (data not shown). Of the sixteen vials sent, cells from 
twelve survived the thaw. Of these, only cells from one vial were lightly pigmented as 
reported by Suzuki et al. Cells from the other 11 vials were very darkly pigmented, and 
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each population contained a heterogenous mixture of melanosomes that were either 
unusually large or comparable in size to those of WT melan-Ink4a cells (Sviderskaya et 
al., 2002) (see Figure 3.2). Unlike the even cytoplasmic distribution of melanosomes seen 
in WT cells, melanosomes in some cells from each of these melan-bf populations were 
unusually clustered in the cell periphery (see Figure 3.2). Among these 11 populations, 
two were single cell clones that contained almost all enlarged melanosomes that 
accumulated around the cell periphery in most individual cells.  
 To confirm that the melan-bf cells expressed only the Vps33abf allele, each 
population was analyzed by RT-PCR for the Vps33a gene using both allele-non-specific 
primers and primers for wild-type or D251E Vps33abf alleles (Figure 3.1a). Figure 3.1b 
shows a representative analysis of melan-bf #1 (a single cell clone) and melan-bf #2 (an 
uncloned population) compared to melan-Ink4a cells. While melan-Ink4a cells were 
homozygous for the Vps33aWT allele, both melan-bf #1 and melan-bf #2 were homozygous 
for the Vps33abf allele. Suzuki et al. stably expressed Vps33aWT and Vps33abf and 
selected cells with hygromycin to rescue their cells (Suzuki et al., 2003). To determine 
whether these melan-bf cells overexpress Vps33abf, we performed RT-PCR with primers 
for the hygromycin resistance gene and used another cell line stably expressing the 
hygromycin resistance gene (melan-coa:HPS3) as a positive control. Neither melan-bf #1 
nor melan-bf #2 cells (nor any of the other cells tested; not shown) expressed the 
hygromycin resistance gene, confirming that these are untransfected melan-bf cells 
(Figure 3.1b). As a corollary experiment, cells were treated with hygromycin but, as 
expected given the PCR results, neither melan-Ink4a cells nor melan-bf cells were 
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resistant to hygromycin (data not shown). For the remaining experiments, we used melan-
bf #1 cells, which we refer to as melan-bf cells. 
 
Figure 3.1: Melan-bf cells are homozygous for Vps33abf allele. (a) Primer design to amplify 
Vps33a in a non-allele-specific manner (primer a + primer d) or specifically Vps33abf (primer b + 
primer d) or Vps33aWT (primer a + primer c). Sizes of expected PCR products are indicated on the 
figure. X marks the one-nucleotide difference between the WT and bf alleles, which was used to 
design allele-specific primers b and c. (b) cDNA reversed transcribed from total RNA purified from 
melan-Ink4a, melan-bf #1, melan-bf #2, and melan-coa:HPS3 (positive control for hygromycin 
resistance gene) was amplified by PCR using the primer sets described in panel a, and then 
analyzed by agarose gel electrophoresis. Lane #1, product using non-allele-specific primers a and 
d; Lane #2, product of Vps33abf-specific primers b and d; Lane #3, product of Vps33aWT-specific 
primers a and c. Primers for the hygromycin resistance gene (lane #4) were used to assess whether 
cells were transfected with a construct conferring hygromycin resistance. Positions of size markers 
(in bp) are indicated to the left, and positions of relevant bands are indicated to the right. Data 
presented are representative of n=3 independent experiments.  
 
Given  that these cells did indeed express only the Vps33abf allele, we were surprised 
that they were hyperpigmented rather than hypopigmented as previously reported 
(Nguyen and Wei, 2004; Suzuki et al., 2003). We considered whether growth conditions 
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might have contributed to the different phenotypes observed; for example, we have found 
that AP-3-deficient melanocytes from the HPS2 and HPS10 model pearl and mocha mice 
generate enlarged, hyperpigmented melanosomes when grown under limiting nutrient 
conditions or low serum (Setty et al., 2007; Jani et al 2015), but are hypopigmented when 
grown in sufficient medium with high serum (Theos et al., 2005; Sitaram et al. 2012) (and 
M.K. Dennis, unpublished observations). To test whether a similar phenomenon occurred 
in melan-bf cells, cells were cultured in RPMI medium with 10% or 20% fetal bovine serum 
(FBS). In addition, cells were cultured with or without cholera toxin (CT), which is 
sometimes included in melanocyte cultures to stimulate adenylate cyclase and bypass 
MC1R signaling (Bennett et al., 1987). We found that CT was not required for melan-bf 
growth, and that cells grew as effectively in both 10% FBS and 20% FBS (data not shown). 
The enlarged melanosome phenotype was seen in all culture conditions; therefore, RPMI 
with 20% FBS without CT was chosen for all further studies because cells recovered from 
thaw more quickly and proliferated well under these conditions. 
3.3.2. Melan-bf cells are hyperpigmented and contain enlarged, mature 
melanosomes.  
To compare melanosome morphology in melan-bf and WT melan-Ink4a cells, we 
used bright field microscopy and thin section transmission electron microscopy. 
Melanosomes in melan-bf cells were heterogeneously sized but consistently larger than 
melanosomes in melan-Ink4a cells (Figure 3.2a). This was confirmed by electron 
microscopy, in which melanosomes in melan-bf cells were on average almost 3 times 
larger in area than melanosomes in melan-Ink4a cells (Figure 3.2b, c). In a majority of 
melan-bf cells, melanosomes were concentrated in the perinuclear area or cell periphery 
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whereas in melan-Ink4a, melanosomes were distributed evenly throughout the cytoplasm 
(Figure 3.2a). Consistent with this observation, melanosomes occupied less area within 
melan-bf cells than melanosomes in melan-Ink4a cells (Fig 3.2d). An increase in 
melanosome area and a decrease in the percent area occupied by melanosomes 
suggests that there are fewer melanosomes in melan-bf cells than in melan-Ink4a cells. 
Despite this, melan-bf cells contain more melanin than melan-Ink4a cells do (Figure 3.2e), 
indicating that these larger melanosomes are more melanized. Using electron microscopy, 
we are able to evaluate melanosome maturation based on morphology and melanin 
content (Seiji et al., 1961). Stage I and stage II melanosomes are unpigmented but stage 
I melanosomes contain disorganized pre-fibrils and stage II melanosomes contain 
organized fibrils aligned in parallel across the melanosome. Stage III melanosomes have 
begun to accumulate melanin, which is deposited on the fibrils; and stage IV melanosomes 
are filled with electron dense pigment such that the fibrils are obscured. Quantification of 
melanosomes by electron microscopy showed that melan-bf cells had a decrease in stage 
III melanosomes and a corresponding increase in stage IV melanosomes compared to 
melan-Ink4a cells (Figure 3.2f). Although the EM results were from a single experiment 
that needs to be repeated, together these data show that melan-bf cells are 
hyperpigmented compared to WT melan-Ink4a cells despite having fewer melanosomes, 
likely due to the increased size and maturity of the melanosomes. 
We hypothesized that the enlarged melanosomes in melan-bf cells may be due to 
aberrant fusion. Melanocytes that are deficient in functional BLOC-3, a putative GTPase 
involved in the retrograde trafficking pathway from melanosomes that causes HPS when 
mutated, have macromelanosomes (Gardner et al., 1997; Suzuki et al., 2002) that 
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sometimes consist of multiple melanosomes fused together. However, by electron 




Figure 3.2: Melan-bf cells are hypopigmented and contain enlarged, mature melanosomes. 
(a) Melan-Ink4a and melan-bf cells were fixed and analyzed by bright field microscopy (a) or 
conventional transmission electron microscopy (b) to visualize melanosomes. In (a), the objective 
lens was 100X Plan Apo; boxed insets were magnified 5X; scale bar, 5 µm. In (b) insets of boxed 
regions were magnified 2X and shown on the right. III, stage III melanosomes; IV, stage IV 
melanosomes. Scale bar (left), 500 nm; scale bar (right), 250 nm. (c) Melanosome area was 
quantified from electron microscopy images and the data are represented as mean ± SEM from 
n=1 EM experiment. Each dot represents one melanosome analyzed; 369 melanosomes from 36 
melan-Ink4a cells and 132 melanosomes from 22 melan-bf cells were analyzed. Statistical 
significance was determined using a two-tailed Mann-Whitney test. (d) The area occupied by 
pigment granules was determined from bright field microscopy images and the data are 
represented as mean ± SEM from n=3 independent experiments with each closed circle represent 
one cell counted with 21 total melan-Ink4a and 32 total melan-bf cells counted. Statistical 
significance was determined by unpaired two-tailed t-test. (e) Melanin content in cell lysates was 
determined by spectrometry relative to total protein content. The data are represented as a 
percentage normalized to melanin content in melan-Ink4a cells ± SEM from n=3 independent 
experiments. Statistical significance was determined by two-tailed Mann-Whitney test. (f) The 
number of stage I/II, stage III, and stage IV melanosomes per cell was quantified for melan-Ink4a 
(black bars) and melan-bf (white bars) and is shown as a percentage of total counted melanosomes 
per cell. For each stage, data represent the mean ± SEM from n=1 EM experiment. 369 
melanosomes from 36 melan-Ink4a cells and 132 melanosomes from 22 melan-bf cells were 
analyzed. Statistical analyses were performed using two-tailed Mann-Whitney tests to compare 
melan-Ink4a and melan-bf samples for each stage. ****, p < 0.0001; ***, p < 0.001; **, p < 0.01; ns, 
no significant difference. 
 
 
Additionally, although stage III melanosomes were rare, in those present we observed 
that fibrils were well-organized and looked similar to stage III melanosomes in melan-Ink4a 
cells (Figure 3.2b). These data suggest that melanosomes in melan-bf cells do not 
undergo aberrant melanosome-melanosome fusion at stages III and IV, and that if 
melanosome-melanosome fusion occurs at all, it is likely prior to the maturation of fibrils 
into organized sheets in stage II.  
3.3.3. Melan-bf melanosomes have an increase in intralumenal vesicles that 
correlates with their increased size.  
Mature melanosomes are characterized by the accumulation of intralumenal vesicles 
(ILVs) (Hurbain et al., 2008; Jimbow and Fitzpatrick, 1974; Sitaram and Marks, 2012; 
Theos et al., 2005), much like in classical multivesicular endosomes as they mature from 
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early to late (Gruenberg, 2020). By electron microscopy, we observed intralumenal 
vesicles (ILVs) in many melan-bf melanosomes (Figure 3.2b). Quantification of ILVs 
revealed that, on average, melan-bf cells contained approximately 10-fold more ILVs per 
melanosome than did melan-Ink4a cells (Figure 3.3a). ILVs serve as the site for fibril 
nucleation during melanosome biogenesis and thus are critical for melanosome 
maturation (Berson et al., 2001; Hurbain et al., 2008; Raposo et al., 2001; Theos et al., 
2006b), but also may play a role in the distribution of enzymes and transporters in mature 
melanosomes (Sitaram and Marks, 2012; Theos et al., 2005). We wondered whether this 
increase in ILVs was a cause or effect of the observed phenotype in melan-bf cells and 
reasoned that if ILV formation was merely a downstream effect of increased melanosome 
size, then the number of ILVs per melanosome would correlate with melanosome area. 
We analyzed the correlation between number of ILVs and melanosome size and 
determined that the correlation was similar for both melan-Ink4a and melan-bf cells (r2 = 
0.413 and r2 = 0.418, respectively; Figure 3.3b). Therefore, for both melan-Ink4a cells 
and melan-bf cells, approximately 41% of the variance in ILV number can be explained by 
the variance in melanosome area. These data suggest that, although factors in addition 
to melanosome size likely play a role in determining ILV number, the increase in ILV 
number in melan-bf cells can be partially explained by the increase in melanosome area.  
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Figure 3.3: Melan-bf cells contain increased ILVs per melanosome due to increased 
melanosome area. (a) The number of ILVs per melanosome as observed by electron microscopy 
was quantified for melan-Ink4a and melan-bf cells. Data are shown as mean ± SEM from n=1 EM 
experiment and each closed circle represents one melanosome counted. 369 melanosomes from 
36 melan-Ink4a cells and 132 melanosomes from 22 melan-bf cells were analyzed. Statistical 
analyses were performed using two-tailed Mann-Whitney test. (b) The number of ILVs per 
melanosome versus the melanosome area was graphed and the squared correlation coefficient 
was determined using GraphPad Prism. Top, melan-Ink4a; Bottom, melan-bf. ****, p < 0.001. 
 
3.3.4. Melanosomal genes and proteins are decreased in melan-bf cells.  
We wondered if a change in melanosomal gene and protein expression could be 
observed in melan-bf cells. An increase in melanosomal gene expression may underlie 
the increase in melanosome size; alternatively, a decrease in melanosomal gene 
expression may explain the decrease in the number of early stage melanosomes. 
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Preliminary data from RT-qPCR analyses indicate that mRNA levels of Vps33a and the 
melanosomal genes Pmel, Tyrp1, and Tyr are reduced in melan-bf cells compared to 
mlean-Ink4a cells (Appendix Figure 1). To assess protein levels, cell lysates from melan-
Ink4a and melan-bf cells were analyzed by quantitative immunoblotting analyses using 
antibodies to VPS33A and the endogenous melanosomal proteins tyrosinase (TYR), 
tyrosinase-related protein 1 (TYRP1) and premelanosome protein (PMEL) (Figure 3.4a). 
The levels of VPS33A and TYRP1 in melan-bf cells were significantly reduced relative to 
melan-Ink4a, and the levels of TYR and the full-length PMEL P1 precursor were slightly 
but not significantly reduced (Figure 3.4). These data indicate that the VPS33A-D251E 
mutation causes a reduction in VPS33A gene and protein levels, supporting predictions 
about the mutation’s effect on protein stability based on structural data (Graham et al., 
2013), and that this may in turn cause reduced melanosomal gene expression and 
reduced TYRP1 protein expression. The significant reduction in TYRP1 protein levels and 
the slight but insignificant reduction in the protein levels of the other melanosomal proteins 
assayed could be a cause or consequence of melan-bf cells having enlarged, fewer 
melanosomes. Lower levels of melanosomal proteins may result in a decrease in 
melanosome biogenesis such that fewer melanosomes are generated but perhaps 
because the decrease in key melanosomal proteins is not dramatic, there are more 
melanosomal proteins per melanosome, resulting in increased melanin synthesis and 
melanosome growth. Alternatively, there may be a reduction in melanosomal proteins 
because there are fewer melanosomes; perhaps melanosomes become saturated with 
cargo and excess protein is degraded. How VPS33A controls this and whether this is 
direct (e.g. if VPS33A is involved in cargo trafficking) or indirect (e.g. if VPS33A function 




Figure 3.4: TYRP1 and VPS33A protein expression is decreased in melan-bf cells. (a, b) 
Whole cell lysates from melan-Ink4a and melan-bf cells were analyzed by immunoblotting for 
expression of the indicated melanosomal protein components relative to tubulin levels. A 
representative immunoblot (a) and quantification of band intensity relative to tubulin (b) are shown. 
Data are represented as mean ± SEM from n=3 independent experiments and are normalized to 
melan-Ink4a at 100%. Statistical analyses were determined by two-tailed Mann-Whitney test. **, p 
< 0.01; ns, no significant difference. 
 
3.3.5. Pigment granules contain TYRP1 but a proportion of TYRP1 is present in a 
distinct compartment in melan-bf cells.  
To assess whether melanosomal protein localization was affected in melan-bf 
cells, fixed cells were analyzed by bright field microscopy (BFM) and immunofluorescence 
microscopy with image deconvolution (dIFM) (Figure 3.5a). A similar percentage of 
pigment granules (i.e. melanosomes observed by BFM) colocalized with the melanosomal 
marker TYRP1 in melan-Ink4a and melan-bf cells (56% vs 62 %, respectively; Figure 
3.5b). However, a significantly smaller fraction of the total pool of TYRP1 colocalized with 
pigment granules in melan-bf cells than in melan-Ink4a cells (38% in melan-bf cells vs 
75% in melan-Ink4a cells; Figure 3.5c). Indeed, whereas in melan-Ink4a cells, the majority 
of TYRP1 puncta have a characteristic donut shape due to its localization to melanosomal 
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membranes, the majority of TYRP1 in most melan-bf cells are small puncta distributed 
throughout the cytosol (Figure 3.5a). Given our data (Figure 3.2) that melan-bf cells are 
depleted of early stage melanosomes, these data suggest that in melan-bf cells the 
majority of TYRP1 is mistrafficked or retained in transport intermediates.  They also 
suggest that the reduction in TYRP1 protein in melan-bf relative to melan-Ink4a might 
reflect mistrafficking towards lysosomes and consequent lysosomal degradation. 
Melanosomes and lysosomes both derive from the endosomal pathway and 
segregate as early endosomes mature to late endosomes (Raposo et al., 2001). A failure 
in this segregation could result in enlarged melanosomes, as observed in OA1-deficient 
melanocytes (Palmisano 2008; Giordano 2009). We thus asked whether these two 
compartments remained separate in melan-bf cells by assessing the localization of the 
lysosomal marker LAMP2 relative to pigment granules in melan-Ink4a and melan-bf cells 
(Figure 3.5a). LAMP2 distribution to pigment granules did not differ significantly between 
melan-Ink4a and melan-bf cells as a percentage of either pigment granules (24% in 
melan-Ink4a cells and 30% in melan-bf cells; Figure 3.5d) or LAMP2 (38% in melan-Ink4a 
cells and 36% in melan-bf cells; Figure 3.5e). However, while the data as a whole are not 
statistically significant, they do not capture appreciable cell-to-cell variation in melan-bf 
cells. Indeed, a substantial fraction of melan-bf cells showed an appreciable but low 
LAMP2 signal surrounding pigment granules (Appendix Figure 2).  Nevertheless, the level 
of overlap between TYRP1 and LAMP2 is even lower in melan-bf cells than in melan-
Ink4a (Figure 3.5f, g), suggesting that the LAMP2-labeled pigment granules represent a 
distinct maturation stage from TYRP1. It is possible that there is some degree of either 
LAMP2 trafficking to melanosomes or fusion between the two compartments, perhaps 
resulting in TYRP1 degradation. Based on these data, we conclude that TYRP1 is partially 
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mislocalized in melan-bf cells, that in the majority of cells the lysosomal and melanosomal 
pathways are well segregated, but that LAMP2 may be incorporated into melanosomes in 




Figure 3.5: Most pigment granules contain TYRP1 but a majority of TYRP1 does not localize 
to pigment granules. (a) Melan-Ink4a and melan-bf cells were fixed, immunolabeled for TYRP1 
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or LAMP2 (magenta), and analyzed by dIFM and bright field (BF) microscopy to visualize pigment 
granules. Insets of boxed regions are magnified 7.5 times. Scale bar, 10 µm. TYRP1 (white arrows) 
or LAMP2 (yellow arrows) that localized to pigment granules are indicated. Imaging was done with 
a 63X Plan apo lens. (b-e) Quantification of the percentage of overlap between: TYRP1 and 
pigment granules as a percentage of pigment granules (b) or of TYRP1 (c); LAMP2 and pigment 
granules as a percentage of pigment granules (d) or of LAMP2 (e). Data are presented as mean ± 
SEM from n=3 independent experiments with each closed dot representing each cell counted, with 
24 melan-Ink4a cells and 32 melan-bf cells counted. Statistical significance was determined using 




3.3.6. The endocytic pathway is normally segregated from melanosomes in melan-
bf cells.  
Since we observed increased LAMP2 localization to pigment granules in some melan-
bf cells, we assessed whether endolysosomal/melanosomal organelle identity was altered 
by labeling lysosomes with fluorescently labeled endocytosed cargo. Upon endocytosis, 
internalized materials are trafficked through the endolysosomal pathway to lysosomes. 
Previous work has shown that endocytosed cargo does not appreciably access 
melanosomes (Fujita et al., 2001; Raposo et al., 2001). Here, we pulsed melan-Ink4a and 
melan-bf cells transiently expressing TYRP1-GFP with Alexa Fluor 594-labeled dextran 
for four hours to allow for dextran uptake. Cells were then washed and chased for 16 hours 
to allow dextran to accumulate in lysosomes, and then analyzed by live cell confocal 
fluorescence microscopy. As observed in WT melan-Ink4a cells, TYRP1-GFP and dextran 
were predominantly in separate compartments in melan-bf cells (Figure 3.6a). Some 
instances of colocalization and sustained contact between the two markers could be 
observed by video microscopy in both melan-bf and melan-Ink4a (Figure 3.6b), but these 
represented a minority of captured events (data quantification will be forthcoming), and 
some instances of apparent colocalization are likely due to compartments in different z 
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planes. By this assay, we see no appreciable differences between the segregation of the 




Figure 3.6: The endocytic pathway is segregated from melanosomes in melan-bf cells. (a, b) 
Melan-Ink4a and melan-bf cells stably expressing TYRP1-GFP were pulsed with dextran-Alexa 
Fluor 594 for 4 hours, chased in dextran-free medium, and analyzed 16 h later by spinning-disk 
confocal microscopy at 2.5 fps using a 100X Plan Apo objective lens. (a) Single frames of cells 
representative of 3 independent experiments showing dextran (left), TYRP1 (middle), or merged 
images (right). Scale, 5 µm. (b) A time-lapse series of the insets in (a). The inset of melan-Ink4a 
cells was rotated 90° counterclockwise. Note that the first frame at time = 0 s is not the same frame 
as the one shown in (a). Arrows show prolonged contact or overlap between dextran-594-labeled 
compartment and TYRP1-GFP-labeled compartment. White and yellow arrowheads show short 
contacts between TYRP1-GFP-labeled compartments and dextran-594-labeled compartments, 
respectively. Note that GFP and Alexafluor594 images were captured simultaneously. Scale, 2 µm. 
 
3.3.7. Knockdown of endogenous VPS33A and overexpression of human VPS33A 
does not replicate the melan-bf phenotype.  
Considering that the phenotype that we observe in melan-bf cells is not the same 
as that described by Suzuki et al. (Suzuki et al., 2003), we wanted to test whether 
introduction of the Vps33aD251E mutation into WT melan-Ink4a cells would reproduce either 
phenotype. Initially, we attempted to knock in the Vps33aD251E mutation into melan-Ink4a 
cells using a CRISPR/Cas9-D10A nickase approach (Gasiunas et al., 2012; Mali et al., 
2013; Ran et al., 2013), but our attempts were unsuccessful potentially due to inefficient 
nucleofection in melanocytes. We then tried to knock out the endogenous Vps33a gene 
using a more standard CRISPR/Cas9 approach with paired sgRNAs (Jinek et al., 2012; 
Ran et al., 2013) with the intention of stably expressing WT VPS33A or VPS33A-D251E 
in knockout cells. However, we were unsuccessful in isolating a clone that lacked VPS33A 
expression, perhaps because VPS33A is necessary for viability in immortalized 
melanocytes. This was supported by a reduction in cell number, either due to cell death 
or reduced proliferation, upon infection of melan-Ink4a cells with recombinant lentiviruses 
expressing short hairpin RNAs (shRNAs) targeted to endogenous Vps33a relative to 
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control shRNA-expressing lentiviruses (data not shown); the reduced cell number was 
prevented upon expression of N-terminally HA-tagged human VPS33A, but not GFP-
tagged VPS33A, prior to knockdown of endogenous mouse Vps33a. These data suggest 
that Vps33a is essential for viability or proliferation, and that N-terminally HA-tagged 
VPS33A but not GFP-tagged VPS33A functions properly within HOPS and/or CORVET 
complexes. Therefore, to assess functionality of VPS33A-D251E in melan-Ink4a cells, we 
chose the approach of stably expressing HA-tagged control or mutant VPS33A and then 
knocking down the endogenous Vps33a using shRNA-containing lentiviruses. 
We hypothesized that the differences in our observed phenotype and the one 
published by Suzuki et al may be due to a cell adaptation over time (Suzuki et al., 2003). 
Therefore, we sought to assess cell phenotypes at early and late time points after shRNA 
knockdown. qPCR analyses in melan-Ink4a cells stably expressing HA-tagged human WT 
VPS33A and shRNA targeting mouse Vps33a or a nontarget control revealed that both 
shRNAs against Vps33a decreased endogenous mRNA levels at 4 days, 6 days, and 8 
days post-selection (Figure 3.7a). Additionally, expression of human VPS33A was high 
relative to expression of the housekeeping gene tubulin at all time points (Figure 3.7b), 
indicating that these cells overexpress the human gene and that it is not substantially 
targeted by shRNAs to the mouse gene. The pattern of expression was similar at 14 days 
post selection with low expression of endogenous Vps33a in cells stably expressing 
Vps33a-specific shRNAs and high expression of human VPS33A in all three samples 
(Appendix Figure 3a, b). Because enlarged melanosomes are the most consistent and 
obvious phenotype of our melan-bf cells, we quantified melanosome size in melan-Ink4a 
cells, melan-bf cells, and melan-Ink4a cells expressing either human WT VPS33A or 
VPS33A-D251E and shRNA targeting Vps33a or a nontarget negative control. Analyses 
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of cells imaged by bright field microscopy showed that pigment granules in melan-bf cells 
are significantly larger than in melan-Ink4a cells (Figure 3.7c, d), confirming that this 
quantification method, while less accurate than analyses of EM images, can sufficiently 
differentiate melanosomes in these populations based on size. However, there was no 
significant difference in pigment granule size between control melan-Ink4a cells  and 
melan-Ink4a cells expressing WT VPS33A/sh-nontarget, WT VPS33A/sh-Vps33a, 
VPS33A-D251E/sh-nontarget, or VPS33A-D251E/sh-Vps33a at 4 days post-selection 
(Figure 3.7c, d). Although there are no significant differences, there is a tendency for 
enlarged melanosomes to accumulate in cells expressing Vps33a shRNA relative to the 
nontarget control, regardless of which form of human VPS33A they express (Figure 3.7c, 
d). This suggests that knock down of the endogenous mouse VPS33A is the underlying 
cause, and that HA-tagged human VPS33A may be partially functionally impaired in 
mouse melanocytes despite 97.5% sequence identity with mouse VPS33A. At 14 days 
post-selection, the data are more variable but follow similar trends (Appendix Figure 3c). 
These data are thus inconclusive and do not yield firm insights into whether VPS33A-
D251E expression results in enlarged melanosomes. These experiments need to be 
repeated but performing EM and quantifying melanosome area would be more accurate 
and may yield statistically significant differences.  
To determine if our method of knockdown/replacement could potentially provide 
insights into a hypofunctional VPS33A mutant, we also depleted endogenous mouse 
Vps33a in cells overexpressing HA-tagged VPS33A mutants that are hypothesized, based 
on the structure of Vps33a from the fungus Chaetomium thermophilum, to disrupt 
VPS33A’s SNARE binding function. VPS33A consists of 4 domains arranged in a classical 
SM fold to accommodate SNARE binding and to coordinate SNARE complex assembly 
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(Baker et al., 2013; Baker et al., 2015; Graham et al., 2013). The D251E mutation lies in 
the core helix of domain 3a, which is conserved across all SM structures and is proximal 
to the site of R-SNARE binding (Graham et al., 2013). vSNAREs bind along the length of 
domain 3a, which has a conserved hinge residue at proline 342 that is proposed to allow 
flexibility for open/closed conformations to facilitate vSNARE and tSNARE complex 
binding (Baker et al., 2013; Baker et al., 2015). VPS33A-G308 is a residue in domain 3a 
that is required for vSNARE binding. Mutagenesis of the yeast ortholog of that residue, 
G338, to E results in loss of vSNARE binding without affecting tSNARE binding and, when 
expressed as the only form of Vps33a in yeast, induced the formation of mutant vacuolar 
structures (Baker et al., 2015). Therefore, we generated a VPS33A-G308E mutant to test 
how destabilization of vSNARE binding impacts melanogenesis. Additionally, the hinge 
residue, P342 in human VPS33A, is believed to be important for binding of both vSNAREs 
and tSNAREs as inflexibility in that residue is predicted to cause steric hindrance and 
prevent SNARE binding (Baker et al., 2013; Baker et al., 2015). While the importance of 
this residue has not been documented in published work, we hypothesized that mutating 
the conserved proline at residue 342 to a tyrosine might interfere with its open/close 
dynamics and separately might also interfere with tSNARE binding based on structural 
data (Rick Baker and Fred Hughson, personal correspondence), thereby interfering with 
SNARE binding in two ways. We also made a P342A mutation which might affect the 
residue’s hinge function but would not otherwise impact the tSNARE binding site. 
 We stably expressed human VPS33A-G308E, P342A, or P342Y in WT melan-
Ink4a cells, and then transduced cells with lentiviruses expressing shRNA to endogenous 
Vps33a. Cells expressing HA-tagged VPS33A-P342Y died even in the presence of 
endogenous Vps33a, suggesting either that this mutant functions in a dominant negative 
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fashion to inhibit SNARE binding or that there is a mutation in the plasmid outside of the 
CDS that affects antibiotic selection or causes cytotoxicity. For cells expressing VPS33A-
G308E and P342A and knocked down for endogenous Vps33a, pigment granule size does 
not show any consistent quantitative increase relative to those in WT melan-Ink4a cells 
either at 4 days or 14 days post-selection (Figure 3.7d and Appendix Figure 3). These 
data suggest that expression of these variants as the only VPS33A isoform in melan-Ink4a 
cells either does not cause a melanosome phenotype or that we have not chosen the 
optimal parameters to assess such a phenotype. Considering that G308 is a conserved 
residue and that expression of the G308E orthologue in yeast results in a vacuolar 
trafficking defect, we expect that the homologous mutation would impact VSP33A function 
in melanocytes. Therefore, in order to draw a conclusion regarding the role of VPS33A in 
melanosome biogenesis, we will need to assess these cells for the known VPS33A 








Figure 3.7: Expression of VPS33A variants in Vps33a knockdown cells does not phenocopy 
melan-bf cells. (a, b) Melan-Ink4a cells stably expressing HA-tagged WT VPS33A were infected 
with recombinant lentiviruses expressing nontarget shRNA or either of two shRNAs targeting 
mouse Vps33a and puromycin resistance. Cells were analyzed by qRT-PCR for mouse Vps33a 
mRNA expression (a) or human VPS33A mRNA expression (b) 4 days (black bars), 6 days (white 
bars), or 8 days (blue bars) post-selection with puromycin. Ct values of target genes were 
normalized to the Ct values of the housekeeping gene β-tubulin to determine relative expression 
levels. Statistical significance for values relative to sh-nontarget for each time point was determined 
using ordinary one-way ANOVA with Sidak’s test for multiple comparisons. (c) Representative 
images of melan-Ink4a cells, melan-bf cells, or melan-Ink4a cells stably expressing HA-tagged 
VPS33A (WT or D251E) and nontarget shRNA or Vps33a-1 shRNA at 4 days post-selection. Boxed 
inset is magnified 5 times. Scale, 10 µm. (d) The average pigment granule diameter per cell in µm 
was quantified and is depicted as mean ± SEM with each dot representing the average pigment 
granule size in one cell with the following number of cell quantified: 37, melan-Ink4a; 47, melan-bf; 
21, +HA-WT +sh-nontarget; 13, +HA-WT +shVps33a; 12, +HA-D251E +sh-nontarget; 15, +HA-
D251E, +shVps33a; 15, +HA-G308E +sh-nontarget; 12, +HA-G308E, +shVps33a; 13, +HA-P342A 
+sh-nontarget; 14, +HA-P342A +shVps33a. Quantification is from n=2 independent experiments. 
Statistical significance was determined using one-way ANOVA with Sidak’s test for multiple 
comparisons and comparisons were made to melan-Ink4a cells. Only statistical differences are 




Here we describe melan-bf cells with a different phenotype than what was 
previously published (Suzuki et al., 2003). These melan-bf cells have enlarged 
melanosomes with many cells having an accumulation of melanosomes around the cell 
periphery. We confirm that these cells express the buff allele of VPS33A and show that 
the cells have reduced mRNA and protein levels of VPS33A. Although TYRP1 protein 
levels are reduced in melan-bf cells, TYRP1 coats the limiting membranes of 
melanosomes, but the remaining TYRP1 is present in small punctate structures 
throughout the cytoplasm, suggesting that TYRP1 is partially missorted. Melanosomes 
appear to segregate normally from the endocytic pathway in melan-bf cells. We were 
unable to phenocopy melan-bf cells by expressing VPS33A-D251E or other variants with 
known or predicted SNARE-binding defects, but we hypothesize that experiments with 
higher resolution (EM) may yield insights into whether VPS33A-D251E causes the 
observed phenotypes. Overall, we find that dark pigmentation is not incompatible with the 
VPS33A-D251E mutation; therefore, this mutation does not interfere with an essential 
transport step in melanosome maturation. 
We show that, although most melanosomes in melan-bf cells are marked by 
TYRP1, the majority of TYRP1 does not colocalize with melanosomes. TYRP1 is 
distributed in small, punctate structures throughout the cytoplasm by IFM in some melan-
bf cells, suggesting altered trafficking. This may reflect a defect in BLOC-1-dependent 
protein sorting to melanosomes (Setty et al., 2007), or alternatively might be a function of 
melan-bf cells having fewer melanosomes than WT immortalized melanocytes as a 
destination for TYRP1 transport carriers. We will further investigate the BLOC-1 transport 
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pathway in melan-bf cells by assessing the localization of BLOC-1-dependent cargo OCA2 
and VAMP7 to determine if they are distributed similarly to TYRP1. Regardless, the fact 
that a substantial cohort of TYRP1 still localizes to melanosomes in these cells suggests 
that the VPS33A-D251E mutation does not interfere with an essential step in BLOC-1-
dependent transport. However, it is not known whether the other trafficking pathways to 
melanosomes are affected in melan-bf cells. To determine this, we will quantify localization 
of tyrosinase (TYR), a cargo of the AP-3-mediated vesicular pathway from endosomes, 
and DCT and MART-1, cargoes of the RAB6-dependent pathway from Golgi. However, 
based on the high level of melanization in melan-bf cells, it is likely that VPS33A does not 
play a critical role in these trafficking pathways. Additionally, our data suggest that the 
segregation of the endosomal and melanosomal pathways observed in WT melanocytes 
remains intact in melan-bf cells, as melan-bf and melan-Ink4a cells do not significantly 
differ in the degree of colocalization between TYRP1 and lysosomes marked by either the 
lysosomal membrane marker LAMP2 or internalized and chased fluorescent dextran. 
Together, our data point to a minor impairment in BLOC-1-dependent TYRP1 transport to 
melanosomes in melan-bf cells, but that this defect is not sufficient to impair the maturation 
of the reduced number of melanosomes in melan-bf cells or to impede melanization.  
Vps33a appears to be essential in mouse melanocytes. We observed that 
knockdown of VPS33A in melan-Ink4a cells is either lethal or prevents cell proliferation. 
While the requirement for functional HOPS has been shown previously in mammalian 
(Peng et al., 2012) and invertebrate animal models (Amsterdam et al., 2004; Lindmo et 
al., 2006; Maldonado et al., 2006; Pulipparacharuvil et al., 2005; Sadler et al., 2005; 
Schonthaler et al., 2008; Sevrioukov et al., 1999; Shestopal et al., 1997), this has not been 
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described in cell lines. Indeed, siRNA-mediated knockdown of CORVET and HOPS 
subunits in HeLa cells has been used extensively to elucidate the fundamental 
mechanisms of these complexes in the endocytic and autophagic systems (Banach-
Orlowska et al., 2018; Button et al., 2017; Jiang et al., 2014; Kvalvaag et al., 2014; 
Kvalvaag et al., 2013; Liang et al., 2008; Pols et al., 2013a; Pols et al., 2013b). It is 
possible that cell death is not observed due to the transient expression of siRNAs and the 
timing of experiments (72 hours post-transfection in most cases). However, shRNA-
mediated knockdown of VPS16 in mouse embryonic fibroblasts (Ganley et al., 2011)  and 
of VPS16 in human osteosarcoma cell line U2OS (Ding et al., 2019) has been described 
without any cell death or anti-proliferative effects reported, although it is unclear how long 
knockdown cells were cultured before experiments. One group generated heterogeneous 
pools of VPS39 knockout or VPS41 knockout HeLa cells that were used in assays 10 days 
after selection (Banach-Orlowska et al., 2018), potentially indicating that HeLa cells do not 
require HOPS to survive. However, the authors note that because single cell clones were 
not generated, mRNA and proteins levels of VPS39 and VPS41 were only reduced by 
~50%. Finally, one group showed that, although siRNA-mediated knockdown of VPS33A 
and of MTOR individually did not reduce cell viability in HeLa cells, knockdown of VPS33A 
and MTOR together increased cell death (Button et al., 2017). Data in this report suggest 
that the increased death may be due to the accumulation of autophagosomes due to 
reduced autophagosome-lysosome fusion (Button et al., 2017). Perhaps immortalized 
melanocytes are more sensitive to loss of VPS33A than other cell lines due to an 
increased requirement for autophagy or higher basal levels of autophagy. One group has 
shown that loss of autophagy in melanocytes due to Atg7 gene deletion induced cellular 
senescence (Zhang et al., 2015). Whether VPS33A knockdown causes cell death or 
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senescence in melanocytes and whether this is due to dysregulated autophagy is of 
interest. While it is unclear whether VPS33A functions directly in melanosome biogenesis, 
it is possible that it indirectly modulates melanosome biogenesis through its well-
characterized role in the endolysosomal or autophagic systems. Mice with melanocyte-
specific deletion of Atg7 have a mild hypopigmentation phenotype, and knockdown of 
autophagy-related genes in melanocytes affects pigmentation production (Ganesan et al., 
2008; Ho et al., 2011; Zhang et al., 2015), suggesting that autophagy is required for normal 
pigmentation. As mentioned previously, mutations in HOPS reduce autophagic flux due to 
its requirement for autophagosome-lysosome fusion (Jiang et al., 2014). Additionally, work 
from our lab has shown that knockdown of MFSD12, an ion transport protein of unknown 
function that is localized to lysosomes, increases pigmentation (Crawford et al., 2017), 
potentially due to disruption of normal lysosomal pH (Shanna Bowman, unpublished 
results). Therefore, mutations in VPS33A or HOPS may affect melanosome biogenesis 
and maturation through alterations in endolysosomal or autophagolysosomal 
homeostasis. The crosstalk between the endolysosomal pathway and melanosomes must 
be investigated further. 
To determine if the Vsp33a buff mutation was causative for the melanosome 
enlargement and TYRP1 mislocalization phenotypes, we attempted to replicate the 
phenotype by knocking down the endogenous Vps33aWT allele in melan-Ink4a cells stably 
expressing HA-tagged forms of human WT VPS33A and VPS33A-D251E. We did not 
observe any appreciable differences in melanosome size or TYRP1 localization in cells 
depleted of endogenous Vps33a KD cells and expressing either WT VPS33A or VPS33A-
D251E. These data suggest that the buff allele may not be responsible for causing the 
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phenotypes observed in melan-bf cells. Further, expression of HA-tagged human 
VPS33A, including the D251E, G308E, and P342A mutant forms of VPS33A,  was able to 
rescue the reduction in cell viability or proliferation that we observed in Vps33a knockdown 
cells, indicating that these proteins are largely functional.  
Our data directly contradict published observations that melan-bf cells are 
hypopigmented and that the pigmentation could be rescued by expression of WT mouse 
VPS33A but not of VPS33A-D251E (Suzuki et al., 2003). Not only do we observe a distinct 
and opposite phenotype, but we were unable to correct this phenotype by expression of 
human WT VPS33A. The differences in our results cannot be explained by a different 
source of cells, since our studies were performed with cells obtained from the Spritz lab 
who published those observations. However, in our hands, 11 out of 12 vials of melan-bf 
cells shared with us by the Spritz lab, including at least two single cell clones, contained 
enlarged melanosomes. Why is there a discrepancy between the cells described by 
Suzuki et al and the cells that they sent to us? It is possible that the buff mutation causes 
cells to be hypopigmented at first but that these cells accumulate enlarged melanosomes 
over time. However, we at no time observed hypopigmentation during thawing of melan-
bf cells. Moreover, our efforts to replicate the buff phenotype by knockdown/replacement 
of Vps33a in melan-Ink4a cells failed to show a consistent impact of VPS33A-D251E 
expression on pigmentation or melanosome size at either 4 or 14 days post-selection, 
suggesting that any phenotype observed in melan-bf cells might not reflect the Vps33a 
mutation.  While it is possible that different culture conditions might underlie these 
differences, our culture conditions match those reported in Suzuki et al. 
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The question remains: why do our melan-bf cells look so different from published 
data? Although the Spritz lab was the first to show images of cultured melan-bf cells in 
published work, they were not the original group who derived the cells from buff mice. The 
melan-bf cell line was first described by Seth Orlow’s group and although they did not 
publish images of the cells, they stated that “cultured melan-bf cells do synthesize 
melanin, and are nearly as dark as melan-a cells,” which, like melan-Ink4a cells, are WT 
melanocytes derived from C57BL/6J mice (Samaraweera et al., 1999). While this 
description does not match the characteristics of our melan-bf cells, it suggests that the 
cells published by the Spritz lab acquired a hypopigmented phenotype. However, 
hypopigmented melanocytes better match the pigment dilution observed in buff mice, 
which have a khaki-colored coat rather than a black coat (Dickie, 1964a; Nguyen and Wei, 
2004; Samaraweera et al., 1999; Suzuki et al., 2003) and have smaller melanosomes and 
fewer mature melanosomes observed by TEM in skin (Nguyen and Wei, 2004).  The 
description of melan-bf cells as normally pigmented (Samaraweera et al., 1999) is difficult 
to judge due to lack of images and the images of hypopigmented melan-bf cells (Suzuki 
et al., 2003) are low magnification and low resolution; however, that the hypopigmentation 
can be rescued by expression of Vps33aWT and that melanosomes are smaller in vivo 
suggest that VPS33A-D251E mutations cause decreased pigmentation and melanosome 
size and that the melan-bf cells described by Suzuki et al. are the true melan-bf cell 
phenotype (Suzuki et al., 2003).  Together, these data suggest that the melan-bf cells we 
obtained may have developed a secondary mutation that is dominant over the phenotype 
caused by VPS33A-D251E, which could explain why stable expression of WT VPS33A 
did not rescue the phenotype in our cells.  
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What could cause enlarged melanosomes? Increased melanosome size could be 
due to fusion between melanosomes, fusion of melanosomes with other organelles, or to 
increased trafficking of melanosomal cargo to maturing melanosomes. If fusion between 
melanosomes of stages II-IV were to occur, we would expect to see evidence by electron 
microscopy that the macromelanosomes would contain multiple individual melanosomes 
with distinct cohorts of PMEL fibrils. This was not the case, and instead we detected 
melanosomes in melan-bf cells that were large but proportionately normal in shape and 
fibril content. While it is possible that increased fusion occurs between stage I 
melanosomes prior to fibril formation, we did not detect any obvious enlargement of 
vacuolar early endosomes or multivesicular bodies in these cells. Enlarged melanosomes 
can be found in other models of altered pigmentation, such as in melanocytes with 
mutations in Hps1 and Hps4, subunits of the biogenesis of lysosome-related organelles 
complex-3 (BLOC-3) (Dennis et al., 2016; Gardner et al., 1997; Nguyen et al., 2002; 
Suzuki et al., 2002), or Gpr143 (Garner and Jay, 1980; Yoshiike et al., 1985). Although 
melanosomes in epidermal and choroidal melanocytes are enlarged (which may indicate 
differences in the requirement for BLOC-3 and downstream processes in the different 
melanocytes and RPE cells), high contrast EM show that these melanosomes appear to 
be fusion products of smaller melanosomes as the outer membrane of the melanosome 
is uneven and distinct ovoid regions of electron dense materials can be found within the 
macromelanosome (Dorothy Bennett, Elena Sviderskaya, and Ray Moss; private 
communications). This might reflect excessive fusion of mature melanosomes with each 
other and with late endosomes/lysosomes due to retention of available VAMP7, a SNARE 
protein involved in fusion events in the late endolysosomal and melanosomal systems 
(Dennis et al., 2016). However, our data indicate that our melan-bf melanosomes are a 
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single, enlarged organelle, suggesting that BLOC-3 mutations and melanosome-
melanosome fusion are not the underlying mechanism for our melan-bf phenotype. Finally, 
our data suggest that increased trafficking of TYRP1 to melanosomes does not occur in 
our melan-bf cells since an increased proportion of TYRP1 appears to be mistrafficked. 
However, whether this is true of other melanosomal cargo or whether specific 
melanosomal transport pathways are aberrantly affected in melan-bf cells remains to be 
seen.   
The phenotypes observed in our melan-bf cells has similarities to those of patients 
with ocular albinism type 1 (OA1) and OA1 mouse models (Garner and Jay, 1980; 
Yoshiike et al., 1985). OA1 is an X-linked form of albinism with more prominent impact in 
the eye and is caused by loss-of-function mutations in the G-protein-coupled receptor 
(GPCR) GPR143 (also known as OA1) (Innamorati et al., 2006; Schiaffino et al., 1999). 
GPR143 is hypothesized to regulate multiple aspects of melanosome biology, and it 
seems to play a critical role in the early stages of melanosome biogenesis. GPR143 
expression on multivesicular bodies (MVB) appears to prevent their fusion with lysosomes 
(Burgoyne et al., 2013), potentially defining the MVB subset that will mature into 
melanosomes. Indeed, analyses of the immediate effects of GPR143 knockdown show 
enlarged stage II melanosomes with disorganized fibrils (Giordano et al., 2009). Stable 
knockdown of GPR143 results in an accumulation of enlarged stage IV melanosomes, a 
decrease in stage II melanosomes, and concentration of melanosomes around the cell 
periphery (Cortese et al., 2005; Garner and Jay, 1980; Incerti et al., 2000; Palmisano et 
al., 2008; Yoshiike et al., 1985), indicating that long-term GPR143 knockdown results in a 
different phenotype than what is seen immediately after GPR143 knockdown. EM 
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analyses of the enlarged melanosomes in Gpr143 knockout (KO) mice show a dense core 
of melanin in the center surrounded by a halo of melanin, suggesting that these enlarged 
melanosomes are a result of excess growth and melanization of a single melanosome 
rather than fusion of multiple melanosomes, which would be expected to look disorganized 
in mature stages (Incerti et al., 2000). A dense core can be seen in some of our enlarged 
melan-bf melanosomes (Figure 3.2b), indicating that increased growth and not increased 
fusion may be the cause of increased melanosome size in our melan-bf cells. GPR143 
localizes to early and late stage melanosomes, where its ligand-binding site is in the 
melanosomal lumen and its downstream signaling pathway is in the cytoplasm (Schiaffino 
et al., 1999). Data indicate that GPR143 also localizes to the lysosomal pathway 
(Giordano et al., 2009; Piccirillo et al., 2006), but whether GPR143 functions similarly in 
both pathways is unknown. The endogenous ligand for GPR143 is unknown; one group 
proposes that it is L-DOPA, allowing GPR143 to act as a sensor for melanin synthesis 
(Lopez et al., 2008), but this is highly controversial. GPR143 signaling regulates the 
expression of Mitf (Chen et al., 2016; Falletta et al., 2014), a transcription factor that 
controls melanosomal gene expression and regulates melanocyte biology. Additionally, 
GPR143 signaling might also regulate the switch between microtubule-dependent 
melanosome transport towards the perinuclear region and actin-dependent transport 
towards the cell periphery, explaining why loss of GPR143 results in exclusion of 
melanosomes from the perinuclear area (Palmisano et al., 2008). Because many of the 
characteristics of GPR143 mutant cells have also been observed in our melan-bf cells, we 
hypothesize that the GPR143 signaling pathway may be impacted in our melan-bf cells.  
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Overall, we show that melanocytes expressing point mutations in VPS33A are able 
to synthesize melanin and undergo melanosome maturation. These data raise questions 
about whether VPS33A functions directly in the melanosomal pathway. Additionally, these 




3.5. Materials and Methods 
3.5.1. Reagents 
Unless otherwise specified, chemicals were obtained from Sigma-Aldrich (St. 
Louis, MO) and tissue culture reagents from Life Technologies/Thermo Fisher Scientific 
(Waltham, MA). Protease inhibitors were purchased from Roche Diagnostics (Rotkreuz, 
Switzerland), gene amplification primers from Integrated DNA Technologies (Coralville, 
IA), GoTaq DNA polymerase from Promega Corp. (Madison, WI), and restriction enzymes 
and T4 DNA ligase from New England Biolabs (Ipswich, MA). 
 
3.5.2. Cell culture 
Immortalized melanocyte cell lines “wild-type” (WT) melan-Ink4a-Arf1-/- (formerly 
called melan-Ink4a-1; referred to here as melan-Ink4a or WT) from C57BL/6J-Ink4a-Arf-/- 
(Cdkn2 null) mice (Sviderskaya et al., 2002) and melan-bf cells (Samaraweera et al., 
1999) have been described and were derived from the skins of neonatal mice. Numbered 
vials of melan-bf cells (#1, #2, etc) were generously provided by Richard Spritz (Suzuki et 
al., 2003) and for figures 2-7, only melan-bf #1 cells, referred to as melan-bf, were used 
because they were uniform in phenotype. The immortalized melanocyte line melan-coa 
has been described and was derived from the skins of neonatal C57BL/10J-Hps3coa/coa 
mice (Suzuki et al., 2001). Melan-coa cells stably expressing HPS3 were used as a 
positive control for the expression of the hygromycin resistance gene. All cells were 
cultured at 37°C and 10% CO2 in RPMI 1640 medium supplemented with 20% FBS 
(Atlanta Biologicals) and 200 nM 12-O-tetradecanoylphorbol-13-acetate (TPA). Melan-
Ink4a and melan-coa cells are typically grown in 10% FBS but were changed to medium 
containing 20% FBS 2-3 days prior to an experiment in order to keep conditions consistent 
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between all cell lines. Cell lines were authenticated by allele-specific amplification of the 
Vps33a gene and were verified to be negative for mycoplasma every 2-3 months using 
the MycoAlert Mycoplasma Detection Kit (Lonza). 
Retrovirus production from transiently transfected Plat-E cells (Morita et al., 2000b) 
and retroviral transduction of melanocyte cell lines were carried out as described 
previously (Meng et al., 2012b; Setty et al., 2007). Briefly, Plat-E cells were transfected 
with retroviral DNA constructs using Lipofectamine 2000 (Thermo Fisher), and the medium 
was replaced the next day. Retrovirus-containing supernatants were collected 48 h later, 
filtered, and added to melan-Inka4, melan-bf, or melan-coa cells in a 1:1 ratio with fresh 
medium and TPA. The medium was replaced the next day, and pools of stable 
transductants were selected 24 h later by adding 300 µg/mL hygromycin B to the medium. 
Stable transfectants were occasionally treated with 200 µg/mL hygromycin B for 2-3 d to 
maintain selective pressure for the transgene.  
To produce lentivirus, HEK-293T cells were transfected with lentiviral DNA 
constructs using Lipofectamine 2000 (Thermo Fisher), and the medium was replaced the 
next day. Lentivirus-containing supernatants were collected 48 h later, filtered, and added 
to melan-Ink4a cells in a 1:1 ratio with fresh medium and TPA. The medium was replaced 
the next day, and pools of stable transductants were selected 24 h later by adding 2 µ/mL 
puromycin to the medium.  
 
 
3.5.3. DNA constructs 
The pBMN-IRES-hygro XN plasmid encoding HA-tagged human wild-type 
VPS33A and GFP-tagged human wild-type VPS33A were generated by subcloning the 
NotI-HA-VPS33A-XhoI or NotI-GFP-VPS33A-XhoI cDNA fragments from pEGFP-C3-
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VPS33A into the pBMN-IRES-hygro XN vector (Setty et al., 2007). pBMN-IRES-hygro XN 
plasmids encoding HA-tagged or GFP-tagged VPS33A mutants D251E, G308E, P342A, 
and P342Y were generated by site-directed mutagenesis using the Q5 Site-Directed 
Mutagenesis Kit (New England Biolabs) on the WT VPS33A plasmids according to 
manufacturer’s protocol. The pBMN-IRES-Hygro-X/N-TYRP1-EGFP encoding EGFP-
tagged human TYRP1 and pBMN-hHPS3-IRES-Hygro N/X encoding human HPS3 have 
been described (Dennis et al., 2015). 
pLKO.1-puromycin derived lentiviral vectors (Stewart et al., 2003) for small hairpin 
RNAs (shRNAs) against Vps33a and non-target shRNAs were obtained from the High-
throughput Screening Core of the University of Pennsylvania. Vps33a #1 sense sequence: 
GCG ACC ACT AAA CTG ATG AAT; Vps33a #2 sense sequence: GCT GAT GTC AAG 
AAC ATC ATT; non-target sense sequence: GCG CGA TAG CGC TAA TAA TTT 
All constructs were verified by sequencing by the Nucleic Acid/Protein Research 
Core Facility at the Children's Hospital of Pennsylvania, the Center for Applied Genomics 
Sequencing Core at the Children’s Hospital of Pennsylvania, or by the University of 




Primary antibodies and their sources (listed in parentheses) include: mouse 
monoclonal antibody TA99/Mel5 to TYRP1 (American Type Culture Collection; Rockville, 
MD); rat anti-LAMP2 (GL2A7; Developmental Studies Hybridoma Bank); rabbit anti-
PEP7h-msm to the cytoplasmic domain of TYR (Berson et al., 2000); rabbit anti-PEP13 
to the C-terminus of PMEL (Berson et al., 2001); rabbit anti-TYRP1 (H-90; Santa Cruz); 
rabbit anti-VPS33A  (16896-1-AP; ProteinTech); and mouse anti-γ-tubulin (GTU88; 
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Sigma). Species-specific secondary antibodies from donkey and conjugated to Alexa 
Fluor 488 or 594 were used for dIFM or to IRDye-790CW or IRDye-680LT for 




3.5.5. PCR and Touchdown PCR 
RNA was extracted from pelleted cells using the RNeasy Plus Mini kit (Qiagen) 
and DNase treatment (Invitrogen). cDNA was synthesized using 1 ug RNA per reaction 
with the High Capacity RNA-to-cDNA kit (Applied Biosystems) according to 
manufacturer’s instructions and the resulting cDNA was used for PCR or Touchdown PCR 
(Korbie and Mattick, 2008) using 2X GoTaq Green Master Mix (Promega) and PCR 
products were analyzed on a 2% agarose gel containing SYBR Safe DNA Gel Stain 
(Invitrogen). Primers used are as follows: 
Vps33a – F: 5’ GTG TTC CCC GTG TTT GAT AAC C 3’ and R: 5’ GCG TTG AAG 
TTC TTG TCT CGG 3’   
Vps33a (WT allele encoding D251) – F: 5’ CTC ACG TAT GAA GGC CTC ATC 
TAT 3’ and R: 5’ GCG TTG AAG TTC TTG TCT CGG 3’   
Vps33a (buff allele encoding D251E) – F: 5’ GTG TTC CCC GTG TTT GAT AAC 
C 3’ and R: 5’ GTT CTG AAT GCC GTA AAT CCC C 3’ 
Hygromycin resistance gene – F: 5’ TGG CAA ACT GTG ATG GAC GA 3’ and R: 
5’ GGC GAC CTC GTA TTG GGA AT 3’  
PCR for Vps33a was run as follows: 1. 95°C, 3 min; 2. 95°C, 30 sec; 3. 56°C, 30 
sec; 4.72°C, 30 sec; 5. Repeat from step 2 for 35 cycles; 6. 72°C, 5 min; 7. 12°C, hold. 
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PCR for the hygromycin resistance gene was the same except step 3 was performed at 
67°C.  
Touchdown PCR for allele-specific priming was run as follows: 1. 95°C, 3 min; 2. 
95°C, 30 sec; 3. 61°C, 30 sec; 4. 72°C, 30 sec; 5. Repeat from step 2 for 7 cycles @ -
1°C/cycle; 6. 95°C, 30 sec; 7. 53°C, 30 sec; 8. 72°C, 30 sec; 9. Repeat from step 6 for 20 
cycles; 10. 72°C, 5 min; 11. 12°C, hold. 
 
 
3.5.6. Bright field microscopy (BFM), immunofluorescence microscopy (IFM), and 
area occupied and colocalization analyses 
BFM and IFM analyses of fixed cells were done essentially as described (Dennis 
et al., 2016). Briefly, cells were plated on Matrigel (BD)-coated coverslips, fixed with 4% 
formaldehyde (VWR) in PBS, labeled for IFM with primary and secondary antibodies 
diluted in PBS/0.02% saponin/0.01% BSA, mounted onto slides using Prolong Gold 
(ThermoFisher) and anlyzed on a Leica DMI-6000 microscope equipped with a 63x or 
100x objective lens (Leica; 1.4 NA), a Hamamatsu Photonics ORCA-Flash4.0 cMOS 
C11440-22CU digital camera, and Leica Application Suite X (LAS X) software. Images in 
sequential z planes (0.2 µm step size) were deconvolved using Microvolution software 
(Biovision Technologies) and further analyzed with ImageJ (http://fiji.sc/Fiji; National 
Institutes of Health). 
The percent area occupied within a cell was quantified using ImageJ on wide-field 
bright field images. Single z planes of cells were cropped and binary images were 
generated using the Make Binary tool. A region of interest (ROI) excluding the nucleus 
and perinuclear area was drawn and the Analyze Particles function with particles from 0.1-
2 µm included was used to calculate the percent area occupied. 
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Because TYRP1 localized to melanosomes in a donut-shape and thus did not fully 
overlap with pigment granules, automated counting could not be reliably used to quantify 
colocalization. Therefore, quantification of overlap between channels was performed 
manually and quantification of single channels was automated, both in ImageJ. In brief the 
following method for manual quantification of overlap was used: single-channel images 
and a merged image were synchronized using “Analyze > Tools > Synchronize Windows;” 
a ROI excluding the nucleus and perinuclear area was drawn around the cell; and signals 
that were localized to the same organelle were counted using the “Multi-Point” tool. For 
quantification of single channels: a thresholded image was generated using the Auto Local 
Threshold Tool (Bernsen method); a binary image was generated using the Make Binary 
tool and Watershed segmentation was performed to ensure close particles were counted 
separately; the same ROI used to quantify overlap was applied to the image; and the 
Analyze Particles tool with particles from 0.1-2 µm included was used to calculate the 
number of particles sin the ROI. The number of particles manually counted in the 
overlapped images was divided by the number of particles quantified in the single 
channels to calculate percent colocalization. 
 
 
3.5.7. Melanin Content Assay 
 
Melanin quantification by spectroscopy was done essentially as described 
(Delevoye et al., 2009b). Briefly, melanocytes seeded on 6-cm dishes were trypsinized, 
pelleted, and sonicated in melanin buffer (50 mM Tris, 2 mM EDTA, and 150 mM NaCl, 
pH 7.4) supplemented with protease inhibitor cocktail (Roche). Insoluble material was 
pelleted for 15 min at 16,000 g (4°C), rinsed in ethanol/diethyl ether (1:1), and dissolved 
in 2 MNaOH/20% DMSO at 60°C. The optical density at 492 nm was measured to estimate 
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melanin content and normalized to protein concentration as determined by BCA protein 
determination kit (Thermo Fisher). Plat-E cells, an unpigmented cell line, were used as a 
negative control and normalized values from Plat-E cells were subtracted from 
experimental samples. Data were normalized to melan-Ink4a cells. Statistical significance 
was determined by two-tailed Mann-Whitney test.  
 
 
3.5.8. Electron microscopy 
Melanocytes were cultured in 10-cm dishes and fixed in situ with Karnovsky's 
fixative [4% paraformaldehyde (VWR Scientific, Radnor, PA), 4 mM calcium chloride, 72 
mM sodium cacodylate, pH 7.4] containing 0.5% glutaraldehyde (Polysciences, 
Warrington, PA) for 1–2 h at room temperature. This solution was then removed and 
replaced with Karnovsky's fixative containing 2% glutaraldehyde, and the cells were fixed 
overnight at room temperature. Cells were collected by scraping using a cell scraper and 
centrifugation at 27 x g for 5 min, resuspended in Karnovsky's fixative containing 0.5% 
glutaraldehyde, and stored at 4°C until processing. After subsequent buffer washes, the 
samples were post-fixed in 2.0% osmium tetroxide with 1.5% K3Fe(CN)6 for 1 hour at room 
temperature, and then rinsed in deonized water prior to en bloc staining with 2% uranyl 
acetate. After dehydration through a graded ethanol series, the tissue was infiltrated and 
embedded in EMbed-812 (Electron Microscopy Sciences, Fort Washington, PA) at the 
Electron Microscopy Resource Laboratory (University of Pennsylvania). Thin sections 
were stained with uranyl acetate and SATO lead and examined with a JEOL 1010 electron 
microscope fitted with a Hamamatsu digital camera (Hamamatsu, Bridgewater, NJ) and 
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AMT Advantage NanoSprint500 software (Advanced Microscopy Techniques, Woburn, 
MA). 
For melanosome area measurement, an ROI was drawn around each 
melanosome and the “Measure” tool was used in ImageJ. Images were calibrated using 
the scale bar in each EM image and the area measurements were reported in nm2. Data 
were graphed using Prism 8 and statistical significance was determined by two-tailed 
Mann-Whitney test. 
For melanosome staging, melanosomes were analyzed for each cell line, the 
number of stage I/II, stage III, and stage IV melanosomes were quantified, and the 
percentage of melanosomes at each stage was calculated for each cell. These data were 
analyzed and plotted using Prism 8 (GraphPad, La Jolla, CA), and statistical significance 
was determined by two-tailed Mann-Whitney test. 
For ILV quantification, the number of ILVs per melanosome was manually counted. 
Data were graphed using Prism 8 and statistical significance was determined by two-tailed 
Mann-Whitney test. The number of ILVs per melanosome was cross-referenced with 
melanosome area to generate an XY graph and the correlation between the two variables 




Melan-Ink4a cells and melan-bf cells were cultured in 60mm or 100 mm dishes 
and collected for immunoblot. Cells were rinsed in cold PBS before pelleting by 
centrifugation. Cell pellets were resuspended in 1X Laemmli buffer (Laemmli, 1970), lysed 
by sonication, and heated at 95°C for 5 minutes. Protein concentration for each sample 
was measured using the BCA assay (Pierce) according to the manufacturer’s protocol. 40 
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µg protein from each sample was fractionated by SDS-PAGE on 10% polyacrylamide gels, 
and transferred to PVDF membranes (Immobilon-FL, Millipore). Membranes were blocked 
with 5% milk in TBS, incubated overnight with primary antibodies diluted in TBS/0.5% 
Tween, washed with TBS/0.5% Tween, and analyzed using Alexa Fluor 680 or 790-
conjugated secondary antibodies and Odyssey imaging system (LI-COR, Lincoln, NE). 
Band intensities were quantified in ImageJ. The background for each blot was subtracted 
from the signal and normalized to background-subtracted loading control (tubulin). 




Total RNA was extracted from cells using the RNeasy Plus Mini Kit (Qiagen) and 
was DNase treated (Invitrogen). Reverse transcriptase reactions were performed with 1 
µg of RNA using the High Capacity RNA-to-cDNA kit (Applied Biosystems) and the 
resulting cDNA was used for qPCR. Results were quantified using real-time PCR with 
SYBR Green Dye on an Applied Biosystems 7900HT Fast Real-Time PCR System 
(ThermoFisher Scientific). Primers were designed using Primer3 
(http://bioinfo.ut.ee/primer3-0.4.0/) to span an exon-exon junction to avoid amplification of 
contaminating genomic DNA, and were as follows: 
Vps33a (NM_029929.3): F: 5’ – GTT CGA GGA GCG ACA CAA CG – 3’ and R: 5’ 
– AAT TGA GGT GTG GTT GGC GA – 3’ 
VPS33A (NM_022916.6): F: 5’ GCA GCA TTC GAG GAA AGA CA – 3’ and R: 5’ 
– GTG GGG CAA CTG GGA AA CAA – 3’ 
Tyr (NM_011661.5): F: 5’ – CCT CCT GGC AGA TCA TTT GT - 3’ and R: 5’ GGC 
AAA TCC TTC CAG TGT GT - 3’ 
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Tyrp1 (NM_031202.3): F: 5’ – AAG TTC AAT GGC CAG GTC AG -3’ and R: 5’ 
TCA GTG AGG AGA GGC TGG TT -3’ 
Pmel (NM_021882.4): F:5’ - GCA CCC AAC TTG TTG TTC CT - 3’ and R: 5’ – 
GTG CTA CCA TGT GGC ATT TG - 3’ 
Tubb4b (NM_146116.2): F: 5’ – CGC ATC AAC GTG TAC TAC AAC G - 3’ and R: 
5’ – ACA ACG TCC AAC ACC GAG TC – 3’ 
Tubulin (Tubb4b) was used as an internal control and all reactions were run in 
triplicate. mRNA levels were quantified by calculating average 2-ΔΔCt values, where Ct is 
the cycle number for the control and target transcript at the chosen threshold. ΔCt = Cttarget 
– Cttubulin was calculated by subtracting the average Ct of tubulin from the average Ct of 
the target transcript. The ΔCtmean was calculated for the reference sample (melan-Ink4a; 
or sh-nontarget) and ΔΔCt = ΔCt - ΔCtmean was calculated by subtracting the ΔCtmean from 
the ΔCt. The relative mRNA expression of samples compared to the reference samples 




3.5.11. Dextran Pulse-Chase and Live Cell Fluorescence Imaging 
Melan-Ink4a and melan-bf cells were plated onto 35mm glass-bottom dishes and 
supernatant containing TYRP1-GFP-expressing retroviruses was added in a 1:1 ratio with 
fresh medium the next day. 24 h later, cells were rinsed 2X with dPBS and cells were 
incubated with 250 µg/mL dextran-594 (D22913; Thermo Fisher) diluted in serum-free 
medium for 4 hours at 37°C in 10% CO2. After the 4 h pulse, cells were gently washed 3X 
with sterile dPBS and incubated in melanocyte medium overnight (~16 h) for live imaging 
the next day. Before imaging, the medium was switched to Lebovitz’s CO2-independent 
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medium without phenol red (Invitrogen) supplemented with 10% FBS and imaging was 
performed in an environmental chamber set to 37°C with 10% CO2. Confocal fluorescence 
images were acquired using a DMI8 inverted microscope (Leica Biosystems) equipped 
with a spinning disc system (VisiScope CSU-W1), a 100X TIRF objective (1.47 NA), and 
a Hamamatsu Photonics ORCA-Flash 4.0 sCMOS digital camera with W-VIEW GEMINI 
Image splitting optics for the simultaneous acquisition of dual wavelengths. Single plane 
images of 488 nm and 594 nm channels were simultaneously captured every 400 ms for 
30 s. Images were processed and analyzed using Image J. 
 
 
3.5.12. Statistical analyses 
Statistical data are presented as mean ± SEM. Statistics were calculated in 
GraphPad Prism 8 using: unpaired two-tailed t test or one-way ANOVA with Sidak’s post 
hoc test for multiple comparisons for normally distributed data; two-tailed Mann-Whitney 
test for data not normally distributed; or Welch’s ANOVA with Dunnett’s T3 test for data 
displaying heteroscedasticity. Normality and heteroscedasticity were determined in 
GraphPad Prism. Significant differences between samples are indicated (****, p < 0.0001; 






CHAPTER 4: DISCUSSION 
4.1. Data Summary 
Melanin is required for protection from UVR and oxidative damage and its 
synthesis is necessary during development for the normal formation of the visual system. 
Loss of normal melanin production results in albinism. Mouse models of albinism have 
been critical for studying the roles of genes involved in albinism, including most known 
genes for which mutations have been identified in human patients with albinism and a few 
additional genes that have not. Therefore, further investigation of mouse models of 
albinism may yield insights into the basic cellular biology underlying melanogenesis and 
may identify genes that can be included in albinism gene panels. We have been 
investigating two mouse models of albinism – the underwhite mouse model of human OCA 
type 4, which has a mutation in Slc45a2, and the buff mouse, which has a mutation in 
Vps33a – to understand how the proteins encoded by these genes are involved in 
melanosome biogenesis and maturation. The work presented in this dissertation (1) 
defined a role for SLC45A2 on melanosomes to regulate pH and (2) characterized 
alterations in the melanosomal and endolysosomal pathways in buff melanocytes. 
In Chapter 2, we found that the putative sugar/proton symporter SLC45A2 
localizes to melanosomes, where it is required for the progression of melanosomes from 
stage III to stage IV. We show that in a heterologous system, SLC45A2 increases the pH 
of lysosomes to which it localizes, indicating that it likely retains its putative sugar/proton 
transport activity at melanosomes to transport protons and sugars from the melanosomal 
lumen to the cytosol. We show that SLC45A2 exists on a subset of melanosomes that 
only partially overlaps with the subset harboring the chloride channel OCA2, which based 
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on our data we hypothesize to be due to SLC45A2’s stability on maturing melanosomes 
as opposed to OCA2’s short half-life. We show that OCA2 can compensate for loss of 
SLC45A2 but that SLC45A2 cannot compensate for loss of OCA2, likely reflecting 
differences in the magnitude of ion transport between a channel protein and a transporter 
protein. Based on these results, our model is that, whereas OCA2 is required to slow or 
inhibit V-ATPase activity, SLC45A2 is required for the gradual expulsion of protons from 
the melanosomal lumen to raise melanosomal pH (Figure 4.1). Furthermore, we show 
that a common SLC45A2 variant associated with decreased skin, hair, and eye 
pigmentation results in decreased protein expression due to increased protein 
degradation. It remains to be seen whether the variant protein functions properly; however, 
a study showed that a mutation analogous to L374F in the SLC45A2 ortholog OsSUT1 
resulted in decreased sucrose transport but no change in substrate affinity (Reinders and 
Ward, 2015b). Our data reveal that the observed decrease in pigmentation in cells 
expressing SLC45A2-F374 correlates with a decrease in total SLC45A2 protein, 
suggesting that lower SLC45A2 levels on melanosomes leads to reduced proton export 
and reduced neutralization of the melanosomal lumen. Our findings indicate that SLC45A2 





Figure 4.1. Model of SLC45A2 function in melanosome pH regulation. (1) V-ATPase promotes 
melanosome acidification by pumping protons into the lumen. (2) OCA2 activity slows or stops V-
ATPase activity to reduce acidification by exporting chloride ions and thus altering membrane 
potential. (3) SLC45A2 actively deacidifies the melanosome by transporting protons out of the 
lumen. 
 
In Chapter 3, we characterized melan-bf cells, immortalized melanocytes derived 
from the buff mouse model. We show that, despite a mutation in VPS33A, melanogenesis 
was able to occur but that melanosomes were reduced in number and larger compared to 
those in WT melanocytes. Furthermore, we show that these cells have reduced 
expression of VPS33A and the melanosomal protein TYRP1, and that although 
melanosomes still harbor TYRP1 as in WT cells, a significant proportion of TYRP1 is 
aberrantly distributed in punctate structures throughout the cytoplasm in melan-bf cells. 
We attempted to determine if the VPS33A-D251E mutation in melan-bf cells caused this 
phenotype, but although our results were inconclusive and we will need to perform 
additional experiments and assess cells at longer time points, the preliminary data suggest 
that the mutation is not responsible for the phenotype. Overall, we show that melan-bf 
cells are hyperpigmented despite having VPS33A-D251E mutation and have a phenotype 
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similar to that of melanocytes and RPE cells from Oa1-/- mice, the mouse model of OA1, 
indicating that melanogenesis can proceed even in the presence of the buff mutation. 
Our studies of mouse models of albinism have raised questions about ion 
regulation and the potential role of VPS33A during melanosome biogenesis. The purpose 
of this chapter is to discuss open questions and future directions pertaining to these topics. 
4.2. Future Directions 
4.2.1. Is there a functional role for SLC45A2 punctate structures? 
 Our data show that SLC45A2 can form discrete puncta on the melanosomal 
membrane, and that this “microdomain” distribution is even more consistent and 
pronounced at the lysosomal membrane when SLC45A2 is expressed in non-pigmented 
cells. Membrane microdomains containing ion transporters have been described, 
particularly as a mechanism for calcium signaling (Filadi and Pozzan, 2015). Whether 
these SLC45A2 puncta form a functional microdomain are unclear but is an intriguing 
question that we would like to test.  
Ideally, we would like to directly determine the relationship between puncta 
formation and transporter activity. One method to test this was used to analyze the puncta 
formation and activity of stromal interacting molecule 1 (STIM1), a calcium sensor and 
calcium channel activator at the endoplasmic reticulum (Wu et al., 2006). By total internal 
reflection fluorescence (TIRF) microscopy of GFP-labeled STIM1 and whole-cell patch 
clamp recordings to measure calcium entry by the STIM1-activated Ca2+ release–
activated Ca2+ (CRAC) channel, it was determined that STIM1 puncta formation always 
immediately preceded calcium transfer (Wu et al., 2006). However, this is not a feasible 
experiment in our system for two reasons: (1) SLC45A2 is on melanosomes and, although 
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patch-clamping has been successfully performed on purified, manipulated melanosomes 
(Bellono et al., 2014; Bellono et al., 2016), purification of melanosomes may alter 
SLC45A2 puncta dynamics and function; and (2) conventional patch clamping to measure 
transporter activity is difficult due a 10,000- to 100,000-fold-lower transport capacity of 
transporters compared to ion channels (Grewer et al., 2013). Therefore, we will instead 
use a combination of imaging and biochemical techniques to determine the functional role, 
if any, for SLC45A2 puncta.  
To visualize the dynamics of SLC45A2 at the melanosomal membrane, we will 
generate fluorescent protein-tagged SLC45A2, express the construct in mouse 
melanocytes, and use live confocal microscopy to assess SLC45A2 puncta formation. Our 
analyses of fixed melanocytes indicate that HA-tagged SLC45A2 can be found either in 
punctate or diffuse forms at the melanosomal membrane. By using live, time-lapse 
microscopy, we will be able to determine whether SLC45A2 transitions from a diffuse 
distribution to a punctate localization and vice versa or whether these two forms are 
distinct and static. A model in which SLC45A2 is redistributed from a diffuse to a punctate 
localization may suggest that it switches between active and inactive forms, which has 
been described for STIM1 (Wu et al., 2006). Furthermore, we would supplement the live 
imaging data with immunogold-labeled EM to identify whether SLC45A2 localizes to 
melanosomal membrane regions that are adjacent to other structures. For example, does 
SLC45A2 localize to regions near tubular membranes? This may suggest a role for 
SLC45A2 function at sites of transport. Alternatively, does SLC45A2 localize to regions 
adjacent to other organelles? This may suggest that SLC45A2 is part of a microdomain 
involved in inter-organelle communication. While these experiments will not inform us 
whether these punctate structures are required for SLC45A2 function, we plan to 
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supplement these live imaging experiments with proteomics analyses to identify SLC45A2 
interacting partners and subsequent knockdown and overexpression experiments to 
determine if SLC45A2 interacting partners are necessary for puncta formation and 
function. 
 SLC45A2 contains a large central cytoplasmic loop between the sixth and seventh 
transmembrane domains (Figure 4.2), which, in related sucrose transporters (e.g. the 
glucose transporter (GLUT) family), has a regulatory role via direct interactions with other 
proteins (Jung, 1998; Schulze et al., 2000; Weinglass and Kaback, 2000). To identify 
SLC45A2 interaction partners, we will express HA-tagged SLC45A2 in melan-uw cells, 
use an antibody to the HA epitope tag to immunoprecipitate SLC45A2 and any associated 
proteins, and perform tandem mass spectrometry analysis with gene ontology enrichment 
analyses to identify bound proteins and their associated pathways. To differentiate 
between proteins that interact with diffuse SLC45A2 and those that interact with punctate 
SLC45A2, we will also perform this experiment using HA-tagged SLC45A2 expressed in 
HeLa cells, in which we observe almost all SLC45A2 in puncta. As a negative control, we 
will use HA-tagged SLC35D3, which is unrelated to SLC45A2 (Chintala et al., 2007a). 
Using this unbiased approach, we hope to identify novel interacting partners of SLC45A2. 
 Potential candidate proteins are scaffolding proteins with known roles in organizing 
microdomains. For example, ankyrins, proteins that link integral membrane proteins with 
the cytoskeleton (Bennett and Healy, 2009; Nilsson and Bennett, 2009),  and 14-3-3 
proteins,  adaptor proteins that mediate protein-protein interactions through their ability to 
bind multiple partner proteins (Jin et al., 2004; Pozuelo Rubio et al., 2004), have both been 
found in microdomains or as part of multiprotein signaling complexes. Indeed, a member 
of the 14-3-3 protein family, 14-3-3-γ, was shown to indirectly interact with SLC45A2 and 
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its plant ortholog OsSUT1 and to negatively regulate their function and localization in yeast 
or in Xenopus laevis oocytes (Vitavska et al., 2018). Further testing of such an interaction 
between mammalian SLC45A2 and 14-3-3 family members in mammalian melanocytes 
warrants investigation. Additionally, 14-3-3 family members interact with most proteins via 
recognition of phosphoserine and phosphothreonine motifs (Muslin et al., 1996; 
Sluchanko, 2018); therefore, one mechanism to regulate SLC45A2 puncta formation may 
be through phosphorylation, but this has not yet been explored.  
To test if candidate proteins identified by mass spectrometry analyses are involved 
in SLC45A2 puncta formation, we will knock down or overexpress these proteins in melan-
uw cells stably expressing fluorescently-tagged SLC45A2 and assess SLC45A2 
localization and dynamics by IFM. We predict that knockdown of proteins involved in 
SLC45A2 puncta formation will result in diffuse SLC45A2 localization while 
overexpression will increase puncta formation. We will also assess cells for melanin 
content to determine if loss of puncta results in a change in melanogenesis, an indirect 
readout for SLC45A2 function. Overall, these proposed studies will identify SLC45A2 
binding partners and will determine if SLC45A2 puncta serve a functional role. 
4.2.2. How does SLC45A2 traffic to melanosomes? 
Our data show that SLC45A2 localizes to melanosomes in pigmented cells and to 
late endosomes/lysosomes when expressed in non-pigmented cells – a common feature 
of melanosomal constituents (Ambrosio et al., 2016; Bellono et al., 2016; Berson et al., 
2001; Bouchard et al., 1989; Calvo et al., 1999; Piccirillo et al., 2006; Simmen et al., 1999; 
Sitaram et al., 2009; Vijayasaradhi et al., 1995). However, how SLC45A2 is transported 
to melanosomes is unknown. As discussed in Chapter 1, melanosomal proteins are 
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transported to melanosomes either directly from Golgi by RAB6 vesicles or via endosomal 
intermediates using AP-3-mediated vesicular or AP-1- and AP-3-mediated tubulovesicular 
transport pathways (Bowman et al., 2019). To test whether SLC45A2 requires RAB6 or 
AP-1, we will knock down RAB6 or AP-1 subunits in melan-uw cells, express HA-tagged 
SLC45A2, and assess protein localization by immunofluorescence microscopy of fixed 
cells. To test whether SLC45A2 requires AP-3, we will express HA-tagged SLC45A2 in 
melan-pearl cells, which are immortalized melanocytes derived from mice with loss-of-
function mutations in the β subunit of AP-3. AP-1 and AP-3 are obligate multisubunit 
complexes; therefore, loss of one subunit results in increased degradation of the 
remaining subunits and loss of complex formation. We will assess localization of HA-
tagged SLC45A2 in these cells. Performing these experiments will determine which 
pathway SLC45A2 uses to traffic to melanosomes. 
If SLC45A2 is mislocalized in either the AP-1 knockdown or AP-3 knockout cells, 
we can further investigate how SLC45A2 engages either of these pathways. AP-1 and 
AP-3 facilitate cargo sorting at endosomes by recognizing and binding linear sequences 
on the cytoplasmic domains of transmembrane proteins. The best characterized binding 
signals conform to a conserved acidic dileucine motif (D/E]XXXL[L/I]) or a tyrosine-based 
motif (YXX), where X represents any amino acid and  represents a bulky hydrophobic 
amino acid. Similar signals in TYR, TYRP1, and OCA2 direct these proteins to 
melanosomes in pigmented cells (Calvo et al., 1999; Simmen et al., 1999; Sitaram et al., 
2012; Theos et al., 2005; Vijayasaradhi et al., 1995). SLC45A2 contains three putative 
tyrosine-based motifs in its cytoplasmic domains (Figure 4.2). Preliminary experiments 
suggest that the Y268 tyrosine motif is required for proper localization to melanosomes 
(Ariel J. Lefkovith, unpublished data); however, the other tyrosine-based motifs in 
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SLC45A2 have not been investigated. We hypothesize that SLC45A2 engages AP-1 
and/or AP-3 to traffic to melanosomes and that this interaction is mediated by tyrosine-
based motifs in the SLC45A2 sequence. 
 
Figure 4.2: Annotated human SLC45A2 amino acid sequence and aligned sequence. (a) 
Human SLC45A2 is a 530 amino acid protein with 12 transmembrane domains. Underlined and 
bold, cytoplasmic topological domains. Underlined, lumenal topological domains. No underline, 
transmembrane domains. Red text, large cytoplasmic loop between sixth and seventh 
transmembrane domains. Cyan highlight, putative tyrosine-based motifs. Only sorting motifs in 
cytoplasmic domains are shown. (b) Mouse, rat, human, Xenopus, and zebrafish SLC45A2 amino 
acid sequences surrounding the human tyrosine-based motif are aligned. The tyrosine-based 
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motifs identified in the human SLC45A2 sequence and the conserved site in other species are 
highlighted in cyan. Note that the tyrosine-based motif at human Y268 is well conserved among all 
five species, the tyrosine-based motif at human Y394 is conserved in mice, rats, human, and 
zebrafish, and the tyrosine-based motif at human Y13 is conserved in mice, rats, and humans. 
Amino acid sequence was performed on SLC45A2 orthologs using Basic Local Alignment Search 
Tool (BLAST) (UniProt, 2019). The UniProt identifiers are as follows: Q9UMX9 (Homo sapiens); 
P58355 (Mus musculus); D3ZR99 (Rattus norvegicus); A0A1L8I2M1 (Xenopus laevis); and 
A8WG95 (Danio rerio). 
 
To test whether SLC45A2 interacts with AP-1 and/or AP-3, we will perform either 
a yeast 2-hybrid assay, a glutathione S-transferase (GST) pulldown assay using GST 
fusion proteins followed by immunoblotting, or both, as previously described (Ohno et al., 
1998; Ohno et al., 1995; Starcevic and Dell'Angelica, 2004; Stephens and Banting, 1998). 
AP-1 and AP-3 are heterotetrameric complexes consisting of β1, µ1, 1, and γ subunits 
for AP-1 and β3, µ3, 3, and  subunits for AP-3 (Robinson and Bonifacino, 2001). The µ 
subunits of AP-1 and AP-3 mediate binding to tyrosine-based motifs (Ohno et al., 1998; 
Ohno et al., 1995). Therefore, we can use a yeast 2-hybrid assay and generate constructs 
with the GAL4 binding domain fused to SLC45A2 cytoplasmic loops containing each 
tyrosine-based motif and use previously published constructs with the GAL4 activation 
domain fused to µ1 of AP-1 or µ3 of-AP-3 (Ohno et al., 1996). These fusion proteins will 
be co-expressed in yeast without endogenous GAL4 activity; an interaction between a 
protein fused to the GAL4 binding domain and a protein fused to the GAL4 activation 
domain will result in GAL4 activity, which can be assessed by growth of His3-negative 
yeast expressing Gal4-His3 on agar plates lacking histidine. The GAL4 binding domain 
fused to the cytoplasmic tail of TGN38, which contains a tyrosine-based motif that is 
recognized by both µ1 and µ3 subunits (Ohno et al., 1998; Ohno et al., 1995; Stephens 
and Banting, 1998), will be used as a positive control. As a negative control, we will use a 
GAL4 binding domain fused to the cytoplasmic tail of OCA2, which is recognized by AP-1 
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and AP-3 through their γ/1 and /3 subunits, respectively (Sitaram et al., 2012). To 
validate these data, we will perform a GST pulldown assay using melanocyte cell lysates 
incubated with GST fusion proteins containing the SLC45A2 cytoplasmic domains with 
tyrosine-based motifs. Interactions with AP-1 or AP-3 will be assessed by immunoblotting 
with antibodies to their respective µ subunits. 
To test whether an interaction between SLC45A2 and AP-1 and/or AP-3 requires 
any of the three tyrosine-based motifs in the cytoplasmic domains of SLC45A2, we will 
generate GST-tagged constructs with mutations in tyrosine-based motifs shown to bind 
AP-1 or AP-3 in the previous set of experiments. If all three tyrosine-based motifs were 
shown to bind, then constructs will be generated in which one, two, or three of the tyrosine-
based motifs are combinatorially mutated. We will then repeat the GST pulldown 
experiment and assess AP-1 and AP-3 binding by immunoblotting.  
It is possible that we will not observe interactions between SLC45A2 cytoplasmic 
domains and AP-1 or AP-3 by either yeast two-hybrid or GST pulldown. Preliminary yeast 
two-hybrid and GST pulldown assays using the Y268 tyrosine motif within the context of 
the cytoplasmic loop between the 6th and 7th transmembrane domains (red in Figure 4.2a) 
failed to demonstrate an interaction (Hayley A. Hanby and Alexa Jaume, unpublished 
data). However, this may be due to folding requirements that are not met when using short 
fragments. If this is the case, we will mutagenize the tyrosine residue in each tyrosine-
based motif and express each HA-tagged mutant SLC45A2 construct in melan-uw cells 
to assess their effects on localization and pigmentation rescue. We will also perform 
proximity ligation assays in cells expressing WT and mutant forms of HA-SLC45A2 using 
antibodies to HA and AP-1 or AP-3 subunits. These assays will determine if WT SLC45A2 
is in close proximity to AP-1 and/or AP-3 and if mutation of any of the tyrosine-based motifs 
158 
 
antagonizes this localization. While these experiments do not inform us whether there are 
direct interactions between the tyrosine-based motifs and AP-1 or AP-3, they do reveal 
whether these motifs are required for sorting and we would expect these results to be 
similar to those of WT SLC45A2 expressed in cells with loss of AP-1 or AP-3. Of note, 
experiments performed with a Y268A mutated tyrosine-based motif indicate that SLC45A2 
is largely mislocalized in these cells (Ho, 2015); however, cells regain partial pigment, 
which could be due to partial localization of SLC45A2 to melanosomes by the other 
tyrosine-based motifs. We will repeat this experiment with mutations in the other tyrosine-
based motifs and quantify localization to melanosomes. Overall, these experiments will 
determine if AP-1 and/or AP-3 bind SLC45A2 (or are at least required for SLC45A2 
localization) and whether and which tyrosine-based motifs are required for any of these 
interactions. 
4.2.3. What is the role of sugar in the melanosome? 
SLC45A2 is predicted to transport protons down their electrochemical gradient 
from the lumen to the cytosol. When expressed in yeast, mouse SLC45A2 functioned as 
a proton-dependent sugar transporter; it facilitated import of the disaccharide sucrose, and 
putatively the monossacharides glucose, mannose, and fructose, from the extracellular 
medium to the cytoplasm only when the growth medium was acidified (Bartolke et al., 
2014). This implies that in the physiological context, SLC45A2 would export a proton with 
a sugar molecule from the melanosome lumen to the cytosol. The source of such sugar 
substrates in melanosomes and whether sugar export is required for melanosome 
biogenesis or merely a byproduct of proton export has not been defined. Nothing has been 
published about the presence or role of sugars within the melanosome except as 
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components of glycoproteins. However, this topic has been discussed in the context of 
lysosomes. Within lysosomes, mature glycoproteins can be catabolized into peptides and 
monosaccharides, primarily by hydrolases such as cathepsins and glycosidases, which 
are then transported into the cytosol for recycling (Winchester, 2005). All known resident 
melanosomal proteins are integral membrane proteins (or in the case of PMEL, fragments 
of integral membrane proteins) that are heavily glycosylated. Additionally, melanosomes 
contain a cohort of lysosomal hydrolases, including cathepsins B and L (Diment et al., 
1995a) and D (G. Raposo and M. S. Marks, unpublished). Thus, catabolism of 
melanosomal glycoproteins by these hydrolases and glycosidases might be a major 
source of sugar molecules within the melanosome.  
To test whether export of these sugar molecules by SLC45A2 is required for proper 
melanosome maturation, the residues required to bind and transport sugar must first be 
identified and then can be mutated to determine if proton transport and sugar transport 
can be uncoupled in SLC45A2. The rice sucrose transporter OsSUT1 is an ortholog of 
SLC45A2 and has been used to study the effects of SLC45A2 mutations and variants at 
conserved sites. The arginine residue at position 188 (R188) in OsSUT1 is located in the 
fourth transmembrane domain and is required for sugar transport; mutation of this residue 
to a lysine (R188K) results in loss of sugar transport and a proton leak (Sun et al., 2012; 
Sun and Ward, 2012). However, in experimental conditions, this proton leak was blocked 
when sucrose was added to the system, putatively because sucrose can still bind the 
transporter but cannot induce a conformational change to trigger export. Therefore, it is 
unclear if a proton leak actually occurs in vivo. In SLC45A2 the orthologous residue is a 
lysine at position 164 (K164). We propose mutating this residue to investigate if it is 
needed for sucrose but not proton transport. Sucrose uptake can be assessed by 
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expressing WT or mutant SLC45A2 in the yeast strain HOD55-4B, which is incapable of 
sucrose uptake due to lack of yeast sucrose transporters; thus these yeast cells cannot 
grow on sucrose-containing minimal medium agar plates without the ectopic expression 
of a functional sucrose transproter (Bartolke et al., 2014). When expressed in yeast, at 
least a fraction of SLC45A2 localizes to the plasma membrane from where it facilitates 
sucrose import into the cell, allowing HOD55-4B cell growth (Bartolke et al., 2014). To test 
whether this mutant can transport protons, we will express it in HeLa cells and measure 
endolysosomal pH with LysoSensor. A SLC45A2 mutant that can transport protons 
without co-transporting sugars will be expressed in melan-uw cells and analyzed by BFM 
and IFM to visualize pigmentation and SLC45A2 localization; EM for melanosome size 
and maturation, and melanin content assay for melanization. In particular, we will be 
looking for evidence of melanosome swelling due to osmotic stress. These tests will 
determine if sugar export is required for proper melanosome maturation.  
4.2.4. How to further investigate the differences between SLC45A2 localization and 
OCA2 localization on melanosomes? 
Our IFM analyses indicate that SLC45A2 and OCA2 localize to different 
populations of melanosomes at steady state and that SLC45A2 localization correlates well 
with the mature melanosome markers TYR and TYRP1 whereas OCA2 localization is less 
correlated with TYRP1. We also show that SLC45A2 is a relatively stable protein with a 
half-life of 53 hours while OCA2 is short-lived with a half-life of <4 hours (Sitaram et al., 
2009). Furthermore, data indicate that a cohort of OCA2 localizes to intralumenal 
membranes/vesicles (ILVs) (Sitaram et al., 2012) and that OCA2 interacts closely with 
melanin (Donatien and Orlow, 1995). These data suggest that, while SLC45A2 is long-
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lived on the melanosome, OCA2 is only transiently expressed at the limiting membrane 
and becomes rapidly internalized and buried by melanin or degraded. However, the 
mechanism by which OCA2 becomes internalized and the functional consequences for 
pH regulation are unclear. 
The major pathway for sorting into ILVs in maturing endosomes is by the 
recognition of ubiquitylated cargo by endosomal sorting complexes required for transport 
(ESCRT)-0, -I, -II, and -III (Gruenberg, 2020). ESCRT complexes exist in the cytoplasm 
and are recruited to endosomal membranes by the interaction between ESCRT-0 and 
phosphatidylinositol 3-phosphate (PtdIns3P). ESCRT-0 binds both ubiquitylated cargo 
and PtdIns3P and recruits ESCRT-1, which recruits ESCRT-II. ESCRT-II nucleates 
ESCRT-III formation and oligomerization; ESCRT-III filaments drive membrane 
deformation to form ILVs (Gruenberg, 2020). Cargo sorting to ILVs can also occur in the 
absence of direct ubiquitylation of a particular cargo; instead, cargo can interact with a 
ubiquitylated protein that is recognized by ESCRT-0 (Hislop et al., 2004). Furthermore, 
there are examples of ESCRT-dependent, ubiquitin-independent cargo sorting, in which 
integral membrane cargo are sorted into ILVs through their direct interactions with ESCRT 
subunits themselves (Yamashita et al., 2008) or with ESCRT-associated proteins (Dores 
et al., 2012; Dores et al., 2016).  
To determine if OCA2 is transported to ILVs via an ESCRT-dependent pathway, 
we will knock down the ESCRT-III subunit charged MVB protein 4 (CHMP4). CHMP4 is 
expressed in 3 isoforms (CHMP4A, CHMP4B, and CHMP4C). RNA-seq data show that 
CHMP4A and CHMP4B are expressed in human melanocytes whereas CHMP4C is only 
expressed at low levels (Reemann et al., 2014). To validate that this is applicable to melan-
p1 cells, we will perform RT-PCR. We will then knock down the expressed isoforms using 
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short hairpin RNAs (shRNAs), express HA-tagged OCA2, and assess localization by IFM 
and IEM. The results from this experiment will indicate whether internalization of OCA2 is 
mediated through an ESCRT-dependent or -independent pathway. However, if the data 
indicate an ESCRT-dependent pathway, they do not inform us whether this occurs through 
a ubiquitylation-dependent pathway.   
To determine if OCA2 requires direct or indirect ubiquitylation for entry into ILVs, 
we will generate a construct where OCA2 is fused to the catalytic domain of the 
deubiquitinating peptidase domain of Herpes Virus UL36 (OCAC2-DUb); thus, OCA2 will 
be resistant to ubiquitylation and may also render associated proteins resistant to 
ubiquitylation. Previous studies have generated cargo-DUb fusion constructs to test 
ubiquitylation requirements for ESCRT-mediated ILV formation (Sette et al., 2013; Stringer 
and Piper, 2011). We will assess the localization of WT OCA2 and OCA2-DUb by IFM and 
IEM. As a negative control, we will generate and analyze constructs in which OCA2 is 
fused to a catalytically inactive deubiquitinating peptidase domain. This experiment will 
determine if ubiquitylation is required for OCA2 sorting into ILVs. 
While the ESCRT-dependent pathway is the canonical pathway for sorting into 
ILVs, some cargo are sorted into ILVs in an ESCRT-independent pathway. For example, 
PMEL, which requires localization to ILVs for proper processing and fibrillization, is sorted 
into ILVs by an ESCRT-independent, CD63- and apolipoprotein E-dependent mechanism 
that is dependent on PMEL’s lumenal domain (Theos et al., 2006b; van Niel et al., 2015; 
van Niel et al., 2011). If our initial experiments indicate that OCA2 uses an ESCRT-
independent pathway for sorting into ILVs, we can determine if CD63 is required for OCA2 
sorting into ILVs. To test if OCA2 internalization is dependent on CD63, we will knock 
down CD63 in melan-p1 cells, express HA-tagged OCA2, and assess protein localization 
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by IFM and IEM. This experiment will determine if OCA2 sorting into ILVs is dependent on 
CD63.  
After identifying the mechanism of OCA2 sorting into ILVs, we will inhibit its 
invagination onto ILVs and investigate how this affects pigmentation. We show that OCA2 
overexpression can rescue loss of SLC45A2 expression. If this is due to increased 
localization of OCA2 at the melanosomal membrane, preventing OCA2 internalization in 
melan-uw cells should result in a similar effect. Additionally, we can perform IFM to 
determine whether restricting OCA2 to the melanosomal limiting membrane results in 
increased colocalization of OCA2 with the mature melanosomal marker TYRP1 and 
perform cycloheximide pulse-chase and immunoblotting, wherein we block protein 
synthesis and observe protein levels at various time points, to determine whether this 
results in increased protein half-life. Overall, these experiments will yield insights into the 
mechanism by which OCA2 is sorted into ILVs and whether OCA2 internalization can 
partially explain some of the differences between OCA2 and SLC45A2 localization and 
half-life, and how OCA2 overexpression can compensate for loss of SLC45A2 activity. 
4.2.5. How to measure melanosomal pH? 
Our data show that expression of HA-tagged SLC45A2 in HeLa cells results in 
increased pH at the late endosomes/lysosomes to which they localize. However, we have 
been unable to measure the pH of melanosomes. Lysotracker and Lysosensor are widely 
used fluorescent reagents to label acidic organelles and to measure their pH, respectively, 
in many cell types. They are membrane-permeable weak bases that are uncharged at 
neutral pH and thus diffuse into organelles, where in acidic organelles they become 
protonated and trapped; Lysosensor fluorescence can be measured after excitation at two 
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wavelengths, and the ratio of fluorescence is dependent on pH. However, in our hands 
(and confirmed by collaborators), Lysosensor and Lysotracker do not reproducibly 
accumulate well within organelles in melanocytes. The mechanism underlying this is 
unclear.  
An alternative method to specifically measure melanosomal pH has been 
developed and termed MELOPS (melanosome-localized pH sensor). MELOPS consists 
of the pH-sensitive fluorescent protein, mNectarine, fused to a lumenal loop of OCA2-
V443I  (Ambrosio et al., 2016), an inactive variant of OCA2 (Bellono et al 2014). 
mNectarine is a dsRed derivative with a pKa of 6.9 and a linear increase in fluorescence 
intensity from pH 6-7.5 (Johnson et al., 2009). mNectarine was originally generated to be 
used for cytoplasmic pH measurements, where the average pH ranges between ~6.8 – 
7.4, which is much higher than the average pH of acidic organelles ranging from ~4.5 – 
6.0. Although one study has successfully used MELOPS to estimate melanosomal pH 
(Ambrosio et al., 2016), when we measured MELOPS fluorescence in melan-Ink4a and 
melan-uw cells and in HeLa cells expressing HA-OCA2 or HA-SLC45A2, the results 
indicated that the melan-Ink4a cells were lower than expected and contradicted our 
previous measurements using Lysosensor (data in Appendix). Based on our data, we 
conclude that mNectarine is not an optimal fluorescent protein for measuring melanosomal 
pH. 
We propose generating a novel MELOPS variant to more accurately monitor 
melanosomal pH within the range expected for acidic early stage and more neutral late 
stage melanosomes. We propose to replace the mNectarine fluorophore with one that was 
optimized for and extensively tested in lumenal compartments. One candidate is the 
fluorescent construct pH-Lemon, a ratiometric pH sensor generated by the fusion of the 
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pH-stable fluorescent protein mTurquoise2 and the pH-sensitive fluorescent protein 
enhanced yellow fluorescent protein (EYFP) (Burgstaller et al., 2019). mTurquoise2 can 
act as a fluorescence resonance energy transfer (FRET) donor, and the close proximity 
of the two fluorescent proteins yields high FRET signals at neutral to basic pH. Therefore, 
pH-Lemon is a ratiometric pH sensor that can be excited at 430 nm and analyzed at 
emission wavelengths 475 and 525 nm, and the ratio of donor (mTurquoise) fluorescence 
to FRET (EYFP) fluorescence can be correlated to pH based on a standard curve. Data 
indicate when this reporter is fused to the lumenal domain of either the LC3B to visualize 
pH changes during autophagosome maturation or to a glycophosphatidylinositol anchor 
to measure pH in the endocytic pathway, it can dynamically and reversibly shift 
fluorescence intensities in response to changes in pH with a range from ~pH 4 – 10 
(Burgstaller et al., 2019). Therefore, we will replace mNectarine in the lumenal loop of 
OCA2-V443I with pH-Lemon and repeat the previously described flow cytometry in HeLa 
cells expressing this modified MELOPS construct to test if it serves as a better 
melanosomal pH sensor. If so, we will use this construct to measure pH in melan-Ink4a 
cells, melan-uw cells, melan-uw cells stably expressing HA-tagged SLC45A2, melan-p1 
cells, and melan-p1 cells stably expressing HA-tagged OCA2. We will also measure 
melanosomal pH in melan-uw cells overexpressing HA-OCA2 and melan-p1 cells 
expressing HA-SLC45A2. Overall, generation of this construct or a similar optimized 
MELOPS construct and performing these experiments will allow us to determine the pH 
of melanosomes in these WT, mutant, rescue, and overexpressing cell lines. A reliable 
MELOPS construct can also be used to measure melanosomal pH in melanocytes from 
other models of albinism (e.g. other OCA subtypes and HPS) to generate novel 
hypotheses regarding the etiology of those disorders and the fates of transporters, 
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channels, and ion pumps in these cells. Additionally, measuring melanosomal pH will be 
useful to determine whether ion transport proteins localized on nonmelanosomal 
organelles affect pigmentation through indirect modulation of melanosomal pH.  
4.2.6. How do other ion transport proteins regulate melanosome pH and 
melanogenesis? 
Ion transport and its regulation of melanogenesis is an important topic of study. 
While the main goal in Chapter 2 was to determine the localization and role of SLC45A2 
in melanocytes and to investigate how SLC45A2 and OCA2 coordinate to regulate 
melanosomal pH, other ion transport proteins have been identified as modulators of 
melanogenesis. What we currently know about other ion transport proteins aside from 
SLC45A2 and OCA2 will be discussed in this subsection. The ion transport proteins that 
have been studied in melanocytes or that result in a pigmentation phenotype when 
mutated are TPC2, SLC24A5, MFSD12, ClC-7, and TRPM1. 
Two-pore channel 2 (TPC2) is a cation channel that localizes to melanosomes in 
pigmented cells (Ambrosio et al., 2016; Bellono et al., 2016). TPC2 is a gated channel 
activated by phosphatidylinositol 3,5-bisphosphate [PtdIns(3,5)P2] that is Na2+-selective 
(Bellono et al., 2016; Wang et al., 2012). Previous data had suggested that TPC2 was 
activated by the second messenger nicotinic acid adenine dinucleotide phosphate 
(NAADP) and was Ca2+-selective (Calcraft et al., 2009), but direct measurements of TPC2 
by patch clamp analysis showed that it does not respond to NAADP and that it is 100 times 
more selective for Na2+ than Ca2+ (Bellono et al., 2016; Wang et al., 2012). TPC2 was 
originally linked to a role in pigmentation by a genome-wide association study (GWAS) in 
which TPC2 variants were associated with blonde versus brown hair color in humans 
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(Sulem et al., 2008), and another study confirmed that the variants identified were 
causative for a decrease in pigmentation and that this was due to TPC2 gain-of-function 
(Chao et al., 2017). Patch clamp experiments show that TPC2 activity increases 
membrane potential (Bellono et al., 2016). Knockdown or knockout of TPC2 in mouse 
melanocytes results in increased lumenal pH, melanin content, and melanosome size, 
while TPC2 overexpression results in decreased pH and decreased melanin content 
(Ambrosio et al., 2016; Bellono et al., 2016). The model of TPC2 function at the 
melanosome is that it increases membrane potential by driving Na2+ efflux, and that this 
enhances V-ATPase activity and promotes melanosomal acidification. Indeed, 
overexpression of TPC2 antagonized the increased pigmentation observed when OCA2 
was overexpressed (Bellono et al., 2016), indicating that the activities of these two ion 
transport proteins counteract each other. Whether TPC2 and OCA2 co-exist on the same 
melanosome or whether they are delivered and function sequentially is unknown. One 
possibility is that TPC2 localizes to immature melanosomes and OCA2 localizes to 
maturing melanosomes. Alternatively, TPC2 may function at a later stage to slow or halt 
melanogenesis in mature melanosomes. 
The SLC24A5 gene encodes the potassium-dependent sodium-calcium 
exchanger 5 (NCKX5) protein, which is expressed in pigmented cell types and localizes 
primarily to the trans-Golgi network (TGN) and/or to mitochondria but not to melanosomes 
(Ginger et al., 2008; Rogasevskaia et al., 2019; Wilson et al., 2013; Zhang et al., 2019). 
NCKX5 is a Na2+/Ca2+ antiporter that is dependent on an outward Na2+ gradient and an 
inward K+ gradient for the inward transport of Ca2+ (where inward is from the cytoplasm 
towards the organelle lumen, and outward is from the organelle lumen towards the 
cytoplasm) (Altimimi and Schnetkamp, 2007; Szerencsei et al., 2016). Mutations in 
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NCKX5 result in OCA6 (Morice-Picard et al., 2014; Wei et al., 2013) and allelic variants 
are associated with pigmentation variation in multiple populations (Cook et al., 2009b; 
Crawford et al., 2017; Ginger et al., 2008; Lamason et al., 2005b). Slc24a5-/- mice have 
smaller melanosomes and reduced pigmentation (Vogel et al., 2008) and knockdown of 
Slc24a5 in mouse and human melanocytes results in decreased melanin content (Ginger 
et al., 2008; Wilson et al., 2013; Zhang et al., 2019), decreased melanosomal protein 
expression (Ginger et al., 2008), reduced MC1R mRNA levels (Wilson et al., 2013), and 
reduced melanosomal Ca2+ content (Zhang et al., 2019). It is unclear how NCKX5 exerts 
its influence on melanogenesis from either the TGN or mitochondria, but several 
hypotheses exist. The TGN is a site of Ca2+ storage and regulated Ca2+ release allows it 
to act as a powerful second messenger (Dolman and Tepikin, 2006); it is possible that 
Ca2+ functions as a second messenger to control melanogenesis, although this might not 
function at the level of controlling melanosomal gene expression  (Wilson et al., 2013). 
Therefore, NCKX5-mediated Ca2+ import may be required for replenishing Ca2+ stores for 
repeated rounds of signaling (Ginger et al., 2008). Zhang et al. report that NCKX5 on 
mitochondria are responsible for Ca2+ transport into melanosomes (Zhang et al., 2019), 
which is known to have a large store of Ca2+ and other divalent cations (Bush and Simon, 
2007); however, how a Ca2+ importer on mitochondria would mediate this has not been 
described and a role for Ca2+ within melanosomes has not been identified. 
Major facilitator superfamily domain containing 12 (MFSD12) belongs to a large 
family of ion transport proteins which have diverse substrates. MFSD12 was first identified 
as a gene associated with pigmentation variation by GWAS of populations in Africa 
(Crawford et al., 2017) and this has been validated in other studies (Adhikari et al., 2019b; 
Lona-Durazo et al., 2019). Mfsd12-/- mice have gray coat color compared to their agouti 
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WT littermates and analysis of hairs from these mice indicate that Mfsd12-/- mice have 
defects in pheomelanin synthesis but not eumelanin synthesis (Crawford et al., 2017). In 
darkly pigmented melanocytes, MFSD12 localizes to lysosomes, but its substrates and 
mechanism of action there are unknown. Knockdown of Mfsd12 in such cells results in 
increased melanosome and melanin content as assessed by BFM and spectroscopy 
(Crawford et al., 2017). Together these data suggest that MFSD12 positively regulates 
pheomelanin synthesis and negatively regulates eumelanin synthesis from its localization 
at lysosomes, indicating that lysosomal crosstalk to melanosomes is an important 
regulator of melanogenesis. 
Chloride channel 7 (ClC-7), encoded by CLCN7, is a Cl-/H+ antiporter that in non-
pigmented cells localizes to lysosomes (Graves et al., 2008; Lange et al., 2006); its 
localization in pigmented cell types has not been identified. ClC-7 forms a molecular 
complex with OSTM1, and mice with loss of function mutations in either protein have a 
grey rather than agouti coat color like Mfsd12-/- mice (Chalhoub et al., 2003; Lange et al., 
2006). ClC-7 imports chloride into the lysosomal lumen via driving protons down their 
electrochemical gradient into the cytosol in a 2:1 Cl-:H+ ratio (Graves et al., 2008). 
Knockdown of Clcn7 results in decreased of H+-driven chloride uptake and reduces 
lysosomal acidification (Graves et al., 2008). This is likely due to the requirement for an 
anion flow parallel to V-ATPase to neutralize the lumenal positive membrane potential, 
allowing further V-ATPase activity (Carraro-Lacroix et al., 2009; Wagner et al., 2004).  
Whether ClC-7 plays a similar role in melanocytes depends on where and when CLC7 is 
expressed and the ion concentrations within the organelle it resides. Based on the coat 
color phenotype of Clcn7-/- mice, it is possible that ClC-7 may play a role in 
pheomelanogenesis and may coordinate this process with MFSD12. 
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Transient receptor potential cation channel, subfamily M, member 1 (TRPM1, 
a.k.a. melastatin) is a Ca2+ channel that localizes primarily to unidentified intracellular 
compartments (not melanosomes) and to the plasma membrane in melanocytes (Oancea 
et al., 2009; Xu et al., 2001). Increased TRPM1 mRNA in human melanocytes correlates 
with increased melanin content (Oancea et al., 2009), suggesting a role for TRPM1 in 
modulating some part of melanogenesis. However, more work needs to be done to 
determine the cellular localization of TRPM1 and the role of Ca2+ in melanin synthesis or 
stabilization. 
4.2.7. How to investigate VPS33A functions in the melanosomal pathway? 
Our data in Chapter 3 showed that immortalized melan-bf melanocytes were able 
to generate high levels of melanin despite bearing the VPS33A-D251E mutation. 
However, our investigation into VPS33A mechanisms was complicated by reports of 
differing phenotypes of melan-bf cells, difficulties recreating the phenotype in melan-Ink4a 
cells, and concerns that the melan-bf cells we received had acquired a different mutation 
that caused the hyperpigmentation phenotype that we observed. There are several 
possible explanations why these melan-bf cells have a different phenotype than the ones 
published (Suzuki et al., 2003). (1) The melan-bf cells that we received may have acquired 
new mutations in culture, in which case we can rederive new melan-bf cells from buff mice. 
(2) The hyperpigmentation phenotype may be due to a compensatory adaptation to the 
VPS33A-D251E mutation, in which case newly derived melan-bf cells will phenocopy the 
published melan-bf cells initially but will eventually develop our observed phenotype. (3) 
Buff mice may have a second mutation that causes the hyperpigmentation phenotype to 
develop over time and would look similar to possibility 2. It would be difficult to distinguish 
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between possibilities 2 and 3 using cells derived from buff mice; rather, we would have to 
express the VPS33A-D251E mutation in WT melan-Ink4a cells to investigate its effect on 
melanosome biogenesis.  Therefore, to distinguish between possibilities 1 and 2 and to 
avoid complications from possibility 3, we will optimize the human VPS33A (WT or D251E) 
stable expression/endogenous Vps33a knockdown model in melan-Ink4a to analyze the 
effects of VPS33A-D251E expression. As a control to validate this method, we will also 
knock down endogenous Vps33a in melan-Ink4a cells stably expressing human VPS33A-
G308E, which results in a sorting defect when the conserved residue is mutated in the 
yeast ortholog Vps33 (Baker et al., 2015). Based on the data published about this mutation 
in yeast, we hypothesize that the G308E mutation will cause defects in the endolysosomal 
pathway. To assess problems in the endolysosomal pathway, we will perform a dextran 
pulse-chase over a short time course to observe dextran co-localization with markers of 
early endosomes, late endosomes, and lysosomes. This will allow us to optimize and 
validate the conditions of this method. 
Published data show that melan-bf cells are hypopigmented with small 
melanosomes and able to be rescued by expression of WT VPS33A (Suzuki et al., 2003), 
indicating that VPS33A-D251E is causative for the hypopigmentation phenotype. 
Therefore, we expect that expression of VPS33A-D251E results in smaller melanosomes, 
and if enlarged melanosomes are due to a compensatory mechanism, they will arise later. 
This is not something we observed in our preliminary experiments using this method; 
however, brightfield microscopy might not be the optimal method to assess these cells 
due to the preexisting melanosomes in the cell. Therefore, we will perform EM of cells at 




Upon determining which time points yield relevant melanosome or endolysosomal 
phenotypes, we will then perform similar experiments to those done in Chapter 3, 
including: BFM and IFM to visualize pigment granules and the localization of melanosomal 
and lysosomal markers; EM to assess melanosome size and maturation; and a dextran 
pulse-chase time course experiment to characterize the endocytic pathway. Since 
VPS33A is involved in membrane fusion, the IFM experiments to assess the localization 
of TYR (vesicular pathway cargo), TYRP1 or OCA2 (tubulovesicular pathway cargo), and 
MART-1 or DCT (RAB6 pathway cargo)  will inform us if there are overt defects in any of 
the three trafficking pathways to melanosomes. If the results from this experiment suggest 
that the tubulovesicular pathway is altered, we can generate WT VPS33A and VPS33A-
D251E tagged with fluorescent proteins to visualize by live confocal microscopy whether 
these proteins associate with tubules or affect tubule number, length, or stability. As 
explained above, the dextran pulse-chase time course will allow us to assess the effects 
of the VPS33A-D251E mutation on the endolysosomal pathway. 
We will also express the HA-tagged WT and mutant VPS33A proteins in WT 
melan-Ink4a cells and immunoprecipitate associated proteins using an antibody to the HA 
epitope. We will blot for HOPS and CORVET subunits to determine whether VPS33A-
D251E alters complex formation. The tSNAREs that mediate fusion at the melanosomal 
membrane are unknown; however, we can assess whether WT VPS33A interacts with the 
melanosomal vSNARE VAMP7 and whether this is altered with VPS33A-D251E. 
 Overall, these experiments will determine whether VPS33A has a role in trafficking 
in the melanosomal pathway and whether the VPS33A-D251E mutation affects the 
melanosomal or endolysosomal trafficking pathway. 
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4.2.8. How to assess GPR143 pathway in melan-bf cells? 
In Chapter 3, we show that the melan-bf cells received from the Spritz lab have a 
phenotype strikingly similar to that of melanocytes from Oa1-/- mice. Melan-bf cells contain 
enlarged, mature melanosomes, and, in many of the cells, melanosomes were restricted 
to the cell periphery. We will first determine if there is a change in GPR143 and/or Gi3 
mRNA and protein levels in melan-bf cells relative to melan-Ink4a cells by qPCR and 
immunoblotting. If levels of these proteins are not altered, we will test if these components 
are functionally impaired in melan-bf cells by stably expressing WT GPR143 or its 
downstream signaling partner Gi3 and visualizing cells by BFM to determine whether 
cells are rescued. Data in Oa1-/- melanocytes show that transient expression of WT 
GPR143 is sufficient to rescue the peripheral melanosome phenotype by 24 hours but 
stable expression of the protein is required for rescue of melanosome size (Palmisano et 
al., 2008). If neither WT GPR143 nor Gi3 rescue the phenotype, it is possible that 
downstream mediators of the GPR143 pathway, which have not been described, are 
mutated in melan-bf cells. One downstream effect of GPR143 overexpression is increased 
MITF mRNA and protein expression (Chen et al., 2016). Therefore, to determine if this 
pathway is functional, we will assess MITF levels in cells with and without expression of 
WT GPR143 or Gi3. We predict that overexpression of either GPR143 or Gi3 would 
increase MITF mRNA levels if the downstream signaling pathway is intact but that there 
would be no change in MITF if the downstream pathway is mutated. As a control, we will 
repeat this experiment in melan-Ink4a cells. If the downstream signaling pathway is 
functional in melan-bf cells, then we expect that overexpression of GPR143 or Gi3 would 
be able to rescue our observed phenotype if either GPR143 or Gi3 are mutated. However, 
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if the downstream pathway is mutated, we would expect that overexpression of GPR143 
or Gi3 would not be sufficient to rescue the phenotypes in melan-bf cells and we would 
not be able to perform a rescue experiment without a knowledge of the proteins involved 
downstream of GPR143. Overall, these experiments will determine if the GPR143 
pathway is functional in melan-bf cells and whether expression of WT GPR143 or Gi3 
can rescue the hyperpigmentation and localization phenotypes we observe in melan-bf 
cells. 
4.3. Concluding remarks 
Over 230 mouse models with pigmentation phenotypes exist; yet only a fraction of 
the genes that are mutated in those mouse models have a defined role in melanogenesis. 
Here, we investigate two mouse models of albinism – the OCA4 mouse model underwhite, 
which has a mutation in Slc45a2, and the HPS model buff, which has a mutation in 
Vps33a. We identify a direct role for SLC45A2 in the pH regulation of melanosomes and 
characterize the phenotype of melan-bf cells.  
Our study of SLC45A2 shows that it is important not only to study ion transport 
channels that modulate melanogenesis but also to study them in the context of other ion 
transport channels to determine how multiple proteins coordinate melanosome pH at 
different stages of maturation. It will be of interest to determine to what stage 
melanosomes TPC2 localizes and how ion transport proteins on other organelles regulate 
melanogenesis. Additionally, given the excitement over the emerging field of studying 
inter-organelle contacts, we are interested to identify whether ion transport channels on 
lysosomes, TGN, or mitochondria are part of contact sites between their resident 
organelles and melanosomes, and whether ion transport proteins mediate their effects 
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through regulation of inter-organelle communication. Alternatively, ion transport proteins 
on non-melanosomal organelles may indirectly regulate melanogenesis through 
modulation of signaling cascades. It will be exciting to discover more about the crosstalk 
between signaling pathways and between organelles within pigmented cells to learn about 
how these cells regulate melanogenesis.  
The role of VPS33A in melanogenesis has been more elusive due to its critical role 
in the endolysosomal pathway. However, our studies show that despite the VPS33A-
D251E mutation, melanocytes can become pigmented. Whether this is due to 
compensatory effects or additional mutations is unclear, but we believe this mutation 
warrants further careful study.  
Overall, our studies highlight the importance of studying mouse models of albinism 
as a way to determine the cellular basis of pigmentation. Additionally, studying gene 
variants associated with pigmentation differences identified by GWAS provides insight into 
whether the proteins encoded by these genes are functional and how variants affect 
melanogenesis. In addition to having a better understanding about the regional differences 
in pigmentation in modern-day humans, identifying functional variants provides insight into 











Appendix A: VPS33A 
 
 
Appendix Figure 1: Decreased expression of melanosomal genes and Vps33a in melan-bf 
cells. (a) RNA from melan-Ink4a and melan-bf cells was reverse transcribed and assessed by 
qPCR to quantify relative expression of Vps33a and the melanosomal genes Pmel, Tyrp1, and Tyr. 
Data were normalized to the housekeeping gene Tubb4b and are shown as fold change relative to 
















Appendix Figure 2: Low levels of LAMP2 colocalize to pigment granules. Melan-bf cells were 
fixed, immunolabeled for TYRP1 or LAMP2 (magenta), and analyzed by dIFM and bright field (BF) 
microscopy to visualize pigment granules (pseudocolored green in merged images). Images on the 
right have were adjusted in Adobe Photoshop to increase brightness so that low levels of LAMP2 
could be seen. Insets of boxed regions are magnified 7.5 times. Scale bar, 10 µm. LAMP2 (yellow 






Appendix Figure 3: Overexpression of human VPS33A and knockdown of endogenous 
Vps33a does not phenocopy melan-bf cells at 14 days post-selection. (a, b) Melan-Ink4a cells 
stably expressing human WT VPS33A were infected with lentivirus expressing non-target shRNA 
or shRNAs against Vps33a and were analyzed by qRT-PCR for mRNA levels of mouse Vps33a (a) 
or human VPS33A (b) 14 days post-selection. Ct values of target genes were normalized to the Ct 
values of the housekeeping gene tubulin to determine relative expression levels. Data are from n=1 
experiment. (c) The average pigment granule size per cell in µm was quantified and is depicted as 
mean ± SEM with each dot representing the average pigment granule size in one cell. 
Quantification is from n=1 experiment, except for melan-Ink4a and melan-bf which are from n=2 
experiments and are the same data and statistical analyses as graphed in Figure 3.7d. 
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Appendix Figure 4: Overexpression of human WT VPS33A or variants does not phenocopy 
melan-bf cells. (a-f) Melan-Ink4a cells (a), melan-bf cells (b), or melan-Ink4a cells stably 
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expressing HA-tagged human WT or variant VPS33A (c-f) were fixed, stained with an antibody to 
TYRP1, and analyzed by BFM (left) and IFM (right). Images are representative of n=1 experiment.  
 
Appendix B: MELOPS 
To measure melanosomal pH using MELOPS, we subcloned MELOPS into a 
retroviral vector, generated retrovirus, and infected melan-Ink4a cells and melan-uw cells 
as a pilot experiment to test the construct. We were concerned that the presence of 
melanin in melan-Ink4a cells might decrease fluorescence intensity independent of pH by 
masking or quenching the fluorophore; therefore, we treated both melan-Ink4a and melan-
uw cells with phenylthiourea, which inhibits TYR function by binding to copper ions at its 
active site (Chang, 2009), until cells were depigmented. We validated MELOPS 
localization to TYRP1-GFP-positive melanosomes by live confocal microscopy (Appendix 
Figure 5). We measured fluorescence intensity by flow cytometry and generated a 
standard curve by incubating cells in buffers at pH 5, 6, 7, and 8 with the ionophores 
nigericin and monensin (Appendix Figure 6a in PTU-treated melan-Ink4a cells; note that 
incubation in pH 5 buffer resulted in cell death). However, the fluorescence intensity of 
melan-Ink4a cells (not treated with ionophores) was lower than expected at ~ pH 5.5 – 5.8 
(Appendix Figure 6b, c). This estimated pH is consistent with the reported pH of MNT-1 
cells, a melanoma line, measured by MELOPS (Ambrosio et al., 2016), but both are low 
considering that melan-Ink4a and MNT-1 cells are well pigmented and thus should contain 
melansoomes closer to near-neutral pH. Additionally, we observed that the fluorescence 
intensity from untreated melan-uw cells was much higher than that of melan-Ink4a cells 
(Appendix Figure 6b, d), which contradicts our model of SLC45A2 function and the pH 
requirement for melanin synthesis. Together, those data suggest that MELOPS 
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fluorescence may be influenced by something other than pH in the melanosomal lumen 
(considering that the standard curves generated in the presence of ionophore are 
reasonable but that measurements of untreated cells yield unexpected results), so it may 
not be an optimal fluorophore for melanosome pH measurements.  
 
 
Appendix Figure 5: MELOPS localizes to TYRP1-containing melanosomes. Melan-Ink4a cells 
were infected with retroviruses to express MELOPS and TYRP1-GFP. 2 days post-infection, cells 
were imaged by live confocal microscopy in pH 8 buffer with ionophores. Arrows, examples of 




Appendix Figure 6: MELOPS indicates a low melanosome pH. Melan-Ink4a (a-c) or melan-uw 
(d) cells were pre-treated for over two months with 300 µM PTU and were uninfected or infected 
with retrovirus encoding MELOPS. Cells were analyzed 2 days later by flow cytometry. MELOPS 
fluorescence intensity from live cells (gated using forward and side scatter) is shown by histogram. 
(a, c) To define a pH standard curve for MELOPS fluorescence, cells were collected, washed with 
PBS, and resuspended in isotonic buffers at pH 6, 7, and 8. Nigericin and monensin (10 µM each) 
were added to each sample at room temperature, and samples were analyzed 5 min later. 
Geometric means of intensity are shown in panel e. (b, d) Live cells not expressing (- Control) or 
expressing MELOPS (+ MELOPS live) were analyzed directly in medium with no ionophores. For 
melan-Ink4a, geometric means of intensity are shown in panel e relative to pH controls. The 
calculated pH of melan-Ink4a melanosomes was ~ 5.8.  
 
To validate our data from melanocytes, we repeated the experiment in HeLa cells, 
were we have shown that ectopically expressed OCA2 or SLC45A2 localizes to lysosomes 
and increases lysosomal pH. HeLa cells were transfected with LAMP1-GFP alone, 
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MELOPS alone, or LAMP1-GFP and MELOPS with or without HA-SLC45A2 or HA-OCA2, 
and then analyzed – with or without treatment with ionophores and defined pH buffers – 
by flow cytometry for GFP and for mNectarine in MELOPS. Using cells expressing GFP-
LAMP1 + MELOPS and treated with ionophores at varying pH, we were able to obtain a 
standard curve for MELOPS for pH 6 – 8 (Appendix Figure 7; Appendix Figure 7a shows 
the gates used to define LAMP1-GFP+ cells and Appendix Figure 7b shows the 
corresponding MELOPS signal in these cells).  
 
Appendix Figure 7: pH curve in LAMP1-GFP/MELOPS-expressing HeLa cells. HeLa cells were 
transfected with MELOPS and LAMP1-GFP and analyzed by flow cytometry 2 days later. For the 
pH standard, cells were collected, washed with PBS,a nd resuspended in buffers at pH 6, 7, and 
8. Nigericin and monensin (10 µM each) were added to each sample for 5 min at room temperature 
before analysis. (a) 2D plot of LAMP1-GFP vs MELOPS signal for live cells gated using forward 
and side scatter. (b) Histogram of MELOPS fluorescence of the GFP+ gate (shown in a) and 




 We then generated a histogram of the MELOPS fluorescence intensity of LAMP1-
GFP+ of HeLa cells expressing LAMP1-GFP and MELOPS; LAMP1-GFP, MELOPS, and 
HA-OCA2; and LAMP1-GFP, MELOPS, and HA-SLC45A2 (Appendix Figure 8a). We 
observed two populations of MELOPS-expressing cells (Appendix Figure 8a, b) and 
excluded the population of with higher MELOPS expression from our analyses because 
we reasoned that these cells likely overexpressed MELOPS, resulting in cell surface 
expression due to competition for sorting machinery (Marks et al., 1996). From this 
histogram, we see that HeLa cells with MELOPS alone have the highest fluorescence 
intensity and the peaks gradually shift left with expression of HA-OCA2 and HA-SLC45A2 
(Appendix Figure 8c), correlating with decreased pH in the MELOPS+ compartments of 
these cells and contradicting work from our lab and others that show that OCA2 (Bellono 
et al., 2014) or SLC45A2 can increase pH. Therefore, we show that, although MELOPS 
responds predictably to ionophore treatment and buffers of increasing pH, the mNectarine 











Appendix Figure 8: MELOPS measurements of HA-OCA2 and HA-SLC45A2 effects on late-
endosomal/lysosomal pH in HeLa cells. HeLa cells were co-transfected with LAMP1-GFP and 
MELOPS with either an empty vector, HA-OCA2, or HA-SLC45A2, and analyzed by flow cytometry 
2 days post-transfection. (a) 2D plot comparing LAMP1-GFP and MELOPS expression in live cells 
gated on forward and side scatter. LAMP1-GFP+ and LAMP1-GFP- gates are indicated for 
histogram analyses in b. Also shown is the gate used to exclude the population of exceedingly high 
MELOPS expressers. (b, c) Histogram analyses of total LAMP1-GFP+ population (b) or Low/Mid 
MELOPS+ population (c). (d) Geometric means of pH standards (from Figure 4.5) and experimental 
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